
<html lang="en"     class="pb-page"  data-request-id="09ae0a57-54a4-4f3b-89bd-3e206e152652"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-15;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c00446"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Generation of Leads for γ-Secretase Modulation" /></meta><meta name="dc.Creator" content="Mihirbaran  Mandal" /></meta><meta name="dc.Creator" content="Alexei  Buevich" /></meta><meta name="dc.Creator" content="John P.  Caldwell" /></meta><meta name="dc.Creator" content="Lynn  Hyde" /></meta><meta name="dc.Creator" content="Xianhai  Huang" /></meta><meta name="dc.Creator" content="Xiaoxiang  Liu" /></meta><meta name="dc.Creator" content="Brian  McKittrick" /></meta><meta name="dc.Creator" content="Robert D.  Mazzola" /></meta><meta name="dc.Creator" content="Dmitri  Pissarnitski" /></meta><meta name="dc.Creator" content="Anandan  Palani" /></meta><meta name="dc.Creator" content="Lili  Zhang" /></meta><meta name="dc.Creator" content="Eric  Parker" /></meta><meta name="dc.Creator" content="Li  Xiao" /></meta><meta name="dc.Creator" content="Diane  Rindgen" /></meta><meta name="dc.Creator" content="Zhaoning  Zhu" /></meta><meta name="dc.Description" content="Herein, we disclose three structurally differentiated γ-secretase modulators (GSMs) based on an oxadiazine scaffold. The analogues from series I potently inhibit the generation of Aβ42 in vitro whe..." /></meta><meta name="Description" content="Herein, we disclose three structurally differentiated γ-secretase modulators (GSMs) based on an oxadiazine scaffold. The analogues from series I potently inhibit the generation of Aβ42 in vitro whe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 27, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00446" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00446" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00446" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00446" /></link>
        
    
    

<title>Generation of Leads for γ-Secretase Modulation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00446" /></meta><meta property="og:title" content="Generation of Leads for γ-Secretase Modulation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0018.jpeg" /></meta><meta property="og:description" content="Herein, we disclose three structurally differentiated γ-secretase modulators (GSMs) based on an oxadiazine scaffold. The analogues from series I potently inhibit the generation of Aβ42 in vitro when the substituents at 3 and 4 positions of the oxadiazine moiety adopt an α orientation (cf. 11). To address the concern around potential reactivity of the exocyclic double bond present in series I toward nucleophilic attack, compounds containing either an endocyclic double bond, such as 20 (series II), or devoid of an olefinic moiety, such as 27 (series III), were designed and validated as novel GSMs. Compound 11 and azepine 20 exhibit robust lowering of CSF Aβ42 in rats treated with a 30 mg/kg oral dose." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00446"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00446">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00446&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00446&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00446&amp;href=/doi/10.1021/acs.jmedchem.0c00446" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 8216-8230</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00426" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b02119" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Generation of Leads for γ-Secretase Modulation</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Mihirbaran Mandal</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mihirbaran Mandal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#44292d2c2d36262536252a6a29252a20252804292136272f6a272b29"><span class="__cf_email__" data-cfemail="cea3a7a6a7bcacafbcafa0e0a3afa0aaafa28ea3abbcada5e0ada1a3">[email protected]</span></a>. Phone: +1 908-740-2369.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mihirbaran++Mandal">Mihirbaran Mandal</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7870-7271" title="Orcid link">http://orcid.org/0000-0002-7870-7271</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexei Buevich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexei Buevich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of NMR Structure Elucidation, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexei++Buevich">Alexei Buevich</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5968-9151" title="Orcid link">http://orcid.org/0000-0002-5968-9151</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John P. Caldwell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John P. Caldwell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+P.++Caldwell">John P. Caldwell</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lynn Hyde</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lynn Hyde</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lynn++Hyde">Lynn Hyde</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xianhai Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xianhai Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xianhai++Huang">Xianhai Huang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0757-2047" title="Orcid link">http://orcid.org/0000-0003-0757-2047</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaoxiang Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaoxiang Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoxiang++Liu">Xiaoxiang Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Brian McKittrick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian McKittrick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian++McKittrick">Brian McKittrick</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert D. Mazzola</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert D. Mazzola</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+D.++Mazzola">Robert D. Mazzola</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dmitri Pissarnitski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dmitri Pissarnitski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dmitri++Pissarnitski">Dmitri Pissarnitski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anandan Palani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anandan Palani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anandan++Palani">Anandan Palani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lili Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lili Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lili++Zhang">Lili Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric Parker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric Parker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Parker">Eric Parker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Li Xiao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Li Xiao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Modeling and Informatics, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Li++Xiao">Li Xiao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Diane Rindgen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diane Rindgen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diane++Rindgen">Diane Rindgen</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Zhaoning Zhu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhaoning Zhu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhaoning++Zhu">Zhaoning Zhu</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00446&amp;href=/doi/10.1021%2Facs.jmedchem.0c00446" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 8216–8230</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 27, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 March 2020</li><li><span class="item_label"><b>Published</b> online</span>27 July 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00446</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8216%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMihirbaran%2BMandal%252C%2BAlexei%2BBuevich%252C%2BJohn%2BP.%2BCaldwell%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D15%26contentID%3Dacs.jmedchem.0c00446%26title%3DGeneration%2Bof%2BLeads%2Bfor%2B%25CE%25B3-Secretase%2BModulation%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8230%26publicationDate%3DAugust%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00446"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">944</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00446" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Generation of Leads for γ-Secretase Modulation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mihirbaran&quot;,&quot;last_name&quot;:&quot;Mandal&quot;},{&quot;first_name&quot;:&quot;Alexei&quot;,&quot;last_name&quot;:&quot;Buevich&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;P. Caldwell&quot;},{&quot;first_name&quot;:&quot;Lynn&quot;,&quot;last_name&quot;:&quot;Hyde&quot;},{&quot;first_name&quot;:&quot;Xianhai&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Xiaoxiang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;McKittrick&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;D. Mazzola&quot;},{&quot;first_name&quot;:&quot;Dmitri&quot;,&quot;last_name&quot;:&quot;Pissarnitski&quot;},{&quot;first_name&quot;:&quot;Anandan&quot;,&quot;last_name&quot;:&quot;Palani&quot;},{&quot;first_name&quot;:&quot;Lili&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Parker&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Diane&quot;,&quot;last_name&quot;:&quot;Rindgen&quot;},{&quot;first_name&quot;:&quot;Zhaoning&quot;,&quot;last_name&quot;:&quot;Zhu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;8216-8230&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00446&quot;},&quot;abstract&quot;:&quot;Herein, we disclose three structurally differentiated γ-secretase modulators (GSMs) based on an oxadiazine scaffold. The analogues from series I potently inhibit the generation of Aβ42 in vitro when the substituents at 3 and 4 positions of the oxadiazine moiety adopt an α orientation (cf. 11). To address the concern around potential reactivity of the exocyclic double bond present in series I toward nucleophilic attack, compounds containing either an endocyclic double bond, such as 20 (series II), or devoid of an olefinic moiety, such as 27 (series III), were designed and validated as novel GSMs. Compound 11 and azepine 20 exhibit robust lowering of CSF Aβ42 in rats treated with a 30 mg/kg oral dose.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00446&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00446" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00446&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00446" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00446&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00446" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00446&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00446&amp;href=/doi/10.1021/acs.jmedchem.0c00446" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00446" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00446" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00446%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DMandal%26date%3D2020%26atitle%3DGeneration%2Bof%2BLeads%2Bfor%2B%25CE%25B3-Secretase%2BModulation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D15%26spage%3D8216%26epage%3D8230%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/jmcmar.2020.63.issue-15/20200813/jmcmar.2020.63.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Herein, we disclose three structurally differentiated γ-secretase modulators (GSMs) based on an oxadiazine scaffold. The analogues from series I potently inhibit the generation of Aβ<sub>42</sub> in vitro when the substituents at 3 and 4 positions of the oxadiazine moiety adopt an α orientation (cf. <b>11</b>). To address the concern around potential reactivity of the exocyclic double bond present in series I toward nucleophilic attack, compounds containing either an endocyclic double bond, such as <b>20</b> (series II), or devoid of an olefinic moiety, such as <b>27</b> (series III), were designed and validated as novel GSMs. Compound <b>11</b> and azepine <b>20</b> exhibit robust lowering of CSF Aβ<sub>42</sub> in rats treated with a 30 mg/kg oral dose.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Despite enormous efforts both in industry and in academia, a disease-modifying therapeutic for Alzheimer’s disease (AD) has not yet been approved.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Current therapies for AD, which are only palliative, include four acetylcholine esterase inhibitors such as donepezil, rivastigmine, tacrine, and galantamine and one <i>N</i>-methyl <span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) antagonist, memantine.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Thus, the development of agents that will halt or reverse the disease progression still represents an important unmet medical need. Toward this overall goal, testing the amyloid hypothesis by inhibiting the beta-site APP-cleaving enzyme (BACE) and γ-secretase was recognized as a promising strategy.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Concurrent with the efforts to discover novel BACE1<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and γ-secretase inhibitors (GSIs),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> designing novel γ-secretase modulators (GSMs) to lower the formation of highly amyloidogenic Aβ<sub>42</sub> with concomitant increase in the formation of Aβ<sub>37</sub> from APP processing while sparing nonamyloid substrates was undertaken.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Our initial efforts resulted in the discovery of two novel chemotypes represented by oxadiazoline <b>3</b> and oxadiazine <b>4</b> inspired by the classes of compounds represented as <b>1</b><a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and <b>2</b>.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Representative analogues from these series demonstrated robust lowering of CSF Aβ<sub>42</sub> after oral dosing.<a onclick="showRef(event, 'cit7h'); return false;" href="javascript:void(0);" class="ref cit7h">(7h)</a> Subsequently, analogue <b>5</b><a onclick="showRef(event, 'cit7d'); return false;" href="javascript:void(0);" class="ref cit7d">(7d)</a> generated by ring expansion from <b>4</b> and the analogue <b>6</b><a onclick="showRef(event, 'cit7i'); return false;" href="javascript:void(0);" class="ref cit7i">(7i)</a> with substitution at 3 position of oxadiazine were also validated as GSMs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the first non-NSAID GSMs <b>1</b>, <b>2</b> and the discovery of oxadiazoline <b>3</b>, oxadiazine <b>4</b>, <b>5</b>, and <b>6</b>, and in parenthesis Aβ<sub>42</sub> IC<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In our further efforts to identify structurally different leads using the oxadiazine scaffold, several strategies were undertaken: (1) developing structure–activity relationship (SAR) at the C-3 position of an oxadiazine moiety of <b>4</b> while incorporating smaller groups at the 4 position (C-4) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, Strategy I); (2) reconfiguration of the exocyclic double bond into the more hindered β, β-disubstituted endocyclic olefin (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, Strategy II); and (3) removal of the olefinic bond without incorporation of an additional aromatic ring (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, Strategy III). This article describes the guiding principles for each of these strategies, the synthesis, and evaluation of the resulting molecules as GSMs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Strategy I: SAR at the 3 Position (C-3) of the Oxadiazine Moiety of 4 while Incorporating Smaller Groups at the 4 Position (C-4)</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5"> Design Considerations</h4><div class="NLM_p">Analysis of reported GSMs revealed a novel chemical series exemplified by analogue <b>7</b> with an IC<sub>50</sub> of 87 nM for the inhibition of Aβ<sub>42</sub> in vitro (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Structural alignment of compound <b>7</b> with <b>4</b> suggested that the aryl moiety from the C-2 position of the imidazole <b>7</b> projected into a distinct binding pocket previously unexplored using the 4-substituted oxadiazine scaffold (cf. <b>4</b>). Although direct follow up of this finding by adding the second aryl at the C-3 position of the oxadiazine moiety of <b>4</b> was a potential approach, we recognized that this strategy would generate analogues with poor physicochemical properties.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Rationale for designing disubstituted oxadiazines. (a) Structure of <b>4</b> and <b>7</b> and conceptualization of 3,4-disubstituted oxadiazine <b>8</b>. Compounds <b>9</b> and <b>10</b> are the diastereomeric pairs differing in orientation of the substitution at their 3 position; (b) overlay of <b>9ea</b> (yellow) and <b>7</b> (magenta) with unsubstituted phenyl at its 2 position; (c) conformational analysis by density functional theory (DFT) at the B3LYP/6-31+G(d,p) level of theory. <b>9ea</b> (R<sup>1</sup> = equatorial Ph, R<sup>2</sup> = axial Me), <b>9ae</b> (R<sup>1</sup> = axial Ph, R<sup>2</sup> = equatorial Me), <b>10ee</b> (R<sup>1</sup> = equatorial Ph, R<sup>2</sup> = equatorial Me), and <b>10aa</b> (R<sup>1</sup> = axial Ph, R<sup>2</sup> = axial Me).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Thus, the computational study was initiated with C-3 aryl and smaller alkyl groups at C-4 (cf. <b>8</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). Relative to our earlier SAR studies at C-3 with no substitution at C-4, where the Aβ<sub>42</sub> IC<sub>50</sub> was independent of the stereochemistry at C-3, the disubstitution both at C-3 and C-4 would provide the opportunity to probe the effect of conformational restriction. Additionally, we wanted to explore the effect of substitution at C-4 in the context of C-3 only substituted oxadiazine (cf. <b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a) reported earlier.<a onclick="showRef(event, 'cit7i'); return false;" href="javascript:void(0);" class="ref cit7i">(7i)</a></div><div class="NLM_p last">Based on the conformational analysis by DFT at the B3LYP/6-31+G(d,p) level of theory, we prioritized the synthesis of diastereomer <b>9</b> over <b>10</b>. Conformer <b>9ae</b> (C-3 pseudo-axial and C-4 pseudo-equatorial orientation) of diastereomer <b>9</b> was stabilized by 4.3 kcal/mmol relative to its conformer <b>9ea</b> (C-3 pseudo-equatorial and C-4 pseudo-axial orientation) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c). Additionally, conformer <b>9ae</b> adopted the desired binding mode with its C-3 aryl projecting into the unexplored binding pocket occupied by the C-2 aryl group of <b>7</b>, while positioning the C-4 alkyl substituent in the binding pocket previously explored using C-4-aryl oxadiazine (cf. 3,4,5-trifluorophenyl in <b>4</b>) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). By comparison, diastereomer <b>10</b> is conformationally more flexible, and the substituents at C-3 and C-4 position of these conformers either did not project into the targeted binding pockets concurrently (<b>10aa</b>) or only with significant distortion of the oxadiazine moiety (<b>10ee</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00446/suppl_file/jm0c00446_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S1).</div></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> In Vitro Characterization</h4><div class="NLM_p last">Consistent with the conformational analysis, analogue <b>11</b> with C-3 3,5-difluorophenyl and C-4 methyl exhibited Aβ<sub>42</sub> IC<sub>50</sub> of 52 nM, while the conformationally flexible analogue <b>12</b> (obtained as the undesired isomer during synthesis) was significantly less potent (Aβ<sub>42</sub> IC<sub>50</sub> of 9289 nM). Increasing bulk at C4 (analogue <b>13</b>), addition of a fluorine into the difluorophenyl at C-3 (analogue <b>14</b>), and replacement of the methyl with a polar hydroxyl methyl moiety (analogue <b>15</b>) were tolerated. Compounds <b>11</b> and <b>14</b> were selected for further profiling based on their potencies, permeabilities, and lack of major off-target liabilities (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Furthermore, the ability of <b>11</b> and <b>14</b> to lower Aβ<sub>42</sub> in plasma and CSF was assessed using in vivo studies.</div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Strategy II—Reconfiguration of the Exocyclic Double Bond into the More Hindered β, β Disubstituted Endocyclic Olefin</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Analysis of Previous SAR</h4><div class="NLM_p">Along with the aforementioned efforts to introduce structural diversity, we undertook several strategies<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> to mitigate the concern related to the exocyclic double bond toward nucleophilic attack that was present in our previous GSMs. We generated multiple scaffolds following a cyclization strategy where heterocycles were installed by tethering the distal methylene of the exocyclic double bond and the amide carbonyl as exemplified by compounds <b>16</b> and <b>17</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'cit11a cit11b'); return false;" href="javascript:void(0);" class="ref cit11a cit11b">(11a,b)</a> Although successful in masking the double bond with minimal loss of in vitro potency, this strategy introduced an additional aromatic ring into the scaffold. In addition, none of these analogues exhibited statistically significant CSF Aβ<sub>42</sub> reduction in vivo at 30 mg/kg oral dose except for <b>17</b>, which demonstrated only modest CSF Aβ<sub>42</sub> lowering at 30 mg/kg with 45% reduction because of poor PK and lack of adequate brain exposure. In another approach,<a onclick="showRef(event, 'cit11c'); return false;" href="javascript:void(0);" class="ref cit11c">(11c)</a> the exocyclic methylene was replaced by an “NH” (cf. <b>18</b>) to create an intramolecular hydrogen bond with the adjacent amide carbonyl to mimic the five-membered heterocycles present in <b>16</b> and <b>17</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Previous strategies to mask the exocyclic double bond.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although this approach was effective in maintaining the in vitro potency without incorporating an additional aromatic ring, it introduced unsaturation in the piperidinone moiety, and analogues from this series generally lacked robust in vivo efficacy. For example, analogue <b>18</b> with in vitro potency of 40 nM lowered CSF Aβ<sub>42</sub> by 40% at 100 mg/kg oral dose in rodents.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Design Considerations</h4><div class="NLM_p">Therefore, in subsequent efforts, we focused on designing scaffolds without the introduction of additional aromatic rings or unsaturation while mitigating the concern around the exocyclic double bond. Detailed SAR analysis of close analogues of compound <b>2</b> from the literature<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> led to the identification of the acyclic analogue <b>19</b> with Aβ<sub>42</sub> IC<sub>50</sub> of 462 nM (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Because it is well-known that the conformers with global minimum energy or even local minimum energy from the potential energy surface often are not the bioactive conformers,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> we wanted to probe the effect of constraining the cisoid conformer of <b>19</b> (cf. <b>19c</b>) by linking the amide NH with the methylene distal to amide (bottom red double-headed arrow on <b>19c</b>) on the in vitro potency. This arrangement forms a sterically encumbered endocyclic β, β-disubstituted double bond with reduced susceptibility for nucleophilic addition.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Although such a strategy could be perceived as high risk because of the presence of transoid conformation among all the previously reported GSMs, it was inspired by the serendipitous discovery of <b>23</b> with an IC<sub>50</sub> of 512 nM during our SAR studies in the oxadiazoline series (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Among several approaches to constrain the cisoid conformation <b>19c</b>, azepines <b>20</b> and <b>21</b> were prepared.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Conformational analysis and building hypothesis for the synthesis of <b>20</b> and <b>21</b>. The calculated energy difference between <b>19t</b> and <b>19c</b> is ∼2.3 kcal/mmol (energy calculations were done at the B3LYP/6-31+g(d,p) level of theory).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> In Vitro Characterization</h4><div class="NLM_p last">Azepines <b>20</b> and <b>21</b> displayed cell Aβ<sub>42</sub> IC<sub>50s</sub> of 107 and 143 nM, respectively, while maintaining a good modulator profile, as shown by selectivity versus Aβ<sub>total</sub> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). These analogues were highly permeable and exhibited reduced binding to the hERG K<sup>+</sup> channel relative to analogue <b>2</b> (IC<sub>50</sub> = 990 nM) in a radiolabeled MK-499 binding<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> assay and possessed no major off-target liability (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). These compounds were selected for characterization in a rat pharmacodynamic model to assess their ability to reduce CSF Aβ<sub>42</sub> in vivo.</div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Strategy III: Removal of the Olefinic Bond without Incorporation of Additional Aromaticity</h3><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Design Considerations and Validation as GSMs</h4><div class="NLM_p">Our third strategy to mitigate the concern around the reactivity of the exocyclic double bond began with careful consideration of the structural features of <b>2</b> and <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). This analysis revealed that the lone pair on the oxygen (represented as red) of the amide carbonyl of <b>2</b> projected toward the fluorobenzyl moiety was not necessary to maintain potency as it was encapsulated by the formation of the oxadiazine ring (<b>2</b> → <b>4</b>). The importance of the other lone pair (represented as blue) oriented toward the exocyclic double bond was unknown. Generation of analogue <b>24</b><a onclick="showRef(event, 'cit11a'); return false;" href="javascript:void(0);" class="ref cit11a">(11a)</a> with IC<sub>50</sub> of 116 nM (racemic) eliminating the nitrogen lone pair oriented toward the exocyclic double bond via the formation of the five-membered heterocycles underscored its lack of importance for binding affinity (comparison of IC<sub>50</sub>s between <b>24</b> and <b>25</b>). This SAR suggests that the amide carbonyl lone pairs of <b>2</b> or the of N-1 nitrogen lone pair of triazole <b>24</b> may not be playing a significant role on the binding affinity via hydrogen bonding or ionic interactions. Recent reports by Pettersson et al. from Pfizer,<a onclick="showRef(event, 'cit7g'); return false;" href="javascript:void(0);" class="ref cit7g">(7g)</a> where the exocyclic double bond was replaced by the isosteric amide, further suggested that the amide carbonyl lone pair of <b>2</b> was either not important or the distance between the H-bond acceptor and the methoxyaryl-imidazole right-hand side was flexible.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Analysis on the importance of the lone pairs of the amide carbonyl of <b>2</b> for potency and building hypothesis for the synthesis <b>26</b> and <b>27</b> via deconstruction of <b>24</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To probe this hypothesis, prototype compound <b>26</b> with an IC<sub>50</sub> of 1554 nM (racemic) was generated by replacing the triazole in <b>24</b> with an amide moiety. Importantly, <b>26</b> lacked the lone pairs that were initially present at the N1 position in <b>24</b>. Furthermore, replacement of the amide of <b>26</b> by an oxadiazine along with the introduction of conformational constraint provided analogue <b>27</b> with an IC<sub>50</sub> of 400 nM (racemic). The increased sp<sup>3</sup> character and reduced aromatic ring count relative to <b>24</b> together with the lack of the exocyclic double bond, compound <b>27</b> represented a promising novel chemotype for GSMs. Further improvement in potency may be necessary before in vivo characterization of this series. Moreover, independently, a recent report revealed that enhancement of potency was feasible via SAR studies related to the chemotype exemplified by compound <b>27</b>. For example, analogue <b>28</b> exhibits improved potency and in vivo efficacy.<a onclick="showRef(event, 'cit7a'); return false;" href="javascript:void(0);" class="ref cit7a">(7a)</a></div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> In Vivo Characterization</h4><div class="NLM_p">Concurrent with our efforts to identify novel structural motifs described above, analogues <b>11</b> and <b>14</b> from the disubstituted oxadiazine series (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and azepines <b>20</b> and <b>21</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) were evaluated to measure their ability to lower CSF Aβ<sub>42</sub> in vivo at a 30 mg/kg oral dose after 3 h drug administration using male CD rats (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Analogues <b>11</b> and <b>14</b> exhibited robust CSF Aβ<sub>42</sub> lowering (73 and 80%, respectively) at 3 h post dose. Azepine <b>20</b> showed 52% lowering of CSF Aβ<sub>42</sub> while no significant reduction was observed with azepine <b>21</b>. In a dose response study, compound <b>11</b> showed a dose-dependent effect on Aβ<sub>42</sub> lowering from 3 to 30 mg/kg oral dose while no significant reduction was observed with 1 mg/kg dose relative to control levels (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a). Approximated free drug concentration in the brain at 3 h post dose calculated using the plasma-free fraction showed that the concentrations of <b>11</b> are within 2–3-fold relative to its cellular IC<sub>50</sub> for 30 and 10 mg/kg oral dose (37 and 21 nM for 30 and 10 mg/kg dose, respectively). However, the free drug concentration of <b>11</b> is much lower at 3 mg/kg dose (4 nM).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Dose-dependent reduction of Aβ<sub>42</sub> by compound <b>11</b> in male CD rats. The value of CSF Aβ<sub>42</sub> is the geometric mean of 29 (for 3 and 10 mg/kg dosing group) and 10 animals (30 mg/kg dosing group), respectively, and the value of <i>C</i><sub>P</sub> and <i>C</i><sub>B</sub> is the geometric mean of 10 (3 mg/kg dosing group), 15 (10 mg/kg dosing group), and 5 (30 mg/kg dosing group) animals. (b) Measured total concentration of <b>11</b> in plasma (<i>C</i><sub>P</sub>) and brain (<i>C</i><sub>B</sub>) of rats at doses ranging from 3 to 30 mg/kg. All animal procedures were performed according to the protocol reviewed and approved by the institutional Animal Care and Use Committee of Merck & Co., Inc., Kenilworth, NJ, USA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. GSM Profile of 3,4-Disubstituted Oxadiazine</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0017.gif" alt="" id="GRAPHIC-d7e1145-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cpd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup> (orientation)</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup> (orientation)</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM) Aβ<sub>42</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM) Aβ<sub>total</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> Aβ<sub>total</sub>/IC<sub>50</sub> Aβ<sub>42</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">3,5-difluorophenyl (α)</td><td class="colsep0 rowsep0" align="left">Me (α)</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">248</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">3,5-difluorophenyl (β)</td><td class="colsep0 rowsep0" align="left">Me (α)</td><td class="colsep0 rowsep0" align="char" char=".">9289</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">3,5-difluorophenyl (α)</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr (α)</td><td class="colsep0 rowsep0" align="char" char=".">113</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">174</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3,4,5-difluorophenyl (α)</td><td class="colsep0 rowsep0" align="left">Me (α)</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>367</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">3,4,5-difluorophenyl (α)</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH (α)</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">221</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Protocols for determination of Aβ<sub>42</sub> IC<sub>50</sub> (nM) and Aβ<sub>total</sub> IC<sub>50</sub> have been previously described.<a onclick="showRef(event, 'cit7h'); return false;" href="javascript:void(0);" class="ref cit7h">(7h)</a></p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">All the measurements are geometric mean of at least <i>n</i> = 2 measurements.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Collective Profile of 11, 14, 20, and 21</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">compounds</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">measured parameters</th><th class="colsep0 rowsep0" align="center"><b>11</b></th><th class="colsep0 rowsep0" align="center"><b>14</b></th><th class="colsep0 rowsep0" align="center"><b>20</b></th><th class="colsep0 rowsep0" align="center"><b>21</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (nM) Aβ<sub>42</sub></td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">107</td><td class="colsep0 rowsep0" align="left">143</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (μM) Aβ<sub>total</sub></td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> (10<sup>–6</sup> cm/s)</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG K<sup>+</sup> MK-499 binding IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">2007</td><td class="colsep0 rowsep0" align="left">1607</td><td class="colsep0 rowsep0" align="left">3352</td><td class="colsep0 rowsep0" align="left">2608</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PXR (μM)</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3A4; 2C9; 2D6 (μM)</td><td class="colsep0 rowsep0" align="left">16; 33; 49</td><td class="colsep0 rowsep0" align="left">29; 37; 49</td><td class="colsep0 rowsep0" align="left">34; 18; 48</td><td class="colsep0 rowsep0" align="left">30; 8.0; 8.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo rat CSF Aβ<sub>42</sub> reduction (30 mg/kg)</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">NS</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>P</sub> (μM); <i>C</i><sub>B</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">8.8; 7.5</td><td class="colsep0 rowsep0" align="left">13.1; 11.1</td><td class="colsep0 rowsep0" align="left">14.2; 2.1</td><td class="colsep0 rowsep0" align="left">1.4; 1.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Measured total concentrations in plasma (<i>C</i><sub>P</sub>) and brain (<i>C</i><sub>B</sub>) of rats at 3 h post oral dose of 30 mg/kg. <i>P</i><sub>app</sub>, apparent permeability; hERG K<sup>+</sup>, human ether-a-go-go-related gene (hERG) potassium channels; and PXR, pregnane X receptor.</p></div></div></div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, compound <b>11</b> displayed an oral bioavailability of 79% with a <i>C</i><sub>max</sub> and total AUC of 1.3 μM and 8 μM·h, respectively, with a 2 mg/kg oral dose. Additionally, it exhibited low in vivo clearance and moderate volume of distribution that resulted in an MRT of 1.7 h.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Rat Pharmacokinetic Parameters of Compound <b>11</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">AUC<sub>(0–∞)</sub> (μM·h)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (μM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>F</i> %<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">PPB (% bound)</th><th class="colsep0 rowsep0" align="center">Cl (mL/min/kg)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Vd,<sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">MRT (h)</th><th class="colsep0 rowsep0" align="center">Pgp-Efflux (rat)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">99.5</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">2.46</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values are average of two experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Data from 2 mg/kg oral dose.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Data from 1 mg/kg iv dose.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Rat Pgp efflux was measured in LLC-PK1 cells transfected with rat MDR1A and reported as a ratio of (B to A)/(A to B). AUC, area under the plasma drug concentration–time curve; <i>C</i><sub>max</sub>, highest concentration; <i>F</i> %, oral bioavailability; PPB, plasma protein binding; Cl, clearance; Vd, volume of distribution; MRT, mean residence time; and Pgp, p-glycoprotein.</p></div></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Modulation of γ-secretase to probe the amyloid cascade hypothesis was one of the multipronged approaches that we had undertaken, and our previous work resulted in the identification of two distinct GSM series represented by compounds <b>3</b> and <b>4</b>. To enhance structural diversity and to mitigate concern around the exocyclic double bond present in oxadiazine series, we pursued a number of strategies to identify new leads. Three distinct strategies were inspired by existing chemical matter and executed upon using a “hypothesis-driven drug discovery” approach, which is complementary to lead identification via traditional approaches such as u-HTS, automated ligand identification system (ALIS), and fragment-based ligand discovery (FBLD) screens. The conceptualization of the 3,4-disubstituted oxadiazine series was inspired by compound <b>7</b> reported in the patent literature. Representative compounds from this series demonstrated robust reduction of CSF Aβ<sub>42</sub> as exemplified by compounds <b>11</b> and <b>14</b>. In a further attempt to mask the exocyclic double bonds present in these molecules, analogues <b>20</b> and <b>21</b> with a β, β-disubstituted endocyclic double bond were designed, synthesized, and validated as novel GSMs, and analogue <b>20</b> exhibited 52% lowering of CSF Aβ<sub>42</sub> with a 30 mg/kg oral dose. Based on the dose-responsive study with <b>11</b>, we surmised that the free concentration of compounds in the brain is required to be near their IC<sub>50</sub> for robust lowering of CSF Aβ<sub>42</sub>. Finally, discovery of <b>27</b>, lacking both the exocyclic double bond and the additional aromatic ring led to a novel GSM chemotype. A recent report from the literature confirmed that such molecular motifs embodied the potential for the generation of orally bioavailable molecules that might ultimately translate into novel therapeutics for the treatment of AD.<a onclick="showRef(event, 'cit7a'); return false;" href="javascript:void(0);" class="ref cit7a">(7a)</a> Additional investigation of these GSMs in the context of newly developed cryo-electron microscopy structures of human γ-secretase in complex with a notch fragment and transmembrane APP fragment would provide the opportunity to further optimize these molecules.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52421" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52421" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our initial route for the synthesis of <b>11</b>, <b>12</b>, and related analogues commenced with the three-step synthesis of aldehyde <b>31</b> from the known intermediate <b>29</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'cit7h'); return false;" href="javascript:void(0);" class="ref cit7h">(7h)</a> The reaction of <b>31</b> with (3,5-difluorophenyl)magnesium bromide led to alcohol <b>32</b> as a diastereomeric mixture. Subjection of <b>32</b> to a three-step sequence, namely, the Mitsunobu reaction with <i>N</i>-hydroxyphthalimide, phthalimide removal, and H<sub>3</sub>PO<sub>4</sub>-mediated dehydrative cyclization resulted in analogues <b>11</b> and <b>12</b>. A detailed investigation revealed that the addition of (3,5-difluorophenyl)magnesium bromide generated the syn isomer as the major product via chelation control, albeit with low diastereoselectivity (step d). Furthermore, use of the pure diastereomer separated from the mixture of diastereomers represented as <b>32</b> in the Mitsunobu reaction with <i>N</i>-hydroxyphthalimide resulted in complete retention of stereochemistry at the alcohol-bearing center. We surmised that this retention of stereochemistry resulted from double inversion because of the neighboring group participation by the proximal amide moiety.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Initial Approach to 3,4-Disubstituted Oxadiazines <b>11</b> and <b>13–15</b> Based on the Mitsunobu Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EDCI, HOBT, DIEA, DMF; (b) NaOMe (25 wt % in MeOH), THF, 25%; (c) (COCl)<sub>2</sub>, DMSO, DCM, −78 °C, 100%; (d) 3,5-difluorophenyl magnesium bromide, THF, 48%; (e) <i>N</i>-hydroxyphthalimide, <i>n</i>-Bu<sub>3</sub>P, ADDP, 2MeTHF, 18%; (f) NH<sub>2</sub>NH<sub>2</sub>, EtOH; and (g) H<sub>3</sub>PO<sub>4</sub>, <i>n</i>-BuOH, 100 °C, 29% yield for <b>11</b>, and 8% yield for <b>12</b>.</p></p></figure><div class="NLM_p">Based on these findings, modified synthetic sequences were envisioned to access <b>11</b> and close analogues rapidly (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The amino alcohol <b>35</b> obtained in three steps from <b>34</b> was condensed with acid <b>29</b>. The subsequent reaction of the resulting amide with NaOMe led to the cyclized compound <b>36</b>. The Mitsunobu reaction of <b>36</b> with <i>N</i>-hydroxyphthalimide followed by hydrazine-mediated phthalimide removal and subsequent H<sub>3</sub>PO<sub>4</sub>-mediated dehydrative cyclization led to the formation of <b>11</b> with overall retention in configuration at the alcohol-bearing center. Analogues <b>14</b> were prepared following this general synthetic sequence.</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Stereoselective Approach to 3,4-Disubstituted Oxadiazines Based on the Observation of Retention of the Configuration Mitsunobu Reaction in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (COCl)<sub>2</sub>, DMSO, DCM, −78 °C; (b) 3,5-difluorophenyl magnesium bromide, THF, 100%; (c) Pd/C, H<sub>2</sub>, MeOH, 84%; (d) EDCI, HOBT, DIEA, DMF; (e) NaOMe (25 wt % in MeOH), THF, 81%; (f) <i>N</i>-hydroxyphthalimide, <i>n</i>-Bu<sub>3</sub>P, DIAD, THF, 76%; and (g) NH<sub>2</sub>NH<sub>2</sub>, EtOH; (h) H<sub>3</sub>PO<sub>4</sub>, <i>n</i>-BuOH, 100 °C, 51%.</p></p></figure><div class="NLM_p">The synthesis of hydroxymethylated analogue <b>15</b> is described in (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The key intermediate <b>38</b> was prepared in three steps from alcohol <b>37</b> via Swern oxidation, nonchelation-controlled 3,4,5-trifluorophenyl Grignard addition, and selective removal of benzyl groups from the amino functionality. Amino alcohol <b>38</b> was progressed to compound <b>40</b> following the reaction sequence described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Treatment of <b>40</b> with BCl<sub>3</sub> to remove the benzyl group led to <b>15</b>.</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogue 15 Based on the Observation of Retention of the Configuration Mitsunobu Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (COCl)<sub>2</sub>, DMSO, DCM, −78 °C; (b) 3,5-difluorophenyl magnesium bromide, THF, 94%; (c) Pd/C, H<sub>2</sub>, MeOH, 100%; (d) EDCI, HOBT, DIEA, DMF; (e) NaOMe, MeOH, 66%; (f) <i>N</i>-hydroxyphthalimide, PPh<sub>3</sub>, DIAD, THF, 0 °C; (g) NH<sub>2</sub>NH<sub>2</sub>, EtOH, 48%; (h) H<sub>3</sub>PO<sub>4</sub>, <i>n</i>-BuOH, 100 °C, 86%; and (i) BCl<sub>3</sub>, DCM, 0 °C, 23%.</p></p></figure><div class="NLM_p">The synthesis of acid <b>47</b> for the preparation of analogues <b>20</b> and <b>21</b> is illustrated in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Alkyne <b>42</b> prepared in a single step from <b>41</b> was treated with hexamethylditin to provide intermediate <b>43</b>. Treatment of <b>43</b> with CuCl resulted in selective removal of trimethyltin α to the ester group. Stille coupling between <b>44</b> and <b>45</b> followed by treatment of the resulting intermediate with trifluoroacetyl (TFA) provided the key acid <b>47</b>, which was used for the synthesis of both core structures <b>20</b> and <b>21</b>.</div><figure id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Key Intermediate <b>47</b> for the Synthesis of Azepine Analogues <b>20</b> and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, Et<sub>2</sub>O, THF, −30 °C, (Boc)<sub>2</sub>O, 34%; (b) Me<sub>6</sub>Sn<sub>2</sub>, Pd(Ph<sub>3</sub>)<sub>4</sub>, 80 °C, THF, 77%; (c) CuCl, DMF, H<sub>2</sub>O, rt, 72%; (d) CuCl, Pd(dppf)Cl<sub>2</sub>, DMF, 100 °C; and (e) TFA, DCM, rt, 68%.</p></p></figure><div class="NLM_p">With the acid <b>47</b> in hand, the initial route for the synthesis of <b>20</b> involved the synthetic sequences described in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. In addition, the seven-membered lactam <b>49</b> was prepared for the subsequent conversion of its hydroxyl to hydroxyl amine moiety functionality. However, the conversion of <b>49</b> to <b>50</b> under a variety of conditions was met with failure.</div><figure id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Failed Attempt to Transform the Hydroxyl Functionality to Hydroxylamine for the Synthesis of <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (1) <i>N</i>-hydroxyphthalimide, <i>n</i>Bu<sub>3</sub>P, DIAD, THF; (2) <i>N</i>-hydroxyphthalimide, <i>n</i>Bu<sub>3</sub>P, ADDP, THF.</p></p></figure><div class="NLM_p">The synthetic strategy was revised to preinstall the hydroxylamino moiety into the amino alcohol <b>51</b> (cf. <b>55</b>) prior to the formation of seven-membered lactam (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). The amino moiety of <b>51</b> was protected with the bis-allyl group for facile generation of free amine <b>55</b> without cleavage of the N–O bond (<b>54</b> → <b>55</b>). Condensation of amine <b>55</b> with acid <b>47</b> followed by cyclization using KHMDS led to the seven-membered lactam <b>57</b>. Removal of the Boc group followed by treatment of the resulting free hydroxylamine with H<sub>3</sub>PO<sub>4</sub> afforded oxadiazine <b>58</b>. The two enantiomers of <b>58</b> were separated using the AD column with 30% i-PrOH in hexanes to afford <b>20</b>.</div><figure id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>20</b> via Development of a New Synthetic Strategy<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) allyl bromide, K<sub>2</sub>CO<sub>3</sub>, <i>n</i>-butyronitrile, 120 °C, 50%; (b) <i>N</i>-hydroxyphthalimide, <i>n</i>-Bu<sub>3</sub>P, DIAD, THF, 0 °C; (c) NH<sub>2</sub>NH<sub>2</sub>, DCM, EtOH; (d) (Boc)<sub>2</sub>O, rt, 65%; (e) 1,3-dimethylbarbituric acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, DCM, rt, 84%; (f) EDCI, HOBt, DIEA, DMF, 0 °C, 85%; (g) KHMDS, THF/DMF, −50 °C, 56%; (h) TFA, DCM, rt; (i) H<sub>3</sub>PO<sub>4</sub>, 105 °C; and (j) Chiralpak AD column, 22% for <b>20</b>, 17% for <b>59</b>.</p></p></figure><figure id="sch7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Unanticipated Transformation of <b>61</b> to <b>62</b> Leading to Stereocontrolled Synthesis of 20<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) allyl bromide, K<sub>2</sub>CO<sub>3</sub>, MeCN, 80 °C, 38%; (b) <i>N</i>-hydroxyphthalimide, <i>n</i>-Bu<sub>3</sub>P, DIAD, THF, 0 °C; (c) NH<sub>2</sub>–NH<sub>2</sub>, EtOH, DCM, 0 °C; and (d) (BOC)<sub>2</sub>O, 37%.</p></p></figure><div class="NLM_p">We recognized that enantiomerically pure amino alcohol <b>60</b> may be useful for the synthesis of <b>21</b> with the 3,4,5-trifluorophenyl moiety at the 4-position of the oxadiazine moiety<named-content content-type="anchor" rid="sch7" type="simple"></named-content> (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>). The route began with the transformation of amino alcohol <b>60</b> to the bis-allyl-protected amino alcohol <b>61</b>. Interestingly, under the Mitsunobu reaction conditions, the bis-allyl-protected amino alcohol <b>61</b> was converted to <b>62</b> with apparent migration of the 3,4,5-trifluorophenyl from the nitrogen to the oxygen-bearing carbon of the allylated amino alcohol <b>61</b>. This transformation occurred presumably via the in situ formation of aziridinium ion followed by regio- and stereoselective opening of the aziridinium ring by the <i>N</i>-hydroxyphthalimide (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). Although intermediate <b>62</b> was not useful for the synthesis of <b>21</b>, it could be used for the synthesis of enantiopure <b>20</b> following the exact sequences of reactions described in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a> (details in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00446/suppl_file/jm0c00446_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Stereocontrolled Synthesis of <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-hydroxyphthalimide, Ph<sub>3</sub>P, DIAD, THF, −30 °C, 98%; (b) NH<sub>2</sub>NH<sub>2</sub>, DCM, EtOH, 88%; (c) DCM, (Boc)<sub>2</sub>O, rt, 80%; (d) Pd/C, H<sub>2</sub>, EtOH, rt, 100%; (e) EDCI, HOBt, DIEA, DMF, 0 °C, 65%; (f) KHMDS, DMF, −30 °C, 64%; and (g) POCl<sub>3</sub>, 80 °C, 20%.</p></p></figure><div class="NLM_p">For the synthesis of <b>21</b>, the amino moiety of amino alcohol <b>60</b> was protected with Cbz to attenuate its nucleophilicity, thereby preventing the formation of the aziridinium ion in the following Mitsunobu reaction (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>). The Cbz-protected alcohol <b>63</b> underwent the Mitsunobu reaction in a desired fashion without rearrangement to generate <b>64</b>. Protecting group manipulation followed by removal of Cbz afforded amine <b>66</b>, which was progressed to <b>21</b> following the similar sequences of the reaction, as described in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>.</div><div class="NLM_p">Synthesis of <b>27</b> began with the ethyl bromoacetate <b>69</b>, which was progressed to racemic <b>70</b> as the major diastereomer following the literature procedure (<a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The Mitsunobu reaction of <b>70</b> with 3,5-difluorophenol resulted in <b>72</b> via inversion of stereochemistry at the carbon-bearing alcohol. Reduction of ester functionality in <b>72</b> to the corresponding alcohol followed by removal of the Boc group provided <b>73</b>. Condensation of <b>73</b> with acid <b>74</b> followed by hydrogenation led to <b>76</b>. Subjection of intermediate <b>76</b> to the Mitsunobu reaction conditions with <i>N</i>-hydroxyphthalimide followed by hydrazine-mediated phthalimide removal generated <b>77</b>, which on treatment with POCl<sub>3</sub> resulted in <b>27</b>.</div><figure id="sch9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Racemic Synthesis of 27<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3,5-difluorophenol, DEAD, PPh<sub>3</sub>, THF, 0 °C; (b) LiAlH<sub>4</sub>,, THF, 42%; (c) 4 N HCl in dioxane, rt; (d) EDCI, HOBt, DIEA, DMF, 50%; (e) Pd/C, H<sub>2</sub>, MeOH, 57%; (f) MeSO<sub>2</sub>Cl, Et<sub>3</sub>N, <i>N</i>-hydroxyl phthalimide, DCM, 43%; (g) NH<sub>2</sub>NH<sub>2</sub>, EtOH, DCM, 63%; and (h) POCl<sub>3</sub>, 90 °C, 22%.</p></p></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General</h3><div class="NLM_p">Measurement of Aβ<sub>42</sub> IC<sub>50</sub>, Aβ<sub>total</sub> IC<sub>50</sub>, and BACE1 <i>K</i><sub>i</sub> and determination of rat CSF Aβ<sub>42</sub> lowering in vivo were carried out following our previously described protocols.<a onclick="showRef(event, 'cit7g'); return false;" href="javascript:void(0);" class="ref cit7g">(7g)</a></div><div class="NLM_p">Unless otherwise mentioned, all reagents and solvents purchased from commercial sources were used directly without further purification. Air-sensitive reactions were performed under an atmosphere of N<sub>2</sub>. Purification of all the final compounds to >95% purity was carried out either by prepacked silica gel cartridge (Analogix, Biotage, or ISCO) or on a reverse-phase C18 column. Water and acetonitrile used as mobile phase A and B, respectively, for the C18 column were supplemented either with 0.05% TFA or 0.1% formic acid. All the NMR data were collected either at 400 or 600 MHz on a Varian or Bruker instrument. Chemical shifts are reported in ppm relative to the residual solvent peak in the indicated solvent, and for <sup>1</sup>H NMR, multiplicities, coupling constants in Hertz, and numbers of protons are indicated parenthetically. Purity and MS information were obtained via liquid chromatography-electrospray-mass spectroscopy with a C18 column using a gradient of 5–95% MeCN in water supplemented with 0.05% TFA or 0.1% formic acid as the mobile phase. The purity of the samples was assessed using a UV detector at 254 nm.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (3<i>R</i>,4<i>S</i>)-3-(3,5-Difluorophenyl)-9-((<i>E</i>)-3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-4-methyl-3,4,6,7,8,9-hexahydropyrido[2,1-<i>c</i>][1,2,4]oxadiazine (<b>11</b>) and (3<i>S</i>,4<i>S</i>)-3-(3,5-difluorophenyl)-9-((<i>E</i>)-3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-4-methyl-3,4,6,7,8,9-hexahydropyrido[2,1-<i>c</i>][1,2,4]oxadiazine (<b>12</b>)</h4><div class="NLM_p">To a solution of TFA salt of <b>29</b> (5 g, 11 mmol), HOBt (2.04 g, 13.3 mmol), and <b>30</b> (1 g, 13.3 mmol) in DMF (30 mL) was added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI) (2.56 g, 13.3 mmol), followed by diisopropylethylamine (DIEA) (4.28 mL, 24.5 mmol) at 0 °C. The resulting mixture was slowly warmed to rt and stirred for 2 h. Then, the reaction mixture was diluted with EtOAc, transferred to a separatory funnel, and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was taken to the next step without further purification. To this crude product in tetrahydrofuran (THF) (30 mL) was added NaOMe (25 wt % in MeOH, 3.61 g, 16.71 mmol) at 0 °C. The resulting mixture was slowly warmed to rt and stirred for 14 h. Then, the reaction mixture was diluted with EtOAc, neutralized with 1 N HCl, and washed with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and evaporated, and the crude product was purified by silica gel chromatography using 0–100% EtOAc in hexanes to afford an alcohol precursor to aldehyde <b>31</b> (1 g, 25% yield).</div><div class="NLM_p">To a solution of oxalyl chloride (0.49 mL, 5.63 mmol) in dichloromethane (DCM) (4 mL) was added a solution of dimethyl sulfoxide (DMSO) (0.79 mL, 11.3 mmol) in DCM (2 mL) at −78 °C. The reaction mixture was stirred at −78 °C for 10 min and then to this mixture was added a solution of an alcohol precursor to aldehyde <b>31</b> (1 g, 2.8 mmol) in DCM (4 mL) and stirred at −78 °C for 30 min. Then, Et<sub>3</sub>N (1.96 mL, 14 mmol) was added, and the resulting solution was slowly warmed to rt over 1 h. The reaction mixture was diluted with EtOAc, transferred to a separatory funnel, and washed first with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and evaporated, and the crude aldehyde <b>31</b> was taken directly to the next step without further purification.</div><div class="NLM_p">To a solution of this crude <b>31</b> (0.99 g, 2.8 mmol) in THF (10 mL) was added a solution of (3,5-difluorophenyl)magnesium bromide (2.81 mL, 5.6 mmol, 2 M in diethyl ether) at 0 °C, and the resulting mixture was slowly warmed to rt and stirred for 2 h. Then, the reaction mixture was diluted with EtOAc, transferred to a separatory funnel, neutralized with 1 N HCl, and washed with brine. The organic layer was separated, dried with MgSO<sub>4</sub>, filtered, and evaporated, and the crude product was purified by silica gel chromatography using 0–10% methanol in DCM to provide <b>32</b> as the mixture of diastereomers (0.63 g, 48% yield).</div><div class="NLM_p">To a solution of <b>32</b> (0.17 g, 0.36 mmol) in 2-MeTHF (5 mL) was added <i>N</i>-hydroxyphthalimide (0.10 g, 0.73 mmol), ADDP (0.12 g, 0.47 mmol), and <i>n</i>-Bu<sub>3</sub>P (0.11 mL, 0.47 mmol). The resulting mixture was degassed and heated at 80 °C for 18 h. The reaction mixture was diluted with EtOAc, transferred to a separatory funnel, and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 1% Et<sub>3</sub>N in EtOAc to provide the corresponding Mitsunobu adduct <b>33</b> (0.04 g, 18% yield).</div><div class="NLM_p">To a solution of <b>33</b> (0.04 g, 0.06 mmol) in EtOH (0.2 mL) was added hydrazine (0.07 mL, 2.23 mmol) at 0 °C, and the resulting solution was slowly warmed to rt and stirred for 30 min. The reaction mixture was diluted with EtOAc, transferred to a separatory funnel, and washed with saturated aqueous solution of NaHCO<sub>3</sub> and brine, and the crude product was taken to the next step without further purification.</div><div class="NLM_p last">To a solution of this crude product (0.03 g, 0.06 mmol) in butan-1-ol was added H<sub>3</sub>PO<sub>4</sub> (0.01 mL, 0.17 mmol) and heated at 100 °C for 12 h. The reaction mixture was concentrated, and the crude reaction mixture was purified by reverse-phase high-performance liquid chromatography (HPLC) to provide <b>11</b> (0.01 g, 29% yield) and <b>12</b> (0.002 g, 7.83% yield). <sup>1</sup>H NMR and <i>m</i>/<i>z</i> of compound <b>11</b> (400 MHz, CD<sub>3</sub>OD): δ 9.19 (d, <i>J</i> = 1.6 Hz, 1H), 7.67–7.58 (m, 2H), 7.47 (s, 1H), 7.36 (d, <i>J</i> = 1.5 Hz, 1H), 7.27 (dd, <i>J</i> = 8.2, 1.2 Hz, 1H), 7.10–6.98 (m, 3H), 5.34 (d, <i>J</i> = 2.2 Hz, 1H), 4.13 (qd, <i>J</i> = 6.6, 2.4 Hz, 1H), 3.97 (s, 3H), 3.78 (m, 1H), 3.58 (m, 1H), 3.04–2.79 (m, 2H), 2.44 (d, <i>J</i> = 1.1 Hz, 3H), 2.21–1.95 (m, 2H), 1.15 (d, <i>J</i> = 6.6 Hz, 3H). <i>m</i>/<i>z</i>: 465. <sup>1</sup>H NMR and <i>m</i>/<i>z</i> of compound <b>12</b> (400 MHz, CD<sub>3</sub>OD): δ 9.16 (d, <i>J</i> = 1.6 Hz, 1H), 7.63–7.51 (m, 2H), 7.35–7.26 (m, 2H), 7.22–7.12 (m, 3H), 7.04 (tt, <i>J</i> = 8.9, 2.2 Hz, 1H), 5.16 (d, <i>J</i> = 3.6 Hz, 1H), 4.16 (td, <i>J</i> = 6.5, 3.7 Hz, 1H), 3.93 (s, 3H), 3.68 (m, 1H), 3.46 (m 1H), 2.79 (m, 2H), 2.42 (d, <i>J</i> = 1.1 Hz, 3H), 2.07–1.78 (m, 2H), 1.47 (d, <i>J</i> = 6.5 Hz, 3H). <i>m</i>/<i>z</i>: 465.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (3<i>R</i>,4<i>S</i>)-3-(3,5-Difluorophenyl)-9-((<i>E</i>)-3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-4-methyl-3,4,6,7,8,9-hexahydropyrido[2,1-<i>c</i>][1,2,4]oxadiazine (<b>11</b>) according to the Synthetic Route Described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a></h4><div class="NLM_p">To a solution of oxalyl chloride (2 mL, 23.5 mmol) in DCM (100 mL) was added a solution of DMSO (2.78 mL, 39.2 mmol) in DCM (10 mL) at −78 °C and stirred for 10 min. Then, a solution of <b>34</b> (5 g, 19.5 mmol) in DCM (10 mL) was added and stirred at −78 °C for 0.5 h before the addition of Et<sub>3</sub>N (10.9 mL, 78 mmol). The reaction mixture was slowly warmed to 0 °C, diluted with EtOAc, transferred to a separatory funnel, and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude aldehyde was taken to the next step without further purification.</div><div class="NLM_p">To a solution of (3,5-difluorophenyl)magnesium bromide (100 mL, 50 mmol, 0.5 M in diethyl ether) was added a solution of the crude aldehyde from the previous step (4.81 g, 19 mmol) in THF (30 mL) at −78 °C, and the reaction mixture was slowly warmed to rt and stirred for 30 min. The reaction mixture was diluted with EtOAc, transferred to a separatory funnel, and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 0–10% EtOAc in hexanes to afford the corresponding alcohol (6.98 g, 100% yield).</div><div class="NLM_p">To a solution of this alcohol (6.98 g, 19 mmol) in MeOH (100 mL) was added 10% Pd/C (2 g, 1.8 mmol), and the resulting solution was degassed and stirred under the atmosphere of H<sub>2</sub> for 12 h. The reaction mixture was filtered, and the filtrate was evaporated to dryness to afford <b>33</b> (3 g, 84% yield) which was taken to the next step without further purification.</div><div class="NLM_p">To a mixture of <b>35</b> (3 g, 16 mmol), TFA salt of <b>29</b> (7.19 g, 16 mmol), and HOBt (2.95 g, 19.2 mmol) in DMF (32 mL) was added EDCI (3.69 g, 19.2 mmol), followed by DIEA (6.16 mL, 35.3 mmol) at 0 °C. The resulting mixture was slowly warmed to rt and stirred for 2 h. The reaction mixture was diluted with EtOAc, transferred to a separatory funnel, and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was taken to the next step without further purification.</div><div class="NLM_p">To a solution of this crude product (6.78 g, 16 mmol) in THF (50 mL) was added sodium methoxide (5.19 g, 24 mmol) at rt and stirred for 12 h. The reaction mixture was diluted with water, neutralized with 1 N aqueous solution of HCl, transferred to a separatory funnel, extracted with EtOAc, and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 0–100% methanol/7 N NH<sub>3</sub> in DCM to <b>36</b> (5 g, 81% yield). To a solution of <b>36</b> (5 g, 10.7 mmol), <i>N</i>-hydroxyphthalimide (2.09 g, 12.8 mmol), and <i>n</i>-Bu<sub>3</sub>P (3.17 mL, 12.8 mmol) in THF (60 mL) was added diisopropyl azodicarboxylate (DIAD) (2.49 mL, 12.8 mmol) at 0 °C, and the resulting mixture was slowly warmed to rt and stirred for 2 h. The reaction mixture was diluted with EtOAc, transferred to a separatory funnel, and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 0–100% EtOAc in hexanes to afford the corresponding Mitsunobu adduct (5 g, 76% yield).</div><div class="NLM_p">To a solution of this Mitsunobu adduct (5 g, 8.2 mmol) in EtOH (24 mL) was added hydrazine (1.04 mL, 33.3 mmol) at 0 °C and stirred for 30 min. Then, the reaction mixture was diluted with EtOAc, transferred to a separatory funnel, and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude hydroxyl amine (3 g, 76%) was taken to the next step for cyclization.</div><div class="NLM_p last">To a solution of this hydroxyl amine (1 g, 2 mmol) in <i>n</i>-BuOH (40 mL) was added H<sub>3</sub>PO<sub>4</sub> (1 mL, 17.1 mmol), and the resulting mixture was heated at 100 °C for 7 h. Then, the reaction mixture was cooled to rt, diluted with EtOAc, and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, concentrated, and purified by silica gel chromatography using 2% TEA in EtOAc to afford <b>11</b> (0.49 g, 51% yield).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (3<i>R</i>,4<i>S</i>)-3-(3,5-Difluorophenyl)-4-isopropyl-9-((<i>E</i>)-3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-3,4,6,7,8,9-hexahydropyrido[2,1-<i>c</i>][1,2,4]oxadiazine (<b>13</b>)</h4><div class="NLM_p last">Compound <b>13</b> was prepared following the synthetic sequences described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> for the synthesis of compound <b>11</b> using (<i>S</i>)-2-amino-3-methylbutan-1-ol. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.19 (d, <i>J</i> = 1.6 Hz, 1H), 7.67–7.57 (m, 2H), 7.46–7.41 (m, 1H), 7.39 (d, <i>J</i> = 1.6 Hz, 1H), 7.33–7.27 (m, 1H), 7.14–7.07 (m, 2H), 7.07–6.98 (m, 1H), 5.29–5.23 (m, 1H), 4.01–3.98 (m, 1H), 3.97 (s, 3H), 3.73–3.59 (m, 2H), 3.02–2.92 (m, 2H), 2.44 (d, <i>J</i> = 1.1 Hz, 3H), 2.20–2.01 (m, 2H), 1.96–1.83 (m, 1H), 1.03–0.86 (m, 6H). <i>m</i>/<i>z</i>: 493.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (3<i>R</i>,4<i>S</i>)-9-((<i>E</i>)-3-Methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-4-methyl-3-(3,4,5-trifluorophenyl)-3,4,6,7,8,9-hexahydropyrido[2,1-<i>c</i>][1,2,4]oxadiazine (<b>14</b>)</h4><div class="NLM_p last">Compound <b>14</b> was prepared following the synthetic sequences described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> for the preparation of compound <b>11</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.71 (d, <i>J</i> = 1.3 Hz, 1H), 7.50 (m, 1H), 7.22 (d, <i>J</i> = 7.9 Hz, 1H), 7.07–6.88 (m, 5H), 4.85–4.75 (m, 1H), 3.83 (s, 3H), 3.53–3.44 (m, 1H), 3.40 (m, 1H), 3.14 (m, 1H), 2.81 (m, 1H), 2.74–2.60 (m, 1H), 2.29 (d, <i>J</i> = 1.0 Hz, 3H), 1.91 (m, 2H), 0.99 (d, <i>J</i> = 6.4 Hz, 3H). <i>m</i>/<i>z</i>: 483.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> ((3<i>R</i>,4<i>S</i>)-9-((<i>E</i>)-3-Methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-3-(3,4,5-trifluorophenyl)-3,4,6,7,8,9-hexahydropyrido[2,1-<i>c</i>][1,2,4]oxadiazin-4-yl)methanol (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was prepared following the synthetic sequences described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.74 (s, 1H), 7.47 (s, 1H), 7.21 (d, <i>J</i> = 7.7 Hz, 1H), 7.12–7.02 (m, 2H), 6.99–6.86 (m, 4H), 4.81 (s, 1H), 3.82 (s, 3H), 3.73–3.51 (m, 3H), 3.27 (m, 1H), 2.79 (m, 2H), 2.29 (s, 3H), 1.93 (m, 2H). <i>m</i>/<i>z</i>: 499.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>E</i>)-6-Chloro-3-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)hex-2-enoic Acid (<b>47</b>)</h4><div class="NLM_p">To a solution of <b>41</b> (25 g, 244 mmol) in Et<sub>2</sub>O (400 mL) was added <i>n</i>-BuLi (117 mL, 293 mmol) at −30 °C and stirred for 30 min. Then, a solution of (Boc)<sub>2</sub>O (67.9 mL, 293 mmol) in Et<sub>2</sub>O (50 mL) was added over 30 min. The reaction mixture was slowly warmed to rt. The resulting mixture was diluted with water, neutralized with 1 N aqueous solution of HCl, and washed with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 5% EtOAc in hexanes to afford <b>42</b> (17 g, 34% yield).</div><div class="NLM_p">To a solution of <b>42</b> (5 g, 24.67 mmol) in THF (30 mL) was added Me<sub>6</sub>Sn<sub>2</sub> (6.33 mL, 30.5 mmol) and Pd(Ph<sub>3</sub>P)<sub>4</sub> (2.85 g, 2.5 mmol). The resulting mixture was degassed and backfilled N<sub>2</sub> (3×) and heated at 80 °C for 12 h. Then, the reaction mixture was evaporated to dryness, and the crude mixture was purified by silica gel chromatography using 5% EtOAc in hexane to provide <b>43</b> (9.57 g, 18 mmol, 77% yield).</div><div class="NLM_p">To a solution of <b>43</b> (8 g, 15.1 mmol) in a mixture of DMF (60 mL) and water (6 mL) was added cuprous chloride (0.015 g, 0.15 mmol) and stirred at rt under the atmosphere of N<sub>2</sub> for 2 h. Then, a mixture of NH<sub>4</sub>Cl/NH<sub>4</sub>OH (20 mL, pH 8) was added and stirred for additional 1 h while exposing the reaction mixture to the air. The resulting mixture was extracted with Et<sub>2</sub>O, dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 2% EtOAc in hexanes to provide <b>44</b> (4 g, 10.9 mmol, 72% yield).</div><div class="NLM_p last">To solution of <b>44</b> (4 g, 10.9 mmol) in DMF (60 mL) were added cuprous chloride (0.323 g, 3.3 mmol), Pd(dppf)Cl<sub>2</sub> (0.398 g, 0.54 mmol), and <b>45</b> (3.4 g, 12.7 mmol), and the resulting solution was degassed and backfilled with N<sub>2</sub> (3×) and heated at 100 °C for 1 h. The reaction mixture was then cooled to rt, diluted with EtOAc, and washed with water and then with brine. The organic layer was dried with MgSO<sub>4</sub>, evaporated, and purified by silica gel chromatography using 0–100% EtOAc in hexanes to provide <b>46</b>, which on treatment with CF<sub>3</sub>CO<sub>2</sub>H acid in DCM (5 mL, 50% CF<sub>3</sub>CO<sub>2</sub>H in DCM) afforded <b>47</b> (2.5 g, 7.5 mmol, 68% yield).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>R</i>)-9-(3-Methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)-3-(3,4,5-trifluorophenyl)-3,4,7,8-tetrahydro-6<i>H</i>-[1,2,4]oxadiazino[4,3-<i>a</i>]azepine (<b>20</b>)</h4><div class="NLM_p">To a solution of <b>51</b> (5 g, 26.2 mmol) in <i>n</i>-butyronitrile (130 mL) were added K<sub>2</sub>CO<sub>3</sub> (10.85 g, 78 mmol) and allyl bromide (4.7 mL, 54.3 mmol) and heated at 120 °C for 2 h. Then, the reaction mixture was filtered and concentrated, and the crude product was purified by silica gel chromatography using 0–10% EtOAc in hexanes to provide <b>52</b> (3 g, 50% yield).</div><div class="NLM_p">To a mixture of <b>52</b> (3 g, 11 mmol), <i>n</i>-Bu<sub>3</sub>P (3.27 mL, 13.3 mmol), and <i>N</i>-hydroxyphthalimide (2.16 g, 13.3 mmol) in THF (55 mL) was added DIAD (2.58 mL, 13.3 mmol) at 0 °C. The resulting mixture was slowly warmed to rt and stirred for 2 h. Then, the reaction mixture was diluted with EtOAc and washed with saturated aqueous solution of NaHCO<sub>3</sub> followed by brine. The organic layer was dried with MgSO<sub>4</sub>, concentrated, and filtered, and the crude product was purified by silica gel chromatography using 15% EtOAc in hexanes to afford the corresponding Mitsunobu product, which was dissolved in a mixture of DCM (50 mL) and ethanol (100 mL) and added hydrazine hydrate (1.1 g, 22 mmol) at 0 °C. The reaction mixture was warmed to rt and stirred for 30 min. The resulting mixture was filtered and concentrated to afford the corresponding hydroxyl amine. To this hydroxyl amine was added neat (Boc)<sub>2</sub>O (2.3 g, 11 mmol) and stirred for 12 h. Then, the reaction mixture was concentrated, and the crude product was purified by silica gel chromatography using 0–100% EtOAc in hexanes to afford <b>54</b> (2.96 g, 65% yield).</div><div class="NLM_p">To a solution of <b>54</b> (2.6 g, 6.7 mmol) in DCM (33 mL) were added 1,3-dimethylpyrimidine-2,4,6(1<i>H</i>,3<i>H</i>,5<i>H</i>)-trione (6 g, 40 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.73 g, 0.67 mmol), and the resulting mixture was degassed and backfilled with N<sub>2</sub> (3×) and stirred under the atmosphere of N<sub>2</sub> for 12 h. Then, the reaction mixture was washed with saturated aqueous solution of NaHCO<sub>3</sub> followed by brine. The DCM layer was dried with MgSO<sub>4</sub>, concentrated, and filtered, and the crude product was purified by silica gel chromatography using 5% MeOH/7 N NH<sub>3</sub> in DCM to afford <b>55</b> (1.6 g, 84% yield).</div><div class="NLM_p">To a solution of ester <b>46</b> (2.8 g, 7.2 mmol) in DCM (10 mL) was added CF<sub>3</sub>CO<sub>2</sub>H (10 mL) at rt and stirred for 2 h. The reaction mixture was evaporated to dryness, and the resulting acid was taken to the next step without further purification. To this acid in DMF (32 mL) were added amine <b>55</b> (2 g, 6.5 mmol), HOBt (1.07 g, 7.8 mmol), and DIEA (4.5 mL, 26.1 mmol), followed by EDCI (1.5 g, 8.83 mmol) at 0 °C. The resulting mixture was slowly warmed to rt and stirred for 12 h. The reaction mixture was diluted with EtOAc and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 0–10% MeOH in DCM to afford <b>56</b> (3.78 g, 85% yield).</div><div class="NLM_p">To a solution of <b>56</b> (3.78 g, 6.1 mmol) in DMF (35 mL) was added a solution of KHMDS (15 mL, 0.9 M in THF, 13.36 mmol) at −50 °C. The resulting mixture was slowly warmed to rt and stirred for 2 h. Then, the reaction mixture was diluted with water, carefully neutralized with 1 N aqueous solution of HCl, and extracted with EtOAc. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 3% MeOH/7 N NH<sub>3</sub> in DCM to afford <b>57</b> (2 g, 56% yield).</div><div class="NLM_p last">To a solution of this Boc-protected intermediate <b>57</b> (1.1 g, 1.9 mmol) in DCM (2 mL) was added CF<sub>3</sub>CO<sub>2</sub>H (2 mL) and stirred at rt for 10 min. The reaction mixture was diluted with EtOAc and carefully neutralized with saturated aqueous solution of NaHCO<sub>3</sub>. The EtOAc layer was separated, washed with brine, dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 4% MeOH/7 N NH<sub>3</sub> in DCM to afford the free amine, which was dissolved in H<sub>3</sub>PO<sub>4</sub> (2 mL) and heated at 105 °C for 2 h. The reaction mixture was diluted with EtOAc and carefully neutralized with saturated aqueous solution of NaHCO<sub>3</sub>. The EtOAc layer was separated, washed with brine, dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 5% MeOH in DCM to afford the racemic <b>58</b>. The enantiomers were separated using chiral HPLC (Chiralpak AD column, 20 μm, 5 cm × 50 cm, 40 mL/min, 70% hexane/isopropanol) to afford the desired enantiomer <b>20</b> (0.194 g, fast eluting, <i>t</i><sub>R</sub> = 15 min, 22% yield) and enantiomer <b>59</b> (0.15 g, slow eluting, <i>t</i><sub>R</sub> = 26.1 min, 17% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.17 (d, <i>J</i> = 1.6 Hz, 1H), 7.66–7.58 (m, 2H), 7.47–7.38 (m, 1H), 7.40–7.26 (m, 3H), 6.33 (s, 1H), 5.21–5.06 (m, 1H), 4.07–3.87 (m, 5H), 3.82–3.66 (m, 2H), 3.09–2.91 (m, 2H), 2.52–2.38 (m, 4H), 2.30 (m, 1H). <i>m</i>/<i>z</i>: 469.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>S</i>)-9-(3-Methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)-4-(3,4,5-trifluorophenyl)-3,4,7,8-tetrahydro-6<i>H</i>-[1,2,4]oxadiazino[4,3-<i>a</i>]azepine (<b>21</b>)</h4><div class="NLM_p">To a mixture of <b>63</b> (5 g, 15.4 mmol), Ph<sub>3</sub>P (4.7 g, 17.9 mmol), and <i>N</i>-hydroxyphthalimide (3 g, 18.4 mmol) in THF (75 mL) was added DIAD (3.59 mL, 18.5 mmol) at −30 °C, and the resulting mixture was slowly warmed to rt and stirred for 12 h. The reaction mixture was diluted with EtOAc, transferred to a separatory funnel, and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 0–25% EtOAc in hexanes to provide <b>64</b> (7.06 g, 98% yield).</div><div class="NLM_p">To a solution of <b>64</b> (7.06 g, 15 mmol) in the mixture of DCM (100 mL) and ethanol (200 mL) was added hydrazine hydrate (2.25 g, 45 mmol) at 0 °C, and the reaction mixture was warmed to rt and stirred for 30 min. The resulting mixture was filtered, and the filtrate was concentrated to afford the crude product, which was purified by silica gel chromatography using 0–60% EtOAc in hexanes to provide the corresponding hydroxyl amine (4.5 g, 88% yield).</div><div class="NLM_p">To a solution of this hydroxylamine (4.5 g, 13.2 mmol) in DCM (20 mL) was added (Boc)<sub>2</sub>O (6.91 mL, 29.8 mmol) and stirred for 12 h. Then, the reaction mixture was concentrated, and the crude product was purified by silica gel chromatography using 0–30% EtOAc in hexanes to afford <b>65</b> (4.54 g, 80% yield).</div><div class="NLM_p">To a solution of <b>65</b> (2 g, 4.5 mmol) in EtOH (20 mL) was added 10% Pd/C (0.50 g, 0.47 mmol), and the resulting mixture was degassed and backfilled with H<sub>2</sub> (3×) and stirred under the atmosphere of H<sub>2</sub> for 1 h. The reaction mixture was filtered and concentrated, and the crude product was purified by silica gel chromatography using 0–100% EtOAc in hexanes to afford <b>66</b> (1.5 g, ∼100% yield).</div><div class="NLM_p">To a mixture of <b>47</b> (1.64 g, 4.9 mmol), <b>66</b> (1.5 g, 4.9 mmol), and HOBt (0.79 g, 5.2 mmol) in DMF (30 mL) was added DIEA (4 mL, 22.9 mmol) followed by EDCI (1.12 g, 5.9 mmol) at 0 °C. The resulting mixture was slowly warmed to rt and stirred for 12 h. The reaction mixture was diluted with EtOAc and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified using 0–5% MeOH in DCM to afford <b>67</b> (2 g, 65% yield).</div><div class="NLM_p">To a solution of <b>67</b> (1 g, 1.6 mmol) in DMF (16 mL) was added a solution of KHMDS (3.50 mL, 3.5 mmol, 1 M in THF) at −30 °C. The resulting mixture was slowly warmed to rt and stirred for 2 h. Then, the reaction mixture was diluted with water, neutralized with 1 N HCl, and extracted with EtOAc. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated to afford <b>68</b> (0.60 g, 63.7% yield), which was taken directly to the next step without further purification.</div><div class="NLM_p last">A mixture of <b>68</b> (0.44 g, 0.75 mmol) and POCl<sub>3</sub> (8 mL) was heated at 80 °C for 45 min. The resulting mixture was evaporated to dryness, and the crude product was purified by reverse-phase HPLC to afford <b>21</b> (0.07 g, 20%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.16 (d, <i>J</i> = 1.4 Hz, 1H), 7.61–7.54 (m, 2H), 7.40 (s, 1H), 7.31 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 7.20 (m, 2H), 6.30 (d, <i>J</i> = 2.5 Hz, 1H), 4.82 (m, 1H), 4.26–4.13 (m, 1H), 4.14–4.02 (m, 1H), 3.98 (s, 3H), 3.57–3.35 (m, 2H), 2.90 (m 2H), 2.43 (d, <i>J</i> = 1.0 Hz, 3H), 2.23 (m, 1H), 2.01 (m, 1H).<i>m</i>/<i>z</i>: 469.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Racemic 9-(3,5-Difluorophenoxy)-4-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)-1,6,7,8,9,9<i>a</i>-hexahydropyrido[1,2-<i>d</i>][1,2,4]oxadiazine (<b>27</b>)</h4><div class="NLM_p">To a solution of alcohol <b>70</b> (1.5 g, 5.5 mmol), 3,5-difluorophenol (0.86 g, 6.6 mmol), and Ph<sub>3</sub>P (1.7 g, 6.6 mmol) in THF (10 mL) was added DEAD (1 mL, 6.6 mmol) at 0 °C and stirred for 0.5 h. Then, the reaction mixture was slowly warmed to rt and stirred for additional 2 h. The reaction mixture was diluted with EtOAc and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 10% EtOAc in hexanes to afford crude <b>72</b> as a mixture with 3,5-difluorophenol (1.6 g).</div><div class="NLM_p">To a solution of LiAlH<sub>4</sub> (4.17 mL, 4.2 mmol) in THF (10 mL) was added a solution of crude <b>72</b> (∼1.6 g, ∼4.2 mmol) in THF (3 mL) at 0 °C and stirred for 10 min. Then, the ice bath was removed and the mixture was stirred at rt for additional 10 min. Excess of EtOAc (4 mL) was added, and the resulting mixture was stirred for 5 min. Then, the reaction mixture was diluted with the mixture of EtOAc/water and solution of aqueous 1 N HCl was added to dissolve the precipitate. The resulting mixture was transferred to a separatory funnel, and the organic layer was separated, washed with brine, dried with MgSO<sub>4</sub>, evaporated, and purified using 0–20% EtOAc in hexanes to afford <b>73</b> in (0.6 g, 42% yield).</div><div class="NLM_p">To this alcohol <b>73</b> (0.2 g, 0.59 mmol) was added a solution of 4 N HCl in dioxane (2 mL) at 0 °C and stirred for 10 min. Then, the ice bath was removed, and the resulting mixture was stirred at rt for 1 h. The reaction mixture was evaporated to dryness, and the resulting HCl salt of the amine was taken to the next step without purification.</div><div class="NLM_p">To this crude amine salt in DMF (1.6 mL) were added acid <b>74</b> (0.129 g, 0.54 mmol), HOBt (0.098 g, 0.64 mmol), and DIEA (0.46 mL, 2.7 mmol) followed by EDCI (0.123 g, 0.64 mmol) at rt and stirred for 18 h. Then, the reaction mixture was diluted with EtOAc and washed with saturated aqueous solution of NaHCO<sub>3</sub> and then with brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated, and the crude product was purified by silica gel chromatography using 5% MeOH in DCM to afford <b>75</b> (0.12 g, 50% yield).</div><div class="NLM_p">To a solution of <b>75</b> (0.122 g, 0.27 mmol) in methanol (2 mL) was added 10% Pd/C (0.028 g, 0.027 mmol), and the reaction mixture was degassed and backfilled with H<sub>2</sub> (3×) and stirred under the atmosphere of H<sub>2</sub> for 12 h. Then, the reaction mixture was filtered, and the filtrate was evaporated to dryness. The crude product was purified by silica gel chromatography using 0–100% EtOAc/ethanol (3:1 v/v) in hexanes as the eluent to give the corresponding hydrogenated alcohol (0.072 g, 57%).</div><div class="NLM_p">To a mixture of this alcohol (0.072 g, 0.15 mmol) and Et<sub>3</sub>N (0.043 mL, 0.31 mmol) in DCM (1 mL) was added MeSO<sub>2</sub>Cl (0.024 mL, 0.31 mmol) at −20 °C and stirred for 30 min. Then, to this mixture was added <i>N</i>-hydroxyphthalimide (0.049 g, 0.31 mmol) followed by Et<sub>3</sub>N (0.043 mL, 0.31 mmol), and the resulting mixture was warmed to rt and stirred for 1 h. Then, the reaction mixture was diluted with EtOAc and washed with saturated aqueous solution of NaHCO<sub>3</sub> followed by brine. The organic layer was dried with MgSO<sub>4</sub> and concentrated, and the crude product was purified by silica gel chromatography using 0–100% EtOAc/ethanol (3:1 v/v) in hexanes as the eluent to give the corresponding Mitsunobu adduct (0.04 g, 43% yield).</div><div class="NLM_p">To this product (0.04 g, 0.07 mmol) in a mixture of EtOH (0.2 mL) and DCM (0.2 mL) was added hydrazine (0.01 mL, 0.33 mmol) at 0 °C. The ice bath was removed and stirred at rt for 0.5 h. The crude reaction mixture was evaporated to dryness and loaded into the column and purified by silica gel chromatography using 0–100% EtOAc/ethanol (3:1 v/v) in hexanes as the eluent to afford <b>77</b> (0.02 g, 64% yield).</div><div class="NLM_p last">A mixture of <b>77</b> (0.02 g, 0.04 mmol) and POCl<sub>3</sub> (0.5 mL) was heated at 90 °C for 3 h. Then, the reaction mixture was evaporated to dryness, and the crude product was purified by reverse-phase HPLC (C18) using 0–90% water/acetonitrile with 0.05% formic acid to afford <b>27</b> (0.004 g, 22% yield). <sup>1</sup>H NMR (599 MHz, CDCl<sub>3</sub>): δ 7.92 (bs, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 1H), 7.24 (d, <i>J</i> = 1.6 Hz, 1H), 7.19 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 6.97 (bs, 1H), 6.50–6.40 (m, 3H), 4.45 (m, 1H), 4.24 (dd, <i>J</i> = 11.6, 5.1 Hz, 1H), 4.12 (dd, <i>J</i> = 11.6, 9.3 Hz, 1H), 3.90 (s, 3H), 3.89–3.82 (m, 1H), 3.58 (d, <i>J</i> = 13.2 Hz, 1H), 2.91 (td, <i>J</i> = 13.1, 2.5 Hz, 1H), 2.34–2.29 (m, 4H), 1.97–1.88 (m, 1H), 1.77–1.66 (m, 1H), 1.56–1.46 (m, 1H). <i>m</i>/<i>z</i>: 455.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00446" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08362" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08362" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00446?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00446</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Protocol for cell-based γ-secretase assay; overlay of <b>4</b>, <b>7</b>, <b>10aa</b>, and <b>10ee</b>; synthesis of compound <b>15</b>; chiral synthesis of compound <b>20</b>; and HPLC traces for compounds <b>11</b>–<b>15</b>, <b>20</b>, <b>21</b>, and <b>27</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00446/suppl_file/jm0c00446_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00446/suppl_file/jm0c00446_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00446/suppl_file/jm0c00446_si_001.pdf">jm0c00446_si_001.pdf (1.14 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00446/suppl_file/jm0c00446_si_002.csv">jm0c00446_si_002.csv (0.78 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00446" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mihirbaran Mandal</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck & Co.,
Inc., 2015 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7870-7271" title="Orcid link">http://orcid.org/0000-0002-7870-7271</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d0bdb9b8b9a2b2b1a2b1befebdb1beb4b1bc90bdb5a2b3bbfeb3bfbd"><span class="__cf_email__" data-cfemail="acc1c5c4c5dececddecdc282c1cdc2c8cdc0ecc1c9decfc782cfc3c1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexei Buevich</span> - <span class="hlFld-Affiliation affiliation">Department
of NMR Structure Elucidation, Merck &
Co., Inc., 2015 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5968-9151" title="Orcid link">http://orcid.org/0000-0002-5968-9151</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John P. Caldwell</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck & Co.,
Inc., 2015 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lynn Hyde</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianhai Huang</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck & Co.,
Inc., 2015 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0757-2047" title="Orcid link">http://orcid.org/0000-0003-0757-2047</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoxiang Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck & Co.,
Inc., 2015 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian McKittrick</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck & Co.,
Inc., 2015 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert D. Mazzola</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck & Co.,
Inc., 2015 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dmitri Pissarnitski</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck & Co.,
Inc., 2015 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anandan Palani</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck & Co.,
Inc., 2015 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lili Zhang</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Parker</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Xiao</span> - <span class="hlFld-Affiliation affiliation">Department
of Modeling and Informatics, Merck &
Co., Inc., 2015 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diane Rindgen</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhaoning Zhu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck & Co.,
Inc., 2015 Galloping
Hill Road, Kenilworth, New
Jersey 07033, United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Ross Yang for his help in LC–MS analysis of the compounds. Rob Garbaccio, Ian Bell, and Dipannita Kalyani are thanked for carefully reading and providing constructive suggestions for the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">ALIS</td><td class="NLM_def"><p class="first last">automated ligand identification system</p></td></tr><tr><td class="NLM_term">FBLD</td><td class="NLM_def"><p class="first last">fragment-based ligand discovery</p></td></tr><tr><td class="NLM_term">BACE</td><td class="NLM_def"><p class="first last">beta-site APP-cleaving enzyme</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">GSM</td><td class="NLM_def"><p class="first last">gamma (γ) secretase modulator</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">H<sub>3</sub>PO<sub>4</sub></td><td class="NLM_def"><p class="first last">phosphoric acid</p></td></tr><tr><td class="NLM_term"><i>n</i>-Bu<sub>3</sub>P</td><td class="NLM_def"><p class="first last">tri-<i>n</i>-butylphosphine</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">CF<sub>3</sub>CO<sub>2</sub>H</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">Pd(Ph<sub>3</sub>)<sub>4</sub></td><td class="NLM_def"><p class="first last">tetrakis(triphenylphosphine)palladium(0)</p></td></tr><tr><td class="NLM_term">Ph<sub>3</sub>P</td><td class="NLM_def"><p class="first last">triphenylphosphine</p></td></tr><tr><td class="NLM_term">Pd(dppf)Cl<sub>2</sub></td><td class="NLM_def"><p class="first last">[1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II)</p></td></tr><tr><td class="NLM_term">ADDP</td><td class="NLM_def"><p class="first last">1,1′-(azodicarbonyl)dipiperidine</p></td></tr><tr><td class="NLM_term">u-HTS</td><td class="NLM_def"><p class="first last">ultrahigh throughput screen</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05015" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05015" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 18 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alzheimer’s
Association</span>. <span> </span><span class="NLM_article-title">Alzheimer’s
Disease Facts and Figures</span>, <span class="NLM_year">2017</span>. <a href="http://www.alz.org/documentscustom/2017-facts-and-figures.pdf" class="extLink">http://www.alz.org/documentscustom/2017-facts-and-figures.pdf</a> (accessed July, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Alzheimer%E2%80%99s%0AAssociation&title=Alzheimer%E2%80%99s%0ADisease+Facts+and+Figures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAlzheimer%25E2%2580%2599s%250ADisease%2520Facts%2520and%2520Figures%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alzheimer’s Disease International</span>. <span> </span><span class="NLM_article-title">World Alzheimer Report</span>, <span class="NLM_year">2016</span>. <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf</a> (accessed July 7, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Alzheimer%E2%80%99s+Disease+International&title=World+Alzheimer+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DWorld%2520Alzheimer%2520Report%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alzheimer’s
Association</span>. <span> </span><span class="NLM_article-title">FDA-approved drugs</span>, <span class="NLM_year">2017</span>. <a href="http://www.alz.org/research/science/alzheimersdiseasetreatments.asp" class="extLink">http://www.alz.org/research/science/alzheimersdiseasetreatments.asp</a> (accessed July, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Alzheimer%E2%80%99s%0AAssociation&title=FDA-approved+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DFDA-approved%2520drugs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federoff, H. J.</span></span> <span> </span><span class="NLM_article-title">Current treatment for Alzheimer’s disease and future prospects</span>. <i>Alzheimer Dis. Assoc. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">S105</span>– <span class="NLM_lpage">S113</span>, <span class="refDoi"> DOI: 10.1097/00002093-200307004-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1097%2F00002093-200307004-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=14512816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Chtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=S105-S113&author=P.+N.+Tariotauthor=H.+J.+Federoff&title=Current+treatment+for+Alzheimer%E2%80%99s+disease+and+future+prospects&doi=10.1097%2F00002093-200307004-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Current Treatment for Alzheimer Disease and Future Prospects</span></div><div class="casAuthors">Tariot, Pierre N.; Federoff, Howard J.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">S105-S113</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  A cascade of pathophysiol. events is triggered in Alzheimer disease (AD) that ultimately involves common cellular signaling pathways and leads to cellular and network dysfunction, failure of neurotransmission, cell death, and a common clin. outcome.  The process is asynchronous, meaning that viable neurons remain as targets for therapy even in the diseased state, and each stage of the cascade affords the possibility for therapeutic intervention.  Cholinesterase inhibitors are the only available treatment in the United States for patients with mild to moderate AD, helping maintain cognitive and functional abilities in most patients and conferring beneficial behavioral effects in some.  Memantine is an NMDA receptor antagonist that has recently been approved in Europe for treatment of moderately severe to severe AD and is under investigation in the United States.  Its mechanism of action may include enhanced neurotransmission in several systems as well as antiexcitotoxic effects.  There are data regarding the effectiveness of the combination of memantine with cholinesterase inhibitors that will be useful for the practicing clinician.  Other agents have shown some benefit in clin. trials, including the antioxidants vitamin E, selegiline, and Ginkgo biloba exts., although the wt. of evidence regarding their effects is not sufficient to define clin. practice.  Potential future therapies currently are in development that target multiple aspects of the illness cascade, including aberrant inflammation, neuro-trophic function, and processing of β amyloid and tau proteins.  These newer approaches hold promise for disease modification but are as yet unproven.  Whether or not disease-modifying or preventive therapies become a reality, clinicians will be faced with AD patients who require treatment at all stages of illness for the indefinite future.  Cholinergic and emerging noncholinergic medications will likely prevail as the stds. of treatment for years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOmJz_fGk1ubVg90H21EOLACvtfcHk0lg6oCXPc2JnQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Chtr4%253D&md5=cf722487ce40361e860b2f890dd8753f</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1097%2F00002093-200307004-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002093-200307004-00005%26sid%3Dliteratum%253Aachs%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26atitle%3DCurrent%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520future%2520prospects%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2003%26volume%3D17%26spage%3DS105%26epage%3DS113%26doi%3D10.1097%2F00002093-200307004-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nordberg, A.</span></span> <span> </span><span class="NLM_article-title">Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease</span>. <i>Alzheimer Dis. Assoc. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">S12</span>– <span class="NLM_lpage">S18</span>, <span class="refDoi"> DOI: 10.1097/01.wad.0000213804.59187.2d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1097%2F01.wad.0000213804.59187.2d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=16772751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFeju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=S12-S18&author=A.+Nordberg&title=Mechanisms+behind+the+neuroprotective+actions+of+cholinesterase+inhibitors+in+Alzheimer+disease&doi=10.1097%2F01.wad.0000213804.59187.2d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer's disease</span></div><div class="casAuthors">Nordberg, Agneta</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2, Suppl. 1</span>),
    <span class="NLM_cas:pages">S12-S18</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the enzyme acetylcholinesterase (AChE) are presently used as long-term symptomatic treatments for patients with Alzheimer's disease (AD), as they enhance central levels of synaptic acetylcholine.  The accumulation of evidence implicating AChE in the pathogenesis of AD raises the question of whether, in addn. to their palliative actions, inhibitors of this enzyme are able to act as disease-modifying agents.  In addn. to their catalytic effects, there is a suggestion that AChE inhibitors may influence expression of AChE isoforms and increase expression of nicotinic receptors, both of which correlate with cognitive improvements in AD patients.  The neuroprotective effect of nicotine, presumably mediated via nicotinic receptors, against β-amyloid (Aβ) toxicity and its effect on amyloid precursor protein (APP) and Aβ prodn. has previously been established.  It has also been shown that AChE inhibitors influence APP processing and attenuate Aβ-induced toxicity via mechanisms including interruption of the prodn. of Aβ, alteration of the levels of Aβ 1-50 and 1-52, and formation of the sol. form of APP.  Some of these effects seem to occur independently of nicotinic receptors, however.  If such exptl. in vitro observations can be extrapolated into clin. neuroprotective properties, AChE inhibitors could pos. modulate the disease course of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_vn_esJ9_SLVg90H21EOLACvtfcHk0lg6oCXPc2JnQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFeju7k%253D&md5=367c676ee4a4c2f1e6eb1985f5f7a556</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1097%2F01.wad.0000213804.59187.2d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.wad.0000213804.59187.2d%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26atitle%3DMechanisms%2520behind%2520the%2520neuroprotective%2520actions%2520of%2520cholinesterase%2520inhibitors%2520in%2520Alzheimer%2520disease%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2006%26volume%3D20%26spage%3DS12%26epage%3DS18%26doi%3D10.1097%2F01.wad.0000213804.59187.2d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, R.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date</span>. <i>Alzheimer Dis. Assoc. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1097/01.wad.0000201847.29836.a5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1097%2F01.wad.0000201847.29836.a5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=16493232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslemu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=23-29&author=R.+Bullock&title=Efficacy+and+safety+of+memantine+in+moderate-to-severe+Alzheimer+disease%3A+the+evidence+to+date&doi=10.1097%2F01.wad.0000201847.29836.a5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of memantine in moderate-to-severe Alzheimer's disease: the evidence to date</span></div><div class="casAuthors">Bullock, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Memantine, a moderate-affinity, uncompetitive N-methyl-D-aspartate receptor antagonist, is currently the only agent approved for moderately severe to severe Alzheimer disease (AD) in Europe and for moderate-to-severe Alzheimer disease in the United States.  In clin. trials, memantine has consistently demonstrated a reduced rate of deterioration on global, cognitive, functional, and behavioral measures, across a range of outcome measures compared with usual care.  Notably, improvements vs. placebo were seen in individual activities of daily living and behavior, particularly agitation.  Efficacy was demonstrated in patients with newly diagnosed Alzheimer disease, patients previously or currently receiving acetylcholinesterase inhibitors, and both institutionalized and community-dwelling Alzheimer disease patients.  Memantine has a tolerability profile similar to placebo.  This review presents the results of key clin. trials, and includes clin. relevant analyses, such as nos.-needed-to-treat and effect sizes.  Increased dependency and institutionalization are significant cost drivers in Alzheimer disease.  Memantine is able to reduce dependency, caregiver time required, and mean monthly caregiver and societal costs.  Recent studies of the relationship between Alzheimer disease progression, caregiver burden, and health-care costs emphasize the need for treatments such as memantine that can slow the rate of decline in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoek-h3moVHKrVg90H21EOLACvtfcHk0liANCQJUfgf0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslemu7Y%253D&md5=4c1ef99e957070d2f300d2e6b5c48de8</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1097%2F01.wad.0000201847.29836.a5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.wad.0000201847.29836.a5%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520memantine%2520in%2520moderate-to-severe%2520Alzheimer%2520disease%253A%2520the%2520evidence%2520to%2520date%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2006%26volume%3D20%26spage%3D23%26epage%3D29%26doi%3D10.1097%2F01.wad.0000201847.29836.a5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the “amyloid cascade hypothesis”</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">1040</span>– <span class="NLM_lpage">1044</span>, <span class="refDoi"> DOI: 10.1111/febs.14004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1111%2Ffebs.14004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=28054745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltl2ltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2017&pages=1040-1044&author=J.+Hardy&title=The+discovery+of+Alzheimer-causing+mutations+in+the+APP+gene+and+the+formulation+of+the+%E2%80%9Camyloid+cascade+hypothesis%E2%80%9D&doi=10.1111%2Ffebs.14004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the "amyloid cascade hypothesis"</span></div><div class="casAuthors">Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1040-1044</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The cloning of APP and genetic anal. of families with Alzheimer's disease were both reported in 1987 and much present work on the disease is based upon the foundations laid at that time.  Progress was not smooth, however, and many errors were made.  In this memoir, I lay out both the progress and the errors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI5L3CEo5OErVg90H21EOLACvtfcHk0liANCQJUfgf0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltl2ltrs%253D&md5=90f7fbd5565cd181d62ce22b81f4b68a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14004%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DThe%2520discovery%2520of%2520Alzheimer-causing%2520mutations%2520in%2520the%2520APP%2520gene%2520and%2520the%2520formulation%2520of%2520the%2520%25E2%2580%259Camyloid%2520cascade%2520hypothesis%25E2%2580%259D%26jtitle%3DFEBS%2520J.%26date%3D2017%26volume%3D284%26spage%3D1040%26epage%3D1044%26doi%3D10.1111%2Ffebs.14004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease at 25 years</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.15252/emmm.201606210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.15252%2Femmm.201606210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=27025652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=595-608&author=D.+J.+Selkoeauthor=J.+Hardy&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease+at+25+years&doi=10.15252%2Femmm.201606210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease at 25 years</span></div><div class="casAuthors">Selkoe, Dennis J.; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">595-608</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Despite continuing debate about the amyloid β-protein or Aβ hypothesis, new lines of evidence from labs. and clinics worldwide support the concept that an imbalance between prodn. and clearance of Aβ42 and related Aβ peptides is a very early, often initiating factor in Alzheimer's disease AD.  Confirmation that presenilin is the catalytic site of γ-secretase has provided a linchpin: all dominant mutations causing early-onset AD occur either in the substrate amyloid precursor protein, APP or the protease presenilin of the reaction that generates Aβ.  Duplication of the wild-type APP gene in Down's syndrome leads to Aβ deposits in the teens, followed by microgliosis, astrocytosis, and neurofibrillary tangles typical of AD.  Apolipoprotein E4, which predisposes to AD in > 40% of cases, has been found to impair Aβ clearance from the brain.  Sol. oligomers of Aβ42 isolated from AD patients' brains can decrease synapse no., inhibit long-term potentiation, and enhance long-term synaptic depression in rodent hippocampus, and injecting them into healthy rats impairs memory.  The human oligomers also induce hyperphosphorylation of tau at AD-relevant epitopes and cause neuritic dystrophy in cultured neurons.  Crossing human APP with human tau transgenic mice enhances tau-pos. neurotoxicity.  In humans, new studies show that low cerebrospinal fluid CSF Aβ42 and amyloid-PET positivity precede other AD manifestations by many years.  Most importantly, recent trials of three different Aβ antibodies solanezumab, crenezumab, and aducanumab have suggested a slowing of cognitive decline in post hoc analyses of mild AD subjects.  Although many factors contribute to AD pathogenesis, Aβ dyshomeostasis has emerged as the most extensively validated and compelling therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGo1qmyvVtbVg90H21EOLACvtfcHk0liANCQJUfgf0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D&md5=b7a2003ba5d341f5eef5c7e9454235ce</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.15252%2Femmm.201606210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201606210%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520at%252025%2520years%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D595%26epage%3D608%26doi%3D10.15252%2Femmm.201606210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+Hardyauthor=G.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lgo0B8Gk1HYeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DHiggins%26aufirst%3DG.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problem on the road to therapeutics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problem+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lgo0B8Gk1HYeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problem%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Aβ oligomers: a decade of discovery</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1172</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04426.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1111%2Fj.1471-4159.2006.04426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=17286590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1172-1184&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=A%CE%B2+oligomers%3A+a+decade+of+discovery&doi=10.1111%2Fj.1471-4159.2006.04426.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3eR"><div class="casContent"><span class="casTitleNuber">3e</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers - a decade of discovery</span></div><div class="casAuthors">Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1172-1184</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Converging lines of evidence suggest that progressive accumulation of the amyloid β-protein (Aβ) plays a central role in the genesis of Alzheimer's disease, but it was long assumed that Aβ had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects.  Over the past decade, data have emerged from the use of synthetic Aβ peptides, cell culture models, β-amyloid precursor protein transgenic mice and human brain to suggest that pre-fibrillar, diffusible assemblies of Aβ are also deleterious.  Although the precise mol. identity of these sol. toxins remains unsettled, accumulating evidence suggests that sol. forms of Aβ are indeed the proximate effectors of synapse loss and neuronal injury.  Here the authors review recent progress in understanding the role of sol. oligomers in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrWrluV1aL7Vg90H21EOLACvtfcHk0lgo0B8Gk1HYeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D&md5=263855754364d2ab520e6fd705b9f5f7</span></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04426.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DA%25CE%25B2%2520oligomers%253A%2520a%2520decade%2520of%2520discovery%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D1172%26epage%3D1184%26doi%3D10.1111%2Fj.1471-4159.2006.04426.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1002/ana.24188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1002%2Fana.24188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=24853080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=185-205&author=E.+Karranauthor=J.+Hardy&title=A+critique+of+the+drug+discovery+and+phase+3+clinical+programs+targeting+the+amyloid+hypothesis+for+Alzheimer+disease&doi=10.1002%2Fana.24188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span></div><div class="casAuthors">Karran, Eric; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-205</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Review of a critique of the drug discovery and phase 3 clin. programs targeting the amyloid hypothesis for Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjQE-UU2jSXbVg90H21EOLACvtfcHk0lhmOetqwMFb0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K&md5=64287890331df95f3e2594ef711cdc27</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1002%2Fana.24188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24188%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DA%2520critique%2520of%2520the%2520drug%2520discovery%2520and%2520phase%25203%2520clinical%2520programs%2520targeting%2520the%2520amyloid%2520hypothesis%2520for%2520Alzheimer%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2014%26volume%3D76%26spage%3D185%26epage%3D205%26doi%3D10.1002%2Fana.24188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrup, K.</span></span> <span> </span><span class="NLM_article-title">Re-imagining Alzheimer’s disease - the diminishing importance of amyloid and a glimpse of what lies ahead</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1111/jnc.14079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1111%2Fjnc.14079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=28547865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVanu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2017&pages=432-444&author=K.-H.+Tseauthor=K.+Herrup&title=Re-imagining+Alzheimer%E2%80%99s+disease+-+the+diminishing+importance+of+amyloid+and+a+glimpse+of+what+lies+ahead&doi=10.1111%2Fjnc.14079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Re-imagining Alzheimer's disease - the diminishing importance of amyloid and a glimpse of what lies ahead</span></div><div class="casAuthors">Tse, Kai-Hei; Herrup, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">432-444</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Many have criticized the amyloid cascade hypothesis of Alzheimer's disease for its inconsistencies and failures to either accurately predict disease symptoms or guide the development of productive therapies.  In addn. to criticisms, however, we believe that the field would benefit from having alternative narratives and disease models that can either replace or function alongside of an amyloid-centric view of Alzheimer's.  This review is an attempt to meet that need.  We offer three exptl. verified amyloid-independent mechanisms, each of which plausibly contributes substantially to the etiol. of Alzheimer's disease: loss of DNA integrity, faulty cell cycle regulation, regression of myelination.  We outline the ways in which the failure of each can contribute to AD initiation and progression, and review how, acting alone or in combination with each other, they are sufficient for explaining the full range of AD pathologies.  Yet, these three alternatives represent only a few of the many non-amyloid mechanisms that can explain AD pathogenesis.  Therefore instead of proposing a single 'alternative hypothesis' to the amyloid cascade theory, sporadic AD is pictured as the result of independent yet intersecting age-related pathologies that afflict the ageing human brain. .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfYujk-b2vULVg90H21EOLACvtfcHk0lhmOetqwMFb0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVanu7jL&md5=957b5135a8eba9702e442ea80d431c09</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1111%2Fjnc.14079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.14079%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DK.-H.%26aulast%3DHerrup%26aufirst%3DK.%26atitle%3DRe-imagining%2520Alzheimer%25E2%2580%2599s%2520disease%2520-%2520the%2520diminishing%2520importance%2520of%2520amyloid%2520and%2520a%2520glimpse%2520of%2520what%2520lies%2520ahead%26jtitle%3DJ.%2520Neurochem.%26date%3D2017%26volume%3D143%26spage%3D432%26epage%3D444%26doi%3D10.1111%2Fjnc.14079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Das, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span> <span> </span><span class="NLM_article-title">A close look at BACE1 inhibitors for Alzheimer’s Disease treatment</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1007/s40263-019-00613-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1007%2Fs40263-019-00613-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=30830576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotFSgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=251-263&author=B.+Dasauthor=R.+Yan&title=A+close+look+at+BACE1+inhibitors+for+Alzheimer%E2%80%99s+Disease+treatment&doi=10.1007%2Fs40263-019-00613-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment</span></div><div class="casAuthors">Das, Brati; Yan, Riqiang</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-263</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), the most common cause of age-dependent dementia, is one of the most significant healthcare problems worldwide.  Aggravating this situation, drugs that are currently US Food and Drug Administration (FDA)-approved for AD treatment do not prevent or delay disease progression.  Therefore, developing effective therapies for AD patients is of crit. urgency.  Human genetic and clin. studies over the past three decades have indicated that abnormal generation or accumulation of amyloid-β (Aβ) peptides is a likely culprit in AD pathogenesis.  Aβ is generated from amyloid precursor protein (APP) via proteolytic cleavage by β-site APP cleaving enzyme 1 (BACE1) (memapsin 2, β-secretase, Asp 2 protease) and γ-secretase.  Mice deficient in BACE1 show abrogated prodn. of Aβ.  Therefore, pharmacol. inhibition of BACE1 is being intensively pursued as a therapeutic approach to treat AD patients.  Recent setbacks in clin. trials with BACE1 inhibitors have highlighted the crit. importance of understanding how to properly inhibit BACE1 to treat AD patients.  This review summarizes the recent studies on the role of BACE1 in synaptic functions as well as our views on BACE1 inhibition as an effective AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogSOzaAUyLKLVg90H21EOLACvtfcHk0lhmOetqwMFb0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotFSgsrs%253D&md5=fb021e993301bde0aeb2be8c5cba6e8c</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1007%2Fs40263-019-00613-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-019-00613-7%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DB.%26aulast%3DYan%26aufirst%3DR.%26atitle%3DA%2520close%2520look%2520at%2520BACE1%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520treatment%26jtitle%3DCNS%2520Drugs%26date%3D2019%26volume%3D33%26spage%3D251%26epage%3D263%26doi%3D10.1007%2Fs40263-019-00613-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbeau, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegmund, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of AM-6494: A potent and orally efficacious β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor with in vivo selectivity over BACE2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2263</span>– <span class="NLM_lpage">2281</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A280%3ADC%252BB3MnlsFemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2263-2281&author=L.+H.+Pettusauthor=M.+P.+Bourbeauauthor=J.+Bradleyauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=D.+Hickmanauthor=M.+Johnsonauthor=Q.+Liuauthor=J.+R.+Manningauthor=A.+Nanezauthor=A.+C.+Siegmundauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=J.+R.+Allenauthor=S.+Wood&title=Discovery+of+AM-6494%3A+A+potent+and+orally+efficacious+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitor+with+in+vivo+selectivity+over+BACE2&doi=10.1021%2Facs.jmedchem.9b01034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2</span></div><div class="casAuthors">Pettus Liping H; Bourbeau Matthew P; Bradley Jodi; Bartberger Michael D; Chen Kui; Hickman Dean; Johnson Michael; Liu Qingyian; Manning James R; Nanez Adrian; Siegmund Aaron C; Wen Paul H; Whittington Douglas A; Allen Jennifer R; Wood Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2263-2281</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is an aspartyl protease that plays a key role in the production of amyloid β (Aβ) in the brain and has been extensively pursued as a target for the treatment of Alzheimer's disease (AD).  BACE2, an aspartyl protease that is structurally related to BACE1, has been recently reported to be involved in melanosome maturation and pigmentation.  Herein, we describe the development of a series of cyclopropylthiazines as potent and orally efficacious BACE1 inhibitors.  Lead optimization led to the identification of 20, a molecule with biochemical IC50 BACE2/BACE1 ratio of 47.  Administration of 20 resulted in no skin/fur color change in a 13-day mouse hypopigmentation study and demonstrated robust and sustained reduction of CSF and brain Aβ40 levels in rat and monkey pharmacodynamic models.  On the basis of a compelling data package, 20 (AM-6494) was advanced to preclinical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmgrDHvGragzjk2McQZ6XmfW6udTcc2ebfBhntsm2iyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnlsFemug%253D%253D&md5=abc7ed1f6b97a705d9b43ea992712a97</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01034%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DManning%26aufirst%3DJ.%2BR.%26aulast%3DNanez%26aufirst%3DA.%26aulast%3DSiegmund%26aufirst%3DA.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520AM-6494%253A%2520A%2520potent%2520and%2520orally%2520efficacious%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitor%2520with%2520in%2520vivo%2520selectivity%2520over%2520BACE2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2263%26epage%3D2281%26doi%3D10.1021%2Facs.jmedchem.9b01034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teisman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urmaliya, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bergh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Discovery of an extremely potent thiazine-based β-secretase inhibitor with reduced cardiovascular and liver toxicity at a low projected human dose</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9337</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01140</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01140" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVentrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9331-9337&author=G.+Tadanoauthor=K.+Komanoauthor=S.+Yoshidaauthor=S.+Suzukiauthor=K.+Nakaharaauthor=K.+Fuchinoauthor=K.+Fujimotoauthor=E.+Matsuokaauthor=T.+Yamamotoauthor=N.+Asadaauthor=H.+Itoauthor=G.+Sakaguchiauthor=N.+Kanegawaauthor=Y.+Kidoauthor=S.+Andoauthor=T.+Fukushimaauthor=A.+Teismanauthor=V.+Urmaliyaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=A.+Van+Den+Berghauthor=N.+Austinauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-I.+Kusakabe&title=Discovery+of+an+extremely+potent+thiazine-based+%CE%B2-secretase+inhibitor+with+reduced+cardiovascular+and+liver+toxicity+at+a+low+projected+human+dose&doi=10.1021%2Facs.jmedchem.9b01140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose</span></div><div class="casAuthors">Tadano, Genta; Komano, Kazuo; Yoshida, Shuhei; Suzuki, Shinji; Nakahara, Kenji; Fuchino, Kouki; Fujimoto, Kazuki; Matsuoka, Eriko; Yamamoto, Takahiko; Asada, Naoya; Ito, Hisanori; Sakaguchi, Gaku; Kanegawa, Naoki; Kido, Yasuto; Ando, Shigeru; Fukushima, Tamio; Teisman, Ard; Urmaliya, Vijay; Dhuyvetter, Deborah; Borghys, Herman; Van Den Bergh, An; Austin, Nigel; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9331-9337</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Genetic evidence points to deposition of amyloid-β (Aβ) as a causal factor for Alzheimer's disease.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  Starting with an oxazine lead 1, we describe the discovery of a thiazine-based BACE1 inhibitor 5 with robust Aβ redn. in vivo at low concns., leading to a low projected human dose of 14 mg/day where 5 achieved sustained Aβ redn. of 80% at trough level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCgZp0A9J8rbVg90H21EOLACvtfcHk0liS9NV1uYrwzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVentrnO&md5=8f6c618bad3fc4bcf7bfb97b48972fa3</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01140%26sid%3Dliteratum%253Aachs%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DKanegawa%26aufirst%3DN.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DTeisman%26aufirst%3DA.%26aulast%3DUrmaliya%26aufirst%3DV.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BDen%2BBergh%26aufirst%3DA.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DDiscovery%2520of%2520an%2520extremely%2520potent%2520thiazine-based%2520%25CE%25B2-secretase%2520inhibitor%2520with%2520reduced%2520cardiovascular%2520and%2520liver%2520toxicity%2520at%2520a%2520low%2520projected%2520human%2520dose%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9331%26epage%3D9337%26doi%3D10.1021%2Facs.jmedchem.9b01140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of selective β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: Targeting the flap to gain selectivity over BACE2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5080</span>– <span class="NLM_lpage">5095</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00309</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00309" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotl2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5080-5095&author=K.+Fujimotoauthor=E.+Matsuokaauthor=N.+Asadaauthor=G.+Tadanoauthor=T.+Yamamotoauthor=K.+Nakaharaauthor=K.+Fuchinoauthor=H.+Itoauthor=N.+Kanegawaauthor=D.+Moecharsauthor=H.+J.+M.+Gijsenauthor=K.-I.+Kusakabe&title=Structure-based+design+of+selective+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+Targeting+the+flap+to+gain+selectivity+over+BACE2&doi=10.1021%2Facs.jmedchem.9b00309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2</span></div><div class="casAuthors">Fujimoto, Kazuki; Matsuoka, Eriko; Asada, Naoya; Tadano, Genta; Yamamoto, Takahiko; Nakahara, Kenji; Fuchino, Kouki; Ito, Hisanori; Kanegawa, Naoki; Moechars, Diederik; Gijsen, Harrie J. M.; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5080-5095</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer's disease.  BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin pigments.  This role of BACE2 implies that nonselective and chronic inhibition of BACE1 may cause side effects derived from BACE2.  Herein, we describe the discovery of potent and selective BACE1 inhibitors using structure-based drug design.  We targeted the flap region, where the shape and flexibility differ between these enzymes.  Anal. of the cocrystal structures of an initial lead 8 prompted us to incorporate spirocycles followed by its fine-tuning, culminating in highly selective compds. 21 and 22.  The structures of 22 bound to BACE1 and BACE2 revealed that a relatively high energetic penalty in the flap of the 22-bound BACE2 structure may cause a loss in BACE2 potency, thereby leading to its high selectivity.  These findings and insights should contribute to responding to the challenges in exploring selective BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGdAN0ejWNyrVg90H21EOLACvtfcHk0liS9NV1uYrwzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotl2nt7w%253D&md5=9ceba959612bdac96dfdda689ad6f0e8</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00309%26sid%3Dliteratum%253Aachs%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DE.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DKanegawa%26aufirst%3DN.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DStructure-based%2520design%2520of%2520selective%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520Targeting%2520the%2520flap%2520to%2520gain%2520selectivity%2520over%2520BACE2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5080%26epage%3D5095%26doi%3D10.1021%2Facs.jmedchem.9b00309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzelak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michener, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of an iminoheterocyclic β-site amyloid precursor protein cleaving enzyme (BACE) inhibitor that lowers central Aβ in nonhuman primates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3231</span>– <span class="NLM_lpage">3248</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01995</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01995" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFaqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3231-3248&author=M.+Mandalauthor=Y.+Wuauthor=J.+Misiaszekauthor=G.+Liauthor=A.+Buevichauthor=J.+P.+Caldwellauthor=X.+Liuauthor=R.+D.+Mazzolaauthor=P.+Orthauthor=C.+Stricklandauthor=J.+Voigtauthor=H.+Wangauthor=Z.+Zhuauthor=X.+Chenauthor=M.+Grzelakauthor=L.+A.+Hydeauthor=R.+Kuvelkarauthor=P.+T.+Leachauthor=G.+Terracinaauthor=L.+Zhangauthor=Q.+Zhangauthor=M.+S.+Michenerauthor=B.+Smithauthor=K.+Coxauthor=D.+Grotzauthor=L.+Favreauauthor=K.+Mitraauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=M.+E.+Kennedyauthor=E.+M.+Parkerauthor=J.+N.+Cummingauthor=A.+W.+Stamford&title=Structure-based+design+of+an+iminoheterocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE%29+inhibitor+that+lowers+central+A%CE%B2+in+nonhuman+primates&doi=10.1021%2Facs.jmedchem.5b01995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates</span></div><div class="casAuthors">Mandal, Mihirbaran; Wu, Yusheng; Misiaszek, Jeffrey; Li, Guoqing; Buevich, Alexei; Caldwell, John P.; Liu, Xiaoxiang; Mazzola, Robert D.; Orth, Peter; Strickland, Corey; Voigt, Johannes; Wang, Hongwu; Zhu, Zhaoning; Chen, Xia; Grzelak, Michael; Hyde, Lynn A.; Kuvelkar, Reshma; Leach, Prescott T.; Terracina, Giuseppe; Zhang, Lili; Zhang, Qi; Michener, Maria S.; Smith, Brad; Cox, Kathleen; Grotz, Diane; Favreau, Leonard; Mitra, Kaushik; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Kennedy, Matthew E.; Parker, Eric M.; Cumming, Jared N.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3231-3248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe successful efforts to optimize the in vivo profile and address off-target liabilities of a series of BACE1 inhibitors represented by 6 that embodies the recently validated fused pyrrolidine iminopyrimidinone scaffold.  Employing structure-based design, truncation of the cyanophenyl group of I that binds in the S3 pocket of BACE1 followed by modification of the thienyl group in S1 was pursued.  Optimization of the pyrimidine substituent that binds in the S2'-S2'' pocket of BACE1 remediated time-dependent CYP3A4 inhibition of earlier analogs in this series and imparted high BACE1 affinity.  These efforts resulted in the discovery of difluorophenyl analog II (MBi-4), which robustly lowered CSF and cortex Aβ40 in both rats and cynomolgus monkeys following a single oral dose.  II represents a unique mol. shape among BACE inhibitors reported to potently lower central Aβ in nonrodent preclin. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoscm_jumartLVg90H21EOLACvtfcHk0lg3uAamLfUOiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFaqur4%253D&md5=7715946acdd54d5b11d856a37e1ef0a2</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01995%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLeach%26aufirst%3DP.%2BT.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DMichener%26aufirst%3DM.%2BS.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DGrotz%26aufirst%3DD.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure-based%2520design%2520of%2520an%2520iminoheterocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE%2529%2520inhibitor%2520that%2520lowers%2520central%2520A%25CE%25B2%2520in%2520nonhuman%2520primates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3231%26epage%3D3248%26doi%3D10.1021%2Facs.jmedchem.5b01995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzelak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9345</span>, <span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5f</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lg3uAamLfUOiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)-A β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29-A+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5g</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0lgl4w09Q7gAug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529-A%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertsik, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-M.</span></span> <span> </span><span class="NLM_article-title">γ-Secretase inhibitors: from chemical probes to drug development</span>. <i>Dev. Ther. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/b978-0-12-802173-6.00004-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fb978-0-12-802173-6.00004-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisV2lsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=63-76&author=J.-Y.+Hurauthor=N.+Gertsikauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=%CE%B3-Secretase+inhibitors%3A+from+chemical+probes+to+drug+development&doi=10.1016%2Fb978-0-12-802173-6.00004-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase inhibitors: from chemical probes to drug development</span></div><div class="casAuthors">Hur, J.-Y.; Gertsik, N.; Johnson, D. S.; Li, Y.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Developing Therapeutics for Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-76</span>CODEN:
                <span class="NLM_cas:coden">69UPPR</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  This chapter discusses about the structure and activity of γ-secretase inhibitors for drug development in treatment of Alzheimer's disease in patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu0ZKZYvGcprVg90H21EOLACvtfcHk0lgl4w09Q7gAug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisV2lsbvK&md5=b62b7897b8d09a67f14b4c8490b62f79</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fb978-0-12-802173-6.00004-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fb978-0-12-802173-6.00004-6%26sid%3Dliteratum%253Aachs%26aulast%3DHur%26aufirst%3DJ.-Y.%26aulast%3DGertsik%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%253A%2520from%2520chemical%2520probes%2520to%2520drug%2520development%26jtitle%3DDev.%2520Ther.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2016%26spage%3D63%26epage%3D76%26doi%3D10.1016%2Fb978-0-12-802173-6.00004-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guarino, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everlof, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haskell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lentz, K. A.</span></span> <span> </span><span class="NLM_article-title">An amide-based sulfenamide prodrug of gamma secretase inhibitor BMS-708163 delivers parent drug from an oral conventional solid dosage form in male beagle dog</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">126856</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.126856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmcl.2019.126856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=31870650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A280%3ADC%252BB3MbjsVartg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=126856&author=V.+R.+Guarinoauthor=R.+E.+Olsonauthor=J.+G.+Everlofauthor=N.+Wangauthor=I.+McDonaldauthor=R.+Haskellauthor=W.+Clarkeauthor=K.+A.+Lentz&title=An+amide-based+sulfenamide+prodrug+of+gamma+secretase+inhibitor+BMS-708163+delivers+parent+drug+from+an+oral+conventional+solid+dosage+form+in+male+beagle+dog&doi=10.1016%2Fj.bmcl.2019.126856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">An amide-based sulfenamide prodrug of gamma secretase inhibitor BMS-708163 delivers parent drug from an oral conventional solid dosage form in male beagle dog</span></div><div class="casAuthors">Guarino Victor R; Olson Richard E; Wang Nenghui; McDonald Ivar; Everlof J Gerry; Haskell Roy; Clarke Wendy; Lentz Kimberley A</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">126856</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The objective of this Letter is to report the first (to our knowledge) in vivo proof of concept for a sulfenamide prodrug to orally deliver a poorly soluble drug containing a weakly-acidic NH-acid from a conventional solid dosage formulation.  This proof of concept was established using BMS-708163 (1), a gamma secretase inhibitor containing a weakly acidic primary amide NH-acid as the chemical handle for attaching a series of thiol-based promoieties via a sulfenamide linkage.  Aqueous stabilities and solubilities are reported for a series of six sulfenamide prodrugs (2-7) of 1.  The sulfenamide prodrug containing the cysteine methyl ester promoiety (5) was chosen for a orally-dosed PK study in male beagle dog comparing a solubilized formulation of 1 against a solid dosage form of 5 in a cross-over fashion at an equivalent molar dose of 3 mg/kg.  Prodrug 5 delivered essentially a superimposable PK profile of 1 compared to the solubilized formulation of 1, without any detectable exposure of 5 in systemic circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_3rnxaibCxsjl5L8hwNX0fW6udTcc2eZZvSXF195Xd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MbjsVartg%253D%253D&md5=223425bc99cab3739d72695cf3604071</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.126856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.126856%26sid%3Dliteratum%253Aachs%26aulast%3DGuarino%26aufirst%3DV.%2BR.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DEverlof%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DMcDonald%26aufirst%3DI.%26aulast%3DHaskell%26aufirst%3DR.%26aulast%3DClarke%26aufirst%3DW.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26atitle%3DAn%2520amide-based%2520sulfenamide%2520prodrug%2520of%2520gamma%2520secretase%2520inhibitor%2520BMS-708163%2520delivers%2520parent%2520drug%2520from%2520an%2520oral%2520conventional%2520solid%2520dosage%2520form%2520in%2520male%2520beagle%2520dog%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D30%26spage%3D126856%26doi%3D10.1016%2Fj.bmcl.2019.126856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josien, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel, potent spirocyclic series of γ-secretase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8806</span>– <span class="NLM_lpage">8817</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00774</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00774" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWltrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8806-8817&author=Z.+Zhaoauthor=D.+A.+Pissarnitskiauthor=H.+B.+Josienauthor=W.-L.+Wuauthor=R.+Xuauthor=H.+Liauthor=J.+W.+Claderauthor=D.+A.+Burnettauthor=G.+Terracinaauthor=L.+Hydeauthor=J.+Leeauthor=L.+Songauthor=L.+Zhangauthor=E.+M.+Parker&title=Discovery+of+a+novel%2C+potent+spirocyclic+series+of+%CE%B3-secretase+inhibitors&doi=10.1021%2Facs.jmedchem.5b00774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors</span></div><div class="casAuthors">Zhao, Zhiqiang; Pissarnitski, Dmitri A.; Josien, Hubert B.; Wu, Wen-Lian; Xu, Ruo; Li, Hongmei; Clader, John W.; Burnett, Duane A.; Terracina, Giuseppe; Hyde, Lynn; Lee, Julie; Song, Lixin; Zhang, Lili; Parker, Eric M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8806-8817</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present paper, we described the design, synthesis, SAR, and biol. profile of a novel spirocyclic sulfone series of γ-secretase inhibitors (GSIs) related to MRK-560.  We utilized an addnl. spirocyclic ring system to stabilize the active chair conformation of the parent γ-secretase inhibitors.  The resulting series is devoid of the CYP2C9 inhibition liability of MRK-560.  A few representative analogs were assessed in a nontransgenic animal model of Alzheimer's disease (AD), demonstrating redn. of amyloid-β (Aβ) in the CNS after acute oral dosing.  A spirocyclic phosphonate was identified as the optimal ring system for both potency and pharmacokinetics.  Compared to GSIs studied in the clinic, representative spirocyclic phosphonate 18a(-) features improved selectivity for the inhibition of the PS-1 isoform of γ-secretase (33-fold vs PS-2), which may alleviate the adverse effect profile of the clin. GSIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7tRDNg55f57Vg90H21EOLACvtfcHk0lidvO1t_GCF4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWltrjO&md5=18b4d8358b5768006308934f471a2c3b</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00774%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DJosien%26aufirst%3DH.%2BB.%26aulast%3DWu%26aufirst%3DW.-L.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DClader%26aufirst%3DJ.%2BW.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520novel%252C%2520potent%2520spirocyclic%2520series%2520of%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8806%26epage%3D8817%26doi%3D10.1021%2Facs.jmedchem.5b00774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubele, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dressen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garofalo, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hom, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konradi, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugg, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neitzel, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semko, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dappen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagodzinski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keim, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latimer, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quincy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldbach, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ness, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zmolek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigham, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kholodenko, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motter, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacayon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santiago, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willits, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bova, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemphill, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruslim, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yednock, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basi, G. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of-(R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-Cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): Metabolically stable γ-secretase inhibitors that selectively inhibit the production of amyloid-β over notch</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5261</span>– <span class="NLM_lpage">5274</span>, <span class="refDoi"> DOI: 10.1021/jm301741t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301741t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVejurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5261-5274&author=G.+Probstauthor=D.+L.+Aubeleauthor=S.+Bowersauthor=D.+Dressenauthor=A.+W.+Garofaloauthor=R.+K.+Homauthor=A.+W.+Konradiauthor=J.+L.+Maruggauthor=M.+N.+Mattsonauthor=M.+L.+Neitzelauthor=C.+M.+Semkoauthor=H.+L.+Shamauthor=J.+Smithauthor=M.+Sunauthor=A.+P.+Truongauthor=X.+M.+Yeauthor=Y.-Z.+Xuauthor=M.+S.+Dappenauthor=J.+J.+Jagodzinskiauthor=P.+S.+Keimauthor=B.+Petersonauthor=L.+H.+Latimerauthor=D.+Quincyauthor=J.+Wuauthor=E.+Goldbachauthor=D.+K.+Nessauthor=K.+P.+Quinnauthor=J.-M.+Sauerauthor=K.+Wongauthor=H.+Zhangauthor=W.+Zmolekauthor=E.+F.+Brighamauthor=D.+Kholodenkoauthor=K.+Huauthor=G.+T.+Kwongauthor=M.+Leeauthor=A.+Liaoauthor=R.+N.+Motterauthor=P.+Sacayonauthor=P.+Santiagoauthor=C.+Willitsauthor=F.+Bardauthor=M.+P.+Bovaauthor=S.+S.+Hemphillauthor=L.+Nguyenauthor=L.+Ruslimauthor=K.+Tanakaauthor=P.+Tanakaauthor=W.+Wallaceauthor=T.+A.+Yednockauthor=G.+S.+Basi&title=Discovery+of-%28R%29-4-cyclopropyl-7%2C8-difluoro-5-%284-%28trifluoromethyl%29phenylsulfonyl%29-4%2C5-dihydro-1H-pyrazolo%5B4%2C3-c%5Dquinoline+%28ELND006%29+and+%28R%29-4-Cyclopropyl-8-fluoro-5-%286-%28trifluoromethyl%29pyridin-3-ylsulfonyl%29-4%2C5-dihydro-2H-pyrazolo%5B4%2C3-c%5Dquinoline+%28ELND007%29%3A+Metabolically+stable+%CE%B3-secretase+inhibitors+that+selectively+inhibit+the+production+of+amyloid-%CE%B2+over+notch&doi=10.1021%2Fjm301741t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (R)-4-Cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-Cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): Metabolically Stable γ-Secretase Inhibitors that Selectively Inhibit the Production of Amyloid-β over Notch</span></div><div class="casAuthors">Probst, Gary; Aubele, Danielle L.; Bowers, Simeon; Dressen, Darren; Garofalo, Albert W.; Hom, Roy K.; Konradi, Andrei W.; Marugg, Jennifer L.; Mattson, Matthew N.; Neitzel, Martin L.; Semko, Chris M.; Sham, Hing L.; Smith, Jenifer; Sun, Minghua; Truong, Anh P.; Ye, Xiaocong M.; Xu, Ying-zi; Dappen, Michael S.; Jagodzinski, Jacek J.; Keim, Pamela S.; Peterson, Brian; Latimer, Lee H.; Quincy, David; Wu, Jing; Goldbach, Erich; Ness, Daniel K.; Quinn, Kevin P.; Sauer, John-Michael; Wong, Karina; Zhang, Hongbin; Zmolek, Wes; Brigham, Elizabeth F.; Kholodenko, Dora; Hu, Kang; Kwong, Grace T.; Lee, Michael; Liao, Anna; Motter, Ruth N.; Sacayon, Patricia; Santiago, Pamela; Willits, Christopher; Bard, Frederique; Bova, Michael P.; Hemphill, Susanna S.; Nguyen, Lam; Ruslim, Lany; Tanaka, Kevin; Tanaka, Pearl; Wallace, William; Yednock, Ted A.; Basi, Guriqbal S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5261-5274</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the authors describe the authors' strategy to design metabolically stable γ-secretase inhibitors which are selective for inhibition of Aβ generation over Notch.  The authors highlight the authors' synthetic strategy to incorporate diversity and chirality.  Compds. ELND006 and ELND007 both entered human clin. trials.  The in vitro and in vivo characteristics for these two compds. are described.  A comparison of inhibition of Aβ generation in vivo between ELND006, ELND007, Semagacestat, Begacestat, and Avagacestat in mice is made. ELND006 lowered Aβ in the CSF of healthy human volunteers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphqWQAuadKJLVg90H21EOLACvtfcHk0lidvO1t_GCF4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVejurg%253D&md5=48ab2a533f077a313c9d934bffd3d713</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1021%2Fjm301741t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301741t%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DAubele%26aufirst%3DD.%2BL.%26aulast%3DBowers%26aufirst%3DS.%26aulast%3DDressen%26aufirst%3DD.%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DHom%26aufirst%3DR.%2BK.%26aulast%3DKonradi%26aufirst%3DA.%2BW.%26aulast%3DMarugg%26aufirst%3DJ.%2BL.%26aulast%3DMattson%26aufirst%3DM.%2BN.%26aulast%3DNeitzel%26aufirst%3DM.%2BL.%26aulast%3DSemko%26aufirst%3DC.%2BM.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DA.%2BP.%26aulast%3DYe%26aufirst%3DX.%2BM.%26aulast%3DXu%26aufirst%3DY.-Z.%26aulast%3DDappen%26aufirst%3DM.%2BS.%26aulast%3DJagodzinski%26aufirst%3DJ.%2BJ.%26aulast%3DKeim%26aufirst%3DP.%2BS.%26aulast%3DPeterson%26aufirst%3DB.%26aulast%3DLatimer%26aufirst%3DL.%2BH.%26aulast%3DQuincy%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGoldbach%26aufirst%3DE.%26aulast%3DNess%26aufirst%3DD.%2BK.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DSauer%26aufirst%3DJ.-M.%26aulast%3DWong%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZmolek%26aufirst%3DW.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DKholodenko%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DKwong%26aufirst%3DG.%2BT.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DA.%26aulast%3DMotter%26aufirst%3DR.%2BN.%26aulast%3DSacayon%26aufirst%3DP.%26aulast%3DSantiago%26aufirst%3DP.%26aulast%3DWillits%26aufirst%3DC.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DBova%26aufirst%3DM.%2BP.%26aulast%3DHemphill%26aufirst%3DS.%2BS.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DP.%26aulast%3DWallace%26aufirst%3DW.%26aulast%3DYednock%26aufirst%3DT.%2BA.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26atitle%3DDiscovery%2520of-%2528R%2529-4-cyclopropyl-7%252C8-difluoro-5-%25284-%2528trifluoromethyl%2529phenylsulfonyl%2529-4%252C5-dihydro-1H-pyrazolo%255B4%252C3-c%255Dquinoline%2520%2528ELND006%2529%2520and%2520%2528R%2529-4-Cyclopropyl-8-fluoro-5-%25286-%2528trifluoromethyl%2529pyridin-3-ylsulfonyl%2529-4%252C5-dihydro-2H-pyrazolo%255B4%252C3-c%255Dquinoline%2520%2528ELND007%2529%253A%2520Metabolically%2520stable%2520%25CE%25B3-secretase%2520inhibitors%2520that%2520selectively%2520inhibit%2520the%2520production%2520of%2520amyloid-%25CE%25B2%2520over%2520notch%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5261%26epage%3D5274%26doi%3D10.1021%2Fjm301741t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorff, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiRico, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efremov, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustilnik, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sneed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capetta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallgren, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7772</span>– <span class="NLM_lpage">7783</span>, <span class="refDoi"> DOI: 10.1021/jm200893p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200893p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7772-7783&author=A.+F.+Stepanauthor=K.+Karkiauthor=W.+S.+McDonaldauthor=P.+H.+Dorffauthor=J.+K.+Dutraauthor=K.+J.+DiRicoauthor=A.+Wonauthor=C.+Subramanyamauthor=I.+V.+Efremovauthor=C.+J.+O%E2%80%99Donnellauthor=C.+E.+Nolanauthor=S.+L.+Beckerauthor=L.+R.+Pustilnikauthor=B.+Sneedauthor=H.+Sunauthor=Y.+Luauthor=A.+E.+Robshawauthor=D.+Riddellauthor=T.+J.+O%E2%80%99Sullivanauthor=E.+Sibleyauthor=S.+Capettaauthor=K.+Atchisonauthor=A.+J.+Hallgrenauthor=E.+Millerauthor=A.+Woodauthor=R.+S.+Obach&title=Metabolism-directed+design+of+oxetane-containing+arylsulfonamide+derivatives+as+%CE%B3-secretase+inhibitors&doi=10.1021%2Fjm200893p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase Inhibitors</span></div><div class="casAuthors">Stepan, Antonia F.; Karki, Kapil; McDonald, W. Scott; Dorff, Peter H.; Dutra, Jason K.; DiRico, Kenneth J.; Won, Annie; Subramanyam, Chakrapani; Efremov, Ivan V.; O'Donnell, Christopher J.; Nolan, Charles E.; Becker, Stacey L.; Pustilnik, Leslie R.; Sneed, Blossom; Sun, Hao; Lu, Yasong; Robshaw, Ashley E.; Riddell, David; O'Sullivan, Theresa J.; Sibley, Evelyn; Capetta, Steven; Atchison, Kevin; Hallgren, Andrew J.; Miller, Emily; Wood, Anthony; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7772-7783</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A metab.-based approach toward the optimization of a series of N-arylsulfonamide-based γ-secretase inhibitors is reported.  The lead cyclohexyl analog 6 suffered from extensive oxidn. on the cycloalkyl motif by cytochrome P 450 3A4, translating into poor human liver microsomal stability.  Knowledge of the metabolic pathways of 6 triggered a structure-activity relationship study aimed at lowering lipophilicity through the introduction of polarity.  This effort led to several tetrahydropyran and THF analogs, wherein the 3- and 4-substituted variants exhibited greater microsomal stability relative to their 2-substituted counterparts.  Further redn. in lipophilicity led to the potent γ-secretase inhibitor and 3-substituted oxetane 1 with a reduced propensity toward oxidative metab., relative to its 2-substituted isomer.  The slower rates of metab. with 3-substituted cyclic ethers most likely originate from redns. in lipophilicity and/or unfavorable CYP active site interactions with the heteroatom.  Preliminary animal pharmacol. studies with a representative oxetane indicate that the series is generally capable of lowering Aβ in vivo.  As such, the study also illustrates the improvement in drug likeness of mols. through the use of the oxetane motif.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1kWyZJuyD97Vg90H21EOLACvtfcHk0ljx8tUH3nNt4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu7rK&md5=b3e9725954a155900563cc5d2f73263b</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1021%2Fjm200893p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200893p%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DW.%2BS.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DDiRico%26aufirst%3DK.%2BJ.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSneed%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DCapetta%26aufirst%3DS.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DHallgren%26aufirst%3DA.%2BJ.%26aulast%3DMiller%26aufirst%3DE.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DMetabolism-directed%2520design%2520of%2520oxetane-containing%2520arylsulfonamide%2520derivatives%2520as%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7772%26epage%3D7783%26doi%3D10.1021%2Fjm200893p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Keown, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaimi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, J. D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Best, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearman, M. S.</span></span> <span> </span><span class="NLM_article-title">Novel orally bioavailable gamma-secretase inhibitors with excellent in vivo activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3441</span>– <span class="NLM_lpage">3444</span>, <span class="refDoi"> DOI: 10.1021/jm900056p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900056p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Grsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3441-3444&author=L.+E.+Keownauthor=I.+Collinsauthor=L.+C.+Cooperauthor=T.+Harrisonauthor=A.+Madinauthor=J.+Mistryauthor=M.+Reillyauthor=M.+Shaimiauthor=C.+J.+Welchauthor=E.+E.+Clarkeauthor=H.+D.+Lewisauthor=J.+D.+J.+Wrigleyauthor=J.+D.+Bestauthor=F.+Murrayauthor=M.+S.+Shearman&title=Novel+orally+bioavailable+gamma-secretase+inhibitors+with+excellent+in+vivo+activity&doi=10.1021%2Fjm900056p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6fR"><div class="casContent"><span class="casTitleNuber">6f</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Orally Bioavailable γ-Secretase Inhibitors with Excellent in Vivo Activity</span></div><div class="casAuthors">Keown, Linda E.; Collins, Ian; Cooper, Laura C.; Harrison, Timothy; Madin, Andrew; Mistry, Jayesh; Reilly, Michael; Shaimi, Mohamed; Welch, Christopher J.; Clarke, Earl E.; Lewis, Huw D.; Wrigley, Jonathan D. J.; Best, Jonathan D.; Murray, Fraser; Shearman, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3441-3444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of potent γ-secretase inhibitors having substituted heterocycles attached to a benzobicyclo[4.2.1]nonane core is described.  This work led to the identification of [6S,9R,11R]-2',3',4',5,5',6,7,8,9,10-decahydro-2-(5-(4-fluorophenyl)-1-methylpyrazol-3-yl)-5'-(2,2,2-trifluoroethyl)spiro[6,9-methanobenzocyclooctene-11,3'-[1,2,5]thiadiazole] 1',1'-dioxide (16), which has excellent in vitro potency (0.06 nM) and which reduced amyloid-β in APP-YAC mice with an ED50 of 1 mg/kg (po).  16 Had a good pharmacokinetic profile in three preclin. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7OIXbqPklvbVg90H21EOLACvtfcHk0lhW9ZI_6X5vYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Grsrs%253D&md5=027fe580c1d9cc066cd780db2edf15c5</span></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1021%2Fjm900056p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900056p%26sid%3Dliteratum%253Aachs%26aulast%3DKeown%26aufirst%3DL.%2BE.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCooper%26aufirst%3DL.%2BC.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DMadin%26aufirst%3DA.%26aulast%3DMistry%26aufirst%3DJ.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DShaimi%26aufirst%3DM.%26aulast%3DWelch%26aufirst%3DC.%2BJ.%26aulast%3DClarke%26aufirst%3DE.%2BE.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%2BJ.%26aulast%3DBest%26aufirst%3DJ.%2BD.%26aulast%3DMurray%26aufirst%3DF.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DNovel%2520orally%2520bioavailable%2520gamma-secretase%2520inhibitors%2520with%2520excellent%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3441%26epage%3D3444%26doi%3D10.1021%2Fjm900056p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, J. D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of highly potent benzodiazepine gamma-secretase inhibitors: preparation of (2S,3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2278</span>, <span class="refDoi"> DOI: 10.1021/jm034058a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm034058a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1Gnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2275-2278&author=I.+Churcherauthor=S.+Williamsauthor=S.+Kerradauthor=T.+Harrisonauthor=J.+L.+Castroauthor=M.+S.+Shearmanauthor=H.+D.+Lewisauthor=E.+E.+Clarkeauthor=J.+D.+J.+Wrigleyauthor=D.+Beherauthor=Y.+S.+Tangauthor=W.+Liu&title=Design+and+synthesis+of+highly+potent+benzodiazepine+gamma-secretase+inhibitors%3A+preparation+of+%282S%2C3R%29-3-%283%2C4-difluorophenyl%29-2-%284-fluorophenyl%29-4-+hydroxy-N-%28%283S%29-1-methyl-2-oxo-5-+phenyl-2%2C3-dihydro-1H-benzo%5Be%5D%5B1%2C4%5D-diazepin-3-yl%29butyramide+by+use+of+an+asymmetric+Ireland-Claisen+rearrangement&doi=10.1021%2Fjm034058a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6gR"><div class="casContent"><span class="casTitleNuber">6g</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Highly Potent Benzodiazepine γ-Secretase Inhibitors: Preparation of (2S,3R)-3-(3,4- Difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]- diazepin-3-yl)butyramide by Use of an Asymmetric Ireland-Claisen Rearrangement</span></div><div class="casAuthors">Churcher, Ian; Williams, Susie; Kerrad, Sonia; Harrison, Timothy; Castro, Jose L.; Shearman, Mark S.; Lewis, Huw D.; Clarke, Earl E.; Wrigley, Jonathan D. J.; Beher, Dirk; Tang, Yui S.; Liu, Wensheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2275-2278</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel benzodiazepine-contg. γ-secretase inhibitors I (R1 = H, Me; R2 = Me, 4-FC6H4; R3 = HO, HOCH2, Me, MeO, BrCH2, etc.; R4 = F, Cl), incorporating a substituted hydrocinnamide C-3 side chain, have been designed for potential use in Alzheimer's disease.  A syn combination of α-alkyl or aryl and β-hydroxy or hydroxymethyl substituents was shown to give highly potent compds.  In particular, benzodiazepine I [R1 = H; R2 = 4-FC6H4; R3 = HOCH2; R4 = F; (II)] demonstrated excellent in vitro potency (IC50 = 0.06nM).  II could also be selectively methylated to give I (R1 = T3C; R2 = 4-FC6H4; R3 = HOCH2; R4 = F), which is of use in radioligand binding assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPzJ36X0rnZrVg90H21EOLACvtfcHk0lhW9ZI_6X5vYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1Gnsbg%253D&md5=7ee4d459a9abb6f6a3308f9736b64191</span></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1021%2Fjm034058a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034058a%26sid%3Dliteratum%253Aachs%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DKerrad%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DCastro%26aufirst%3DJ.%2BL.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DClarke%26aufirst%3DE.%2BE.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%2BJ.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DY.%2BS.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520highly%2520potent%2520benzodiazepine%2520gamma-secretase%2520inhibitors%253A%2520preparation%2520of%2520%25282S%252C3R%2529-3-%25283%252C4-difluorophenyl%2529-2-%25284-fluorophenyl%2529-4-%2520hydroxy-N-%2528%25283S%2529-1-methyl-2-oxo-5-%2520phenyl-2%252C3-dihydro-1H-benzo%255Be%255D%255B1%252C4%255D-diazepin-3-yl%2529butyramide%2520by%2520use%2520of%2520an%2520asymmetric%2520Ireland-Claisen%2520rearrangement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2275%26epage%3D2278%26doi%3D10.1021%2Fjm034058a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bursavich, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgdon, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrdlicka, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapadnis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffit, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patzke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blain, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, D. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of a novel series of oxadiazine gamma secretase modulators for familial Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2383</span>– <span class="NLM_lpage">2400</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01620</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01620" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlyjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2383-2400&author=M.+G.+Bursavichauthor=B.+A.+Harrisonauthor=R.+Acharyaauthor=D.+E.+Costaauthor=E.+A.+Freemanauthor=H.+E.+Hodgdonauthor=L.+A.+Hrdlickaauthor=H.+Jinauthor=S.+Kapadnisauthor=J.+S.+Moffitauthor=D.+A.+Murphyauthor=S.+Nolanauthor=H.+Patzkeauthor=C.+Tangauthor=M.+Wenauthor=G.+Koenigauthor=J.-F.+Blainauthor=D.+A.+Burnett&title=Design%2C+synthesis%2C+and+evaluation+of+a+novel+series+of+oxadiazine+gamma+secretase+modulators+for+familial+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b01620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer's Disease</span></div><div class="casAuthors">Bursavich, Matthew G.; Harrison, Bryce A.; Acharya, Raksha; Costa, Donald E.; Freeman, Emily A.; Hodgdon, Hilliary E.; Hrdlicka, Lori A.; Jin, Hong; Kapadnis, Sudarshan; Moffit, Jeffrey S.; Murphy, Deirdre A.; Nolan, Scott; Patzke, Holger; Tang, Cuyue; Wen, Melody; Koenig, Gerhard; Blain, Jean-Francois; Burnett, Duane A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2383-2400</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the design, synthesis, and evaluation of a novel series of oxadiazine-based gamma secretase modulators obtained via isosteric amide replacement and crit. consideration of conformational restriction.  Oxadiazine lead 47 possesses good in vitro potency with excellent predicted CNS drug-like properties and desirable ADME/PK profile.  This lead compd. demonstrated robust Aβ42 redns. and subsequent Aβ37 increases in both rodent brain and CSF at 30 mg/kg dosed orally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr84T77SPqu9LVg90H21EOLACvtfcHk0lgLEXbnyLy3xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlyjtrw%253D&md5=a14e653792d665cd842cf279c11b2be6</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01620%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DAcharya%26aufirst%3DR.%26aulast%3DCosta%26aufirst%3DD.%2BE.%26aulast%3DFreeman%26aufirst%3DE.%2BA.%26aulast%3DHodgdon%26aufirst%3DH.%2BE.%26aulast%3DHrdlicka%26aufirst%3DL.%2BA.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DKapadnis%26aufirst%3DS.%26aulast%3DMoffit%26aufirst%3DJ.%2BS.%26aulast%3DMurphy%26aufirst%3DD.%2BA.%26aulast%3DNolan%26aufirst%3DS.%26aulast%3DPatzke%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DM.%26aulast%3DKoenig%26aufirst%3DG.%26aulast%3DBlain%26aufirst%3DJ.-F.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520oxadiazine%2520gamma%2520secretase%2520modulators%2520for%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2383%26epage%3D2400%26doi%3D10.1021%2Facs.jmedchem.6b01620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">am Ende, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fish, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetelino, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustilnik, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span> <span> </span><span class="NLM_article-title">Design of pyridopyrazine-1,6-dione γ-secretase modulators that align potency, MDR efflux ratio, and metabolic stability</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVaksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=596-601&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=J.+M.+Humphreyauthor=T.+W.+Butlerauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=P.+B.+Mullinsauthor=C.+J.+O%E2%80%99Donnellauthor=A.+F.+Stepanauthor=C.+M.+Stiffauthor=C.+Subramanyamauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=E.+Yangauthor=L.+Xieauthor=K.+R.+Balesauthor=L.+R.+Pustilnikauthor=S.+J.+Steynauthor=K.+M.+Woodauthor=P.+R.+Verhoest&title=Design+of+pyridopyrazine-1%2C6-dione+%CE%B3-secretase+modulators+that+align+potency%2C+MDR+efflux+ratio%2C+and+metabolic+stability&doi=10.1021%2Facsmedchemlett.5b00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Humphrey, John M.; Butler, Todd W.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Mullins, Patrick B.; O'Donnell, Christopher J.; Stepan, Antonia F.; Stiff, Cory M.; Subramanyam, Chakrapani; Tran, Tuan P.; Vetelino, Beth Cooper; Yang, Eddie; Xie, Longfei; Bales, Kelly R.; Pustilnik, Leslie R.; Steyn, Stefanus J.; Wood, Kathleen M.; Verhoest, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the design and synthesis of a series of pyridopyrazine-1,6-dione γ-secretase modulators (GSMs) for Alzheimer's disease (AD) that achieve good alignment of potency, metabolic stability, and low MDR efflux ratios, while also maintaining favorable physicochem. properties.  Specifically, incorporation of fluorine enabled design of metabolically less liable lipophilic alkyl substituents to increase potency without compromising the sp3-character.  The lead compd. I (PF-06442609) displayed a favorable rodent pharmacokinetic profile, and robust redns. of brain Aβ42 and Aβ40 were obsd. in a guinea pig time-course expt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhW3RYEYEcOrVg90H21EOLACvtfcHk0lgLEXbnyLy3xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVaksrg%253D&md5=ba402f2e67fd9500123cbc7b215d3361</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00070%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DButler%26aufirst%3DT.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDesign%2520of%2520pyridopyrazine-1%252C6-dione%2520%25CE%25B3-secretase%2520modulators%2520that%2520align%2520potency%252C%2520MDR%2520efflux%2520ratio%252C%2520and%2520metabolic%2520stability%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D596%26epage%3D601%26doi%3D10.1021%2Facsmedchemlett.5b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">am Ende, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fish, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navaratnam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustilnik, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetelino, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozdnyakov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-Secretase Modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1021/jm401782h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401782h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1046-1062&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=B.+C.+Vetelinoauthor=K.+M.+Woodauthor=N.+Pozdnyakovauthor=P.+R.+Verhoestauthor=C.+J.+O%E2%80%99Donnell&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+a+novel+series+of+pyridopyrazine-1%2C6-dione+%CE%B3-Secretase+Modulators&doi=10.1021%2Fjm401782h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Vetelino, Beth C.; Wood, Kathleen M.; Pozdnyakov, Nikolay; Verhoest, Patrick R.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1046-1062</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the design and synthesis of a novel series of γ-secretase modulators (GSMs) that incorporates a pyridopiperazine-1,6-dione ring system.  To align improved potency with favorable ADME and in vitro safety, we applied prospective physicochem. property-driven design coupled with parallel medicinal chem. techniques to arrive at a novel series contg. a conformationally restricted core.  Lead compd. I exhibited good in vitro potency and ADME, which translated into a favorable in vivo pharmacokinetic profile.  Furthermore, robust redn. of brain Aβ42 was obsd. in guinea pig at 30 mg/kg dosed orally.  Through chem. biol. efforts involving the design and synthesis of a clickable photoreactive probe, we demonstrated specific labeling of the presenilin N-terminal fragment (PS1-NTF) within the γ-secretase complex, thus gaining insight into the binding site of this series of GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZjw9nXaFFiLVg90H21EOLACvtfcHk0lgLEXbnyLy3xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVGkug%253D%253D&md5=a3d743eea05981a29143a0ec6b43549f</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1021%2Fjm401782h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401782h%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520pyridopyrazine-1%252C6-dione%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1046%26epage%3D1062%26doi%3D10.1021%2Fjm401782h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhondi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicarel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josien, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span> <span> </span><span class="NLM_article-title">The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer’s disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmcl.2012.11.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=23253441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVOrurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=466-471&author=H.+Liauthor=J.+Qinauthor=P.+Dhondiauthor=W.+Zhouauthor=M.+Vicarelauthor=T.+Baraauthor=D.+Coleauthor=H.+Josienauthor=D.+Pissarnitskiauthor=Z.+Zhuauthor=A.+Palaniauthor=R.+Aslanianauthor=J.+Claderauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=M.+Cohen-Williamsauthor=L.+Hydeauthor=L.+Songauthor=L.+Zhangauthor=I.+Chuauthor=X.+Huang&title=The+discovery+of+fused+oxadiazepines+as+gamma+secretase+modulators+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2012.11.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's disease</span></div><div class="casAuthors">Li, Hongmei; Qin, Jun; Dhondi, Pawan; Zhou, Wei; Vicarel, Monica; Bara, Thomas; Cole, David; Josien, Hubert; Pissarnitski, Dmitri; Zhu, Zhaoning; Palani, Anandan; Aslanian, Robert; Clader, John; Czarniecki, Michael; Greenlee, William; Cohen-Williams, Mary; Hyde, Lynn; Song, Lixin; Zhang, Lili; Chu, Inhou; Huang, Xianhai</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">466-471</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an attempt to further improve overall profiles of the oxadiazine series of GSMs, in particular the hERG activity, conformational modifications of the core structure resulted in the identification of fused oxadiazepines such as 7i (I) which had an improved hERG inhibition profile and was a highly efficacious GSM in vitro and in vivo in rats.  These SAR explorations offer opportunities to identify potential drugs to treat Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJUUyjEiaFDbVg90H21EOLACvtfcHk0lhXEhNEbwQzXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVOrurrI&md5=d2c0ec5773714fe62e9056a98823343e</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.055%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DThe%2520discovery%2520of%2520fused%2520oxadiazepines%2520as%2520gamma%2520secretase%2520modulators%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D466%26epage%3D471%26doi%3D10.1016%2Fj.bmcl.2012.11.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthelot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minne, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieters, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masungi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9089</span>– <span class="NLM_lpage">9106</span>, <span class="refDoi"> DOI: 10.1021/jm201710f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201710f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9089-9106&author=F.+Bischoffauthor=D.+Berthelotauthor=M.+De+Cleynauthor=G.+Macdonaldauthor=G.+Minneauthor=D.+Oehlrichauthor=S.+Pietersauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=I.+Velterauthor=M.+Zajaauthor=H.+Borghysauthor=C.+Masungiauthor=M.+Merckenauthor=H.+J.+M.+Gijsen&title=Design+and+synthesis+of+a+novel+series+of+bicyclic+heterocycles+as+potent+%CE%B3-secretase+modulators&doi=10.1021%2Fjm201710f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators</span></div><div class="casAuthors">Bischoff, Francois; Berthelot, Didier; De Cleyn, Michel; MacDonald, Gregor; Minne, Garrett; Oehlrich, Daniel; Pieters, Serge; Surkyn, Michel; Trabanco, Andres A.; Tresadern, Gary; Van Brandt, Sven; Velter, Ingrid; Zaja, Mirko; Borghys, Herman; Masungi, Chantal; Mercken, Marc; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9089-9106</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and the synthesis of several chem. subclasses of imidazole contg. γ-secretase modulators (GSMs) is described.  Conformational restriction of an aminopyridone into bicyclic pyridone isosteres has led to compds. with high in vitro and in vivo potency.  This has resulted in the identification of benzimidazole I as a GSM with low nanomolar potency in vitro.  In mouse, rat, and dog, this compd. displayed the typical γ-secretase modulatory profile by lowering Aβ42 and Aβ40 levels combined with an esp. pronounced increase in Aβ38 and Aβ37 levels while leaving the total levels of amyloid peptides unchanged.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtfwoI1AvXwLVg90H21EOLACvtfcHk0lhXEhNEbwQzXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGrurw%253D&md5=8edaf14f066220910e0d510a563ce02f</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1021%2Fjm201710f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201710f%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMinne%26aufirst%3DG.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DI.%26aulast%3DZaja%26aufirst%3DM.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DMasungi%26aufirst%3DC.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520series%2520of%2520bicyclic%2520heterocycles%2520as%2520potent%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9089%26epage%3D9106%26doi%3D10.1021%2Fjm201710f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creaser, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loureiro, R. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronk, B. S.</span></span> <span> </span><span class="NLM_article-title">Optimization of a Natural Product-Based Class of γ-Secretase Modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9270</span>– <span class="NLM_lpage">9282</span>, <span class="refDoi"> DOI: 10.1021/jm300976b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300976b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9270-9282&author=J.+L.+Hubbsauthor=N.+O.+Fullerauthor=W.+F.+Austinauthor=R.+Shenauthor=S.+P.+Creaserauthor=T.+D.+McKeeauthor=R.+M.+B.+Loureiroauthor=B.+Tateauthor=W.+Xiaauthor=J.+Ivesauthor=B.+S.+Bronk&title=Optimization+of+a+Natural+Product-Based+Class+of+%CE%B3-Secretase+Modulators&doi=10.1021%2Fjm300976b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a Natural Product-Based Class of γ-Secretase Modulators</span></div><div class="casAuthors">Hubbs, Jed L.; Fuller, Nathan O.; Austin, Wesley F.; Shen, Ruichao; Creaser, Steffen P.; McKee, Timothy D.; Loureiro, Robyn M. B.; Tate, Barbara; Xia, Weiming; Ives, Jeffrey; Bronk, Brian S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9270-9282</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of triterpene-based γ-secretase modulators is optimized.  An acetate present at the C24 position of the natural product was replaced with either carbamates or ethers to provide compds. with better metabolic stability.  With one of those pharmacophores in place at C24, morpholines or carbamates were installed at the C3 position to refine the physicochem. properties of the analogs.  This strategy gave compds. with low clearance and good distribution into the central nervous system (CNS) of CD-1 mice.  Two of these compds., I and II, were tested for a pharmacodynamic effect and exhibited statistically significant lowering of brain Aβ42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHBWy3p0wjU7Vg90H21EOLACvtfcHk0lheI_oSeg_8GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLfO&md5=3a826577aa836f3235a4b61468fa0c0e</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1021%2Fjm300976b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300976b%26sid%3Dliteratum%253Aachs%26aulast%3DHubbs%26aufirst%3DJ.%2BL.%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DAustin%26aufirst%3DW.%2BF.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DCreaser%26aufirst%3DS.%2BP.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DLoureiro%26aufirst%3DR.%2BM.%2BB.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DIves%26aufirst%3DJ.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26atitle%3DOptimization%2520of%2520a%2520Natural%2520Product-Based%2520Class%2520of%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9270%26epage%3D9282%26doi%3D10.1021%2Fjm300976b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">am Ende, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fish, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navaratnam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetelino, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustilnik, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2906</span>– <span class="NLM_lpage">2911</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmcl.2012.02.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=22429469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2906-2911&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=R.+Liraauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=K.+M.+Woodauthor=C.+J.+O%E2%80%99Donnell&title=Design+and+synthesis+of+dihydrobenzofuran+amides+as+orally+bioavailable%2C+centrally+active+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2012.02.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7gR"><div class="casContent"><span class="casTitleNuber">7g</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Lira, Ricardo; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Vetelino, Beth C.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Wood, Kathleen M.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2906-2911</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a novel series of dihydrobenzofuran amides as γ-secretase modulators (GSMs) is reported.  Strategies for aligning in vitro potency with drug-like physicochem. properties and good microsomal stability while avoiding P-gp mediated efflux are discussed.  Lead compds. such as I and II have moderate to good in vitro potency and excellent selectivity against Notch.  Good oral bioavailability was achieved as well as robust brain Aβ42 lowering activity at 100 mg/kg po dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcSb2qlgrNLVg90H21EOLACvtfcHk0lheI_oSeg_8GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D&md5=63746bd0db38a20bb33b5e990e66610c</span></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dihydrobenzofuran%2520amides%2520as%2520orally%2520bioavailable%252C%2520centrally%2520active%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2906%26epage%3D2911%26doi%3D10.1016%2Fj.bmcl.2012.02.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asberom, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josien, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacCoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicarel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span> <span> </span><span class="NLM_article-title">Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.1021/jm201407j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201407j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=489-502&author=Z.-Y.+Sunauthor=T.+Asberomauthor=T.+Baraauthor=C.+Bennettauthor=D.+Burnettauthor=I.+Chuauthor=J.+Claderauthor=M.+Cohen-Williamsauthor=D.+Coleauthor=M.+Czarnieckiauthor=J.+Durkinauthor=G.+Galloauthor=W.+Greenleeauthor=H.+Josienauthor=X.+Huangauthor=L.+Hydeauthor=N.+Jonesauthor=I.+Kazakevichauthor=H.+Liauthor=X.+Liuauthor=J.+Leeauthor=M.+MacCossauthor=M.+B.+Mandalauthor=T.+McCrackenauthor=A.+Nomeirauthor=R.+Mazzolaauthor=A.+Palaniauthor=E.+M.+Parkerauthor=D.+A.+Pissarnitskiauthor=J.+Qinauthor=L.+Songauthor=G.+Terracinaauthor=M.+Vicarelauthor=J.+Voigtauthor=R.+Xuauthor=L.+Zhangauthor=Q.+Zhangauthor=Z.+Zhaoauthor=X.+Zhuauthor=Z.+Zhu&title=Cyclic+hydroxyamidines+as+amide+isosteres%3A+discovery+of+oxadiazolines+and+oxadiazines+as+potent+and+highly+efficacious+%CE%B3-secretase+modulators+in+vivo&doi=10.1021%2Fjm201407j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7hR"><div class="casContent"><span class="casTitleNuber">7h</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo</span></div><div class="casAuthors">Sun, Zhong-Yue; Asberom, Theodros; Bara, Thomas; Bennett, Chad; Burnett, Duane; Chu, Inhou; Clader, John; Cohen-Williams, Mary; Cole, David; Czarniecki, Michael; Durkin, James; Gallo, Gioconda; Greenlee, William; Josien, Hubert; Huang, Xianhai; Hyde, Lynn; Jones, Nicholas; Kazakevich, Irina; Li, Hongmei; Liu, Xiaoxiang; Lee, Julie; MacCoss, Malcolm; Mandal, Mihir B.; McCracken, Troy; Nomeir, Amin; Mazzola, Robert; Palani, Anandan; Parker, Eric M.; Pissarnitski, Dmitri A.; Qin, Jun; Song, Lixin; Terracina, Giuseppe; Vicarel, Monica; Voigt, Johannes; Xu, Ruo; Zhang, Lili; Zhang, Qi; Zhao, Zhiqiang; Zhu, Xiaohong; Zhu, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">489-502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality.  Compds. with these structural motifs were found to be metabolically stable and to possess highly desirable pharmacokinetic profiles.  These designs were applied in the identification of γ-secretase modulators leading to highly efficacious agents for redn. of central nervous system Aβ42 in various animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGuNLMGYzw7Vg90H21EOLACvtfcHk0lhlETbHSg7CjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL&md5=5f64483cba26060a60de990fa423014e</span></div><a href="/servlet/linkout?suffix=cit7h&amp;dbid=16384&amp;doi=10.1021%2Fjm201407j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201407j%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.-Y.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMandal%26aufirst%3DM.%2BB.%26aulast%3DMcCracken%26aufirst%3DT.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DCyclic%2520hydroxyamidines%2520as%2520amide%2520isosteres%253A%2520discovery%2520of%2520oxadiazolines%2520and%2520oxadiazines%2520as%2520potent%2520and%2520highly%2520efficacious%2520%25CE%25B3-secretase%2520modulators%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D489%26epage%3D502%26doi%3D10.1021%2Fjm201407j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicarel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCraken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR studies of fused oxadiazines as γ-secretase modulators for treatment of alzheimer’s disease</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">931</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1021/ml300209g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300209g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=931-935&author=X.+Huangauthor=W.+Zhouauthor=X.+Liuauthor=H.+Liauthor=G.+Sunauthor=M.+Mandalauthor=M.+Vicarelauthor=X.+Zhuauthor=C.+Bennettauthor=T.+McCrakenauthor=D.+Pissarnitskiauthor=Z.+Zhaoauthor=D.+Coleauthor=G.+Galloauthor=Z.+Zhuauthor=A.+Palaniauthor=R.+Aslanianauthor=J.+Claderauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=D.+Burnettauthor=M.+Cohen-Williamsauthor=L.+Hydeauthor=L.+Songauthor=L.+Zhangauthor=I.+Chuauthor=A.+Buevich&title=Synthesis+and+SAR+studies+of+fused+oxadiazines+as+%CE%B3-secretase+modulators+for+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1021%2Fml300209g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7iR"><div class="casContent"><span class="casTitleNuber">7i</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Huang, Xianhai; Zhou, Wei; Liu, Xiaoxiang; Li, Hongmei; Sun, George; Mandal, Mihirbaran; Vicarel, Monica; Zhu, Xiaohong; Bennett, Chad; McCraken, Troy; Pissarnitski, Dmitri; Zhao, Zhiqiang; Cole, David; Gallo, Gioconda; Zhu, Zhaoning; Palani, Anandan; Aslanian, Robert; Clader, John; Czarniecki, Michael; Greenlee, William; Burnett, Duane; Cohen-Williams, Mary; Hyde, Lynn; Song, Lixin; Zhang, Lili; Chu, Inhou; Buevich, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">931-935</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fused oxadiazines such as imidazolylbenzylidene pyridooxadiazines I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) and imidazolylbenzylidene oxazinooxadiazines I (R = F; R1 = H, F; R2 = Me; X = O) were prepd. as selective and orally bioavailable γ-secretase modulators (GSMs) derived by analogy from pyridooxadiazoline GSMs.  The effect of structural modifications on pyridooxadiazoline GSMs differed significantly from the effects of modifications to pyridooxadiazine GSMs.  I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) were found to be highly efficacious in vitro and in vivo in a no. of animal models with highly desirable phys. and pharmacol. properties.  Fused morpholine oxadiazines such as I (R = F; R1 = H, F; R2 = Me; X = O) showed improved in vitro activities and selectivities as GSMs.  The shift in specificity of APP cleavage rather than a redn. in overall γ-secretase activity and the lack of changes in substrate accumulation and Notch processing as obsd. in the animal studies of compd. I (R = R1 = F; R2 = H; X = CH2) confirm that imidazolylbenzylidene pyridooxadiazines are potent GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrLJKqS8YPSLVg90H21EOLACvtfcHk0lhlETbHSg7CjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L&md5=42883463705abaa95287df4ea07f8936</span></div><a href="/servlet/linkout?suffix=cit7i&amp;dbid=16384&amp;doi=10.1021%2Fml300209g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300209g%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DMcCraken%26aufirst%3DT.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DBuevich%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520fused%2520oxadiazines%2520as%2520%25CE%25B3-secretase%2520modulators%2520for%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D931%26epage%3D935%26doi%3D10.1021%2Fml300209g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7j"><span><span class="NLM_label">(j) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talreja, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumaravel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humora, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackett, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollate, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunah, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snodgrass-Belt, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taveras, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of BIIB042, a potent, selective, and orally bioavailable γ-secretase modulator</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1021/ml200175q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200175q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVagsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=786-791&author=H.+Pengauthor=T.+Talrejaauthor=Z.+Xinauthor=J.+H.+Cuervoauthor=G.+Kumaravelauthor=M.+J.+Humoraauthor=L.+Xuauthor=E.+Rohdeauthor=L.+Ganauthor=M.-y.+Jungauthor=M.+N.+Shackettauthor=S.+Chollateauthor=A.+W.+Dunahauthor=P.+A.+Snodgrass-Beltauthor=H.+M.+Arnoldauthor=A.+G.+Taverasauthor=K.+J.+Rhodesauthor=R.+H.+Scannevin&title=Discovery+of+BIIB042%2C+a+potent%2C+selective%2C+and+orally+bioavailable+%CE%B3-secretase+modulator&doi=10.1021%2Fml200175q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7jR"><div class="casContent"><span class="casTitleNuber">7j</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BIIB042, a Potent, Selective, and Orally Bioavailable γ-Secretase Modulator</span></div><div class="casAuthors">Peng, Hairuo; Talreja, Tina; Xin, Zhili; Cuervo, J. Hernan; Kumaravel, Gnanasambandam; Humora, Michael J.; Xu, Lin; Rohde, Ellen; Gan, Lawrence; Jung, Mi-young; Shackett, Melanie N.; Chollate, Sowmya; Dunah, Anthone W.; Snodgrass-Belt, Pamela A.; Arnold, H. Moore; Taveras, Arthur G.; Rhodes, Kenneth J.; Scannevin, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">786-791</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have investigated a novel series of acid-derived γ-secretase modulators as a potential treatment of Alzheimer's disease.  Optimization based on cellular potency and brain pharmacodynamics after oral dosing led to the discovery of 10a (BIIB042).  Compd. 10a is a potent γ-secretase modulator, which lowered Aβ42, increased Aβ38, but had little to no effect on Aβ40 levels both in vitro and in vivo.  In addn., compd. 10a did not affect Notch signaling in our in vitro assessment.  Compd. 10a demonstrated excellent pharmacokinetic parameters in multiple species.  Oral administration of 10a significantly reduced brain Aβ42 levels in CF-1 mice and Fischer rats, as well as plasma Aβ42 levels in cynomolgus monkeys.  Compd. 10a was selected as a candidate for preclin. safety evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFxWt4VF-jWrVg90H21EOLACvtfcHk0lhlETbHSg7CjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVagsLzL&md5=10ca58300441819def9dc7a9b9b42386</span></div><a href="/servlet/linkout?suffix=cit7j&amp;dbid=16384&amp;doi=10.1021%2Fml200175q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200175q%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DTalreja%26aufirst%3DT.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DCuervo%26aufirst%3DJ.%2BH.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DHumora%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DRohde%26aufirst%3DE.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DM.-y.%26aulast%3DShackett%26aufirst%3DM.%2BN.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DDunah%26aufirst%3DA.%2BW.%26aulast%3DSnodgrass-Belt%26aufirst%3DP.%2BA.%26aulast%3DArnold%26aufirst%3DH.%2BM.%26aulast%3DTaveras%26aufirst%3DA.%2BG.%26aulast%3DRhodes%26aufirst%3DK.%2BJ.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26atitle%3DDiscovery%2520of%2520BIIB042%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520%25CE%25B3-secretase%2520modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D786%26epage%3D791%26doi%3D10.1021%2Fml200175q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7k"><span><span class="NLM_label">(k) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span> <span> </span><span class="NLM_article-title">Iminoheterocycles as γ-secretase modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5380</span>– <span class="NLM_lpage">5384</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.07.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7k&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmcl.2010.07.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7k&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=20724152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5380-5384&author=J.+P.+Caldwellauthor=C.+E.+Bennettauthor=T.+M.+McCrackenauthor=R.+D.+Mazzolaauthor=T.+Baraauthor=A.+Buevichauthor=D.+A.+Burnettauthor=I.+Chuauthor=M.+Cohen-Williamsauthor=H.+Joseinauthor=L.+Hydeauthor=J.+Leeauthor=B.+McKittrickauthor=L.+Songauthor=G.+Terracinaauthor=J.+Voigtauthor=L.+Zhangauthor=Z.+Zhuauthor=Z.+Zhu&title=Iminoheterocycles+as+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2010.07.121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7kR"><div class="casContent"><span class="casTitleNuber">7k</span><div class="casTitle"><span class="NLM_cas:atitle">Iminoheterocycles as γ-secretase modulators</span></div><div class="casAuthors">Caldwell, John P.; Bennett, Chad E.; McCracken, Troy M.; Mazzola, Robert D.; Bara, Thomas; Buevich, Alexei; Burnett, Duane A.; Chu, Inhou; Cohen-Williams, Mary; Josein, Hubert; Hyde, Lynn; Lee, Julie; McKittrick, Brian; Song, Lixin; Terracina, Giuseppe; Voigt, Johannes; Zhang, Lili; Zhu, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5380-5384</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis of a novel series of iminoheterocycles, e.g., I and their structure-activity relationship (SAR) as modulators of γ-secretase activity will be detailed.  Encouraging SAR generated from a monocyclic core led to a structurally unique bicyclic core.  Selected compds. exhibit good potency as γ-secretase modulators, excellent rat pharmacokinetics, and lowering of Aβ42 levels in various in vivo models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJTxu6-DIEj7Vg90H21EOLACvtfcHk0lgDyIYwbEWJ4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jt7%252FK&md5=4bf01dde9eac151d16e0ebd1fa681685</span></div><a href="/servlet/linkout?suffix=cit7k&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.07.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.07.121%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DBennett%26aufirst%3DC.%2BE.%26aulast%3DMcCracken%26aufirst%3DT.%2BM.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DJosein%26aufirst%3DH.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMcKittrick%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DIminoheterocycles%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5380%26epage%3D5384%26doi%3D10.1016%2Fj.bmcl.2010.07.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S.</span>; <span class="NLM_string-name">Comer, D. D.</span>; <span class="NLM_string-name">Mao, L.</span>; <span class="NLM_string-name">Balow, G. P.</span>; <span class="NLM_string-name">Pleynet, D.</span></span> <span> </span><span class="NLM_article-title">Aryl compounds and uses thereof in modulating amyloid β</span>. PCT Int. Appl. <span class="NLM_patent">WO 2004110350 A2</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Cheng&author=D.+D.+Comer&author=L.+Mao&author=G.+P.+Balow&author=D.+Pleynet&title=Aryl+compounds+and+uses+thereof+in+modulating+amyloid+%CE%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.%26atitle%3DAryl%2520compounds%2520and%2520uses%2520thereof%2520in%2520modulating%2520amyloid%2520%25CE%25B2%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kounnas, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danks, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyree, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Come, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleynet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digregorio, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velicelebi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauderman, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobley, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisodia, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanzi, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S. L.</span></span> <span> </span><span class="NLM_article-title">Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer’s disease</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">780</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2010.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.neuron.2010.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=20826309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=769-780&author=M.+Z.+Kounnasauthor=A.+M.+Danksauthor=S.+Chengauthor=C.+Tyreeauthor=E.+Ackermanauthor=X.+Zhangauthor=K.+Ahnauthor=P.+Nguyenauthor=D.+Comeauthor=L.+Comerauthor=C.+Yuauthor=D.+Pleynetauthor=P.+J.+Digregorioauthor=G.+Velicelebiauthor=K.+A.+Staudermanauthor=W.+T.+Comerauthor=W.+C.+Mobleyauthor=Y.-M.+Liauthor=S.+S.+Sisodiaauthor=R.+E.+Tanziauthor=S.+L.+Wagner&title=Modulation+of+gamma-secretase+reduces+beta-amyloid+deposition+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuron.2010.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Kounnas, Maria Z.; Danks, Anne M.; Cheng, Soan; Tyree, Curtis; Ackerman, Elizabeth; Zhang, Xulun; Ahn, Kwangwook; Nguyen, Phuong; Comer, Dan; Mao, Long; Yu, Chengzhi; Pleynet, David; Digregorio, Paul J.; Velicelebi, Gonul; Stauderman, Kenneth A.; Comer, William T.; Mobley, William C.; Li, Yue-Ming; Sisodia, Sangram S.; Tanzi, Rudolph E.; Wagner, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">769-780</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized pathol. by the abundance of senile plaques and neurofibrillary tangles in the brain.  We synthesized over 1200 novel γ-secretase modulator (GSM) compds. that reduced Aβ42 levels without inhibiting ε-site cleavage of APP and Notch, the generation of the APP and Notch intracellular domains, resp.  These compds. also reduced Aβ40 levels while concomitantly elevating levels of Aβ38 and Aβ37.  Immobilization of a potent GSM onto an agarose matrix quant. recovered Pen-2 and to a lesser degree PS-1 NTFs from cellular exts.  Moreover, oral administration (once daily) of another potent GSM to Tg 2576 transgenic AD mice displayed dose-responsive lowering of plasma and brain Aβ42; chronic daily administration led to significant redns. in both diffuse and neuritic plaques.  These effects were obsd. in the absence of Notch-related changes (e.g., intestinal proliferation of goblet cells), which are commonly assocd. with repeated exposure to functional γ-secretase inhibitors (GSIs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWuvRc6SXyvbVg90H21EOLACvtfcHk0lgDyIYwbEWJ4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamtb%252FI&md5=0963d1dd659c7a9b0e7e876244eeab97</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DKounnas%26aufirst%3DM.%2BZ.%26aulast%3DDanks%26aufirst%3DA.%2BM.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DTyree%26aufirst%3DC.%26aulast%3DAckerman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DCome%26aufirst%3DD.%26aulast%3DComer%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPleynet%26aufirst%3DD.%26aulast%3DDigregorio%26aufirst%3DP.%2BJ.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DStauderman%26aufirst%3DK.%2BA.%26aulast%3DComer%26aufirst%3DW.%2BT.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DY.-M.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DModulation%2520of%2520gamma-secretase%2520reduces%2520beta-amyloid%2520deposition%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D769%26epage%3D780%26doi%3D10.1016%2Fj.neuron.2010.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span>; <span class="NLM_string-name">Kawano, K.</span>; <span class="NLM_string-name">Doi, E.</span>; <span class="NLM_string-name">Kitazawa, N.</span>; <span class="NLM_string-name">Shin, K.</span>; <span class="NLM_string-name">Miyagawa, T.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Ito, K.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Sasaki, T.</span>; <span class="NLM_string-name">Hagiwara, H.</span></span> <span> </span><span class="NLM_article-title">Cinnamide compound</span>. U.S. Patent <span class="NLM_patent">200,60,004,013 A1</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=K.+Shin&author=T.+Miyagawa&author=T.+Kaneko&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=H.+Hagiwara&title=Cinnamide+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DCinnamide%2520compound%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuck, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rege, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logovinsky, V.</span></span> <span> </span><span class="NLM_article-title">P3-415: E2012, a novel gamma-secretase modulator, decreases plasma amyloid-beta (Aβ) levels in humans</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">S574</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.1958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.jalz.2010.05.1958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S574&author=C.+Nagyauthor=E.+Schuckauthor=A.+Ishibashiauthor=Y.+Nakataniauthor=B.+Regeauthor=V.+Logovinsky&title=P3-415%3A+E2012%2C+a+novel+gamma-secretase+modulator%2C+decreases+plasma+amyloid-beta+%28A%CE%B2%29+levels+in+humans&doi=10.1016%2Fj.jalz.2010.05.1958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.1958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.1958%26sid%3Dliteratum%253Aachs%26aulast%3DNagy%26aufirst%3DC.%26aulast%3DSchuck%26aufirst%3DE.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DNakatani%26aufirst%3DY.%26aulast%3DRege%26aufirst%3DB.%26aulast%3DLogovinsky%26aufirst%3DV.%26atitle%3DP3-415%253A%2520E2012%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520decreases%2520plasma%2520amyloid-beta%2520%2528A%25CE%25B2%2529%2520levels%2520in%2520humans%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS574%26doi%3D10.1016%2Fj.jalz.2010.05.1958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span>; <span class="NLM_string-name">Kitazawa, N.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Sato, N.</span>; <span class="NLM_string-name">Kawano, K.</span>; <span class="NLM_string-name">Ito, K.</span>; <span class="NLM_string-name">Doi, E.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Sasaki, T.</span>; <span class="NLM_string-name">Doko, T.</span>; <span class="NLM_string-name">Miyagawa, T.</span>; <span class="NLM_string-name">Hagiwara, H.</span></span> <span> </span><span class="NLM_article-title">Preparation of Phenylvinylheterocyclic Compounds as Amyloid β Production Lowering Agents for Treatment of Amyloid β-Induced Diseases</span>. PCT Int. Appl. <span class="NLM_patent">WO 2007102580 A1</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Kimura&author=N.+Kitazawa&author=T.+Kaneko&author=N.+Sato&author=K.+Kawano&author=K.+Ito&author=E.+Doi&author=M.+Takaishi&author=T.+Sasaki&author=T.+Doko&author=T.+Miyagawa&author=H.+Hagiwara&title=Preparation+of+Phenylvinylheterocyclic+Compounds+as+Amyloid+%CE%B2+Production+Lowering+Agents+for+Treatment+of+Amyloid+%CE%B2-Induced+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Phenylvinylheterocyclic%2520Compounds%2520as%2520Amyloid%2520%25CE%25B2%2520Production%2520Lowering%2520Agents%2520for%2520Treatment%2520of%2520Amyloid%2520%25CE%25B2-Induced%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhondi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">664</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmcl.2010.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=21195610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=664-669&author=J.+Qinauthor=P.+Dhondiauthor=X.+Huangauthor=M.+Mandalauthor=Z.+Zhaoauthor=D.+Pissarnitskiauthor=W.+Zhouauthor=R.+Aslanianauthor=Z.+Zhuauthor=W.+Greenleeauthor=J.+Claderauthor=L.+Zhangauthor=M.+Cohen-Williamsauthor=N.+Jonesauthor=L.+Hydeauthor=A.+Palani&title=Discovery+of+fused+5%2C6-bicyclic+heterocycles+as+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2010.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators</span></div><div class="casAuthors">Qin, Jun; Dhondi, Pawan; Huang, Xianhai; Mandal, Mihirbaran; Zhao, Zhiqiang; Pissarnitski, Dmitri; Zhou, Wei; Aslanian, Robert; Zhu, Zhaoning; Greenlee, William; Clader, John; Zhang, Lili; Cohen-Williams, Mary; Jones, Nicholas; Hyde, Lynn; Palani, Anandan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">664-669</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of four series of fused 5,6-bicyclic heterocycles, e.g., I [R = 4-FC6H4CHMe, 4-(MeO)C6H4CH2, n-pentyl, etc.], as γ-secretase modulators was reported.  The synthesis and SAR of these series were discussed.  These compds. represented a new class of γ-secretase modulators that demonstrated moderate to good in vitro potency in inhibiting Aβ42 prodn.  Specifically, compd. II demonstrated good in vitro and moderate in vivo efficacy as a γ-secretase modulator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnTq6NEaz9XbVg90H21EOLACvtfcHk0lhUx7naNJ4jOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqsw%253D%253D&md5=a85b7d068d89d39d18ce06d6ad748806</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520fused%25205%252C6-bicyclic%2520heterocycles%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D664%26epage%3D669%26doi%3D10.1016%2Fj.bmcl.2010.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhondi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent pyrazolopyridine series of γ-secretase modulators</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1021/ml2000438</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml2000438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=471-476&author=J.+Qinauthor=W.+Zhouauthor=X.+Huangauthor=P.+Dhondiauthor=A.+Palaniauthor=R.+Aslanianauthor=Z.+Zhuauthor=W.+Greenleeauthor=M.+Cohen-Williamsauthor=N.+Jonesauthor=L.+Hydeauthor=L.+Zhang&title=Discovery+of+a+potent+pyrazolopyridine+series+of+%CE%B3-secretase+modulators&doi=10.1021%2Fml2000438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent pyrazolopyridine series of γ-secretase modulators</span></div><div class="casAuthors">Qin, Jun; Zhou, Wei; Huang, Xianhai; Dhondi, Pawan; Palani, Anandan; Aslanian, Robert; Zhu, Zhaoning; Greenlee, William; Cohen-Williams, Mary; Jones, Nicholas; Hyde, Lynn; Zhang, Lili</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationship of a novel series of pyrazolopyridines are reported.  These compds. represent a new class of γ-secretase modulators that demonstrate good in vitro potency in inhibiting Aβ42 prodn.  Examples with statistically significant in vivo efficacy in reducing the prodn. of rat cerebrospinal fluid Aβ42 were also identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2w7CtUkvQh7Vg90H21EOLACvtfcHk0lhUx7naNJ4jOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOlsr0%253D&md5=6c36b585797281fe037510750b111d57</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fml2000438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000438%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520pyrazolopyridine%2520series%2520of%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D471%26epage%3D476%26doi%3D10.1021%2Fml2000438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span> <span> </span><span class="NLM_article-title">The discovery of pyridone and pyridazone heterocycles as γ-secretase modulators</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1021/ml1000799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlyjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=184-187&author=X.+Huangauthor=R.+Aslanianauthor=W.+Zhouauthor=X.+Zhuauthor=J.+Qinauthor=W.+Greenleeauthor=Z.+Zhuauthor=L.+Zhangauthor=L.+Hydeauthor=I.+Chuauthor=M.+Cohen-Williamsauthor=A.+Palani&title=The+discovery+of+pyridone+and+pyridazone+heterocycles+as+%CE%B3-secretase+modulators&doi=10.1021%2Fml1000799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase Modulators</span></div><div class="casAuthors">Huang, Xianhai; Aslanian, Robert; Zhou, Wei; Zhu, Xiaohong; Qin, Jun; Greenlee, William; Zhu, Zhaoning; Zhang, Lili; Hyde, Lynn; Chu, Inhou; Cohen-Williams, Mary; Palani, Anandan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">184-187</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel pyridazone and pyridone compds., e.g., I, as γ-secretase modulators were discovered.  Starting from the initial lead, structure-activity relationship studies were carried out in which an internal hydrogen bond was introduced to conformationally fix the side chain, and compds. with improved in vitro Aβ42 inhibition activity and good Aβtotal/Aβ42 selectivity were quickly discovered.  Compd. I displayed very good in vitro activity and excellent selectivity with good in vivo efficacy in both CRND8 mouse and nontransgenic rat models.  This compd. displayed a good overall profile in terms of rat pharmacokinetics and ancillary profile.  No abnormal behavior and side effects were obsd. in all of the studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqki-gEswVL97Vg90H21EOLACvtfcHk0ljQCAFjwgp1yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlyjtbo%253D&md5=2e738a3fdbcddce0c87e7e25130e9f86</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1021%2Fml1000799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000799%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520pyridone%2520and%2520pyridazone%2520heterocycles%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D184%26epage%3D187%26doi%3D10.1021%2Fml1000799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span>; <span class="NLM_string-name">Kawano, K.</span>; <span class="NLM_string-name">Doi, E.</span>; <span class="NLM_string-name">Kitazawa, N.</span>; <span class="NLM_string-name">Shin, K.</span>; <span class="NLM_string-name">Miyagawa, T.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Ito, K.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Sasaki, T.</span>; <span class="NLM_string-name">Hagiwara, H.</span></span> <span> </span><span class="NLM_article-title">Preparation of Cinnamide, 3-Benzylidenepiperidin-2-one, Phenylpropynamide Compounds as Amyloid β Production Inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2005115990 A1</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=K.+Shin&author=T.+Miyagawa&author=T.+Kaneko&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=H.+Hagiwara&title=Preparation+of+Cinnamide%2C+3-Benzylidenepiperidin-2-one%2C+Phenylpropynamide+Compounds+as+Amyloid+%CE%B2+Production+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Cinnamide%252C%25203-Benzylidenepiperidin-2-one%252C%2520Phenylpropynamide%2520Compounds%2520as%2520Amyloid%2520%25CE%25B2%2520Production%2520Inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span> <span> </span><span class="NLM_article-title">Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2499</span>– <span class="NLM_lpage">2510</span>, <span class="refDoi"> DOI: 10.1021/jm030563w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030563w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2499-2510&author=E.+Perolaauthor=P.+S.+Charifson&title=Conformational+analysis+of+drug-like+molecules+bound+to+proteins%3A+an+extensive+study+of+ligand+reorganization+upon+binding&doi=10.1021%2Fjm030563w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Analysis of Drug-Like Molecules Bound to Proteins: An Extensive Study of Ligand Reorganization upon Binding</span></div><div class="casAuthors">Perola, Emanuele; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2499-2510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes a large-scale study on the nature and the energetics of the conformational changes drug-like mols. experience upon binding.  Ligand strain energies and conformational reorganization were analyzed with different computational methods on 150 crystal structures of pharmaceutically relevant protein-ligand complexes.  The common knowledge that ligands rarely bind in their lowest calcd. energy conformation was confirmed.  Addnl., the authors found that over 60% of the ligands do not bind in a local min. conformation.  While approx. 60% of the ligands were calcd. to bind with strain energies lower than 5 kcal/mol, strain energies over 9 kcal/mol were calcd. in at least 10% of the cases regardless of the method used.  A clear correlation was found between acceptable strain energy and ligand flexibility, while there was no correlation between strain energy and binding affinity, thus indicating that expensive conformational rearrangements can be tolerated in some cases without overly penalizing the tightness of binding.  On the basis of the trends obsd., thresholds for the acceptable strain energies of bioactive conformations were defined with consideration of the impact of ligand flexibility.  An anal. of the degree of folding of the bound ligands confirmed the general tendency of small mols. to bind in an extended conformation.  The results suggest that the unfolding of hydrophobic ligands during binding, which exposes hydrophobic surfaces to contact with protein residues, could be one of the factors accounting for high reorganization energies.  Finally, different methods for conformational anal. were evaluated, and guidelines were defined to maximize the prevalence of bioactive conformations in computationally generated ensembles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMrN0dFKglcbVg90H21EOLACvtfcHk0ljQCAFjwgp1yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVans78%253D&md5=8f54a8285ef1ffc5e1a19f748f4674bf</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fjm030563w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030563w%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DConformational%2520analysis%2520of%2520drug-like%2520molecules%2520bound%2520to%2520proteins%253A%2520an%2520extensive%2520study%2520of%2520ligand%2520reorganization%2520upon%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2499%26epage%3D2510%26doi%3D10.1021%2Fjm030563w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span> <span> </span><span class="NLM_article-title">Toward accurate relative energy predictions of the bioactive conformation of drugs</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1002/jcc.21087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1002%2Fjcc.21087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=18711721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Knsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=601-610&author=K.+T.+Butlerauthor=F.+J.+Luqueauthor=X.+Barril&title=Toward+accurate+relative+energy+predictions+of+the+bioactive+conformation+of+drugs&doi=10.1002%2Fjcc.21087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Toward accurate relative energy predictions of the bioactive conformation of drugs</span></div><div class="casAuthors">Butler, Keith T.; Luque, F. Javier; Barril, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-610</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Quantifying the relative energy of a ligand in its target-bound state (i.e. the bioactive conformation) is essential to understand the process of mol. recognition, to optimize the potency of bioactive mols. and to increase the accuracy of structure-based drug design methods.  This is, nevertheless, seriously hampered by 2 inter-related issues, namely the difficulty in carrying out an exhaustive sampling of the conformational space and the shortcomings of the energy functions, usually based on parametric methods of limited accuracy.  Matters are further complicated by the exptl. uncertainty on the at. coordinates, which precludes a univocal definition of the bioactive conformation.  In this article the authors investigate the relative energy of bioactive conformations introducing 2 major improvements over previous studies: the use sophisticated QM-based methods to take into account both the internal energy of the ligand and the solvation effect, and the application of phys. meaningful constraints to refine the bioactive conformation.  On a set of 99 drug-like mols., the authors find that, contrary to previous observations, 2 thirds of bioactive conformations lie within 0.5 kcal mol-1 of a local min., with penalties above 2.0 kcal mol-1 being generally attributable to structural detn. inaccuracies.  The methodol. herein described opens the door to obtain quant. ests. of the energy of bioactive conformations and can be used both as an aid in refining crystallog. structures and as a tool in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoukwCddY9zl7Vg90H21EOLACvtfcHk0ljHuaa9lo6cZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Knsrw%253D&md5=31ddffa90fb7f61e96b3b97ddeaac367</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21087%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DBarril%26aufirst%3DX.%26atitle%3DToward%2520accurate%2520relative%2520energy%2520predictions%2520of%2520the%2520bioactive%2520conformation%2520of%2520drugs%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D601%26epage%3D610%26doi%3D10.1002%2Fjcc.21087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Boström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norrby, P.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liljefors, T.</span></span> <span> </span><span class="NLM_article-title">Conformational energy penalties of protein-bound ligands</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">383</span>, <span class="refDoi"> DOI: 10.1023/a:1008007507641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1023%2Fa%3A1008007507641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=9777496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADyaK1cXms1elsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=383&author=J.+Bostr%C3%B6mauthor=P.-O.+Norrbyauthor=T.+Liljefors&title=Conformational+energy+penalties+of+protein-bound+ligands&doi=10.1023%2Fa%3A1008007507641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational energy penalties of protein-bound ligands</span></div><div class="casAuthors">Bostrom, Jonas; Norrby, Per-Ola; Liljefors, Tommy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-396</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">The conformational energies required for ligands to adopt their bioactive conformations were calcd. for 33 ligand-protein complexes including 28 different ligands.  In order to monitor the force field dependence of the results, two force fields, MM3* and AMBER*, were employed for the calcns.  Conformational analyses were performed in vacuo and in aq. soln. by using the generalized Born/solvent accessible surface (GB/SA) solvation model.  The protein-bound conformations were relaxed by using flat-bottomed Cartesian constraints.  For about 70% of the ligand-protein complexes studied, the conformational energies of the bioactive conformations were calcd. to be ≤3 kcal/mol.  It is demonstrated that the aq. conformational ensemble for the unbound ligand must be used as a ref. state in this type of calcns.  The calcns. for the ligand-protein complexes with conformational energy penalties of the ligand calcd. to be larger than 3 kcal/mol suffer from uncertainties in the interpretation of the exptl. data or limitations of the computational methods.  For example, in the case of long-chain flexible ligands (e.g. fatty acids), it is demonstrated that several conformations may be found which are very similar to the conformation detd. by x-ray crystallog. and which display significantly lower conformational energy penalties for binding than obtained by using the exptl. conformation.  For strongly polar mols., e.g. amino acids, the results indicate that further developments of the force fields and of the dielec. continuum solvation model are required for reliable calcns. on the conformational properties of this type of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOYXSRdHvDEbVg90H21EOLACvtfcHk0ljHuaa9lo6cZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1elsr4%253D&md5=d3108c97e8b080d5567b65653f9eff0d</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1023%2Fa%3A1008007507641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252Fa%253A1008007507641%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DNorrby%26aufirst%3DP.-O.%26aulast%3DLiljefors%26aufirst%3DT.%26atitle%3DConformational%2520energy%2520penalties%2520of%2520protein-bound%2520ligands%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1998%26volume%3D12%26spage%3D383%26doi%3D10.1023%2Fa%3A1008007507641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span> The rate of Michael
addition of GSH (kGSH (M<sup>–1</sup> s<sup>–1</sup>)) to cyclized β, β-disubstituted enone (cf. 3-methyl
cyclopentenone) is 11 time slower relative to α, β-disubstituted
acyclic enone (cf. (<i>E</i>)-3-methylpent-3-en-2-one).<span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harki, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummond, K. M.</span></span> <span> </span><span class="NLM_article-title">Covalent modifiers: A chemical perspective on the reactivity of α,β-unsaturated carbonyls with thiols via hetero-michael addition reactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2rtbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=839-885&author=P.+A.+Jacksonauthor=J.+C.+Widenauthor=D.+A.+Harkiauthor=K.+M.+Brummond&title=Covalent+modifiers%3A+A+chemical+perspective+on+the+reactivity+of+%CE%B1%2C%CE%B2-unsaturated+carbonyls+with+thiols+via+hetero-michael+addition+reactions&doi=10.1021%2Facs.jmedchem.6b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions</span></div><div class="casAuthors">Jackson, Paul A.; Widen, John C.; Harki, Daniel A.; Brummond, Kay M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">839-885</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although Michael acceptors display a potent and broad spectrum of bioactivity, they have largely been ignored in drug discovery because of their presumed indiscriminate reactivity.  As such, a dearth of information exists relevant to the thiol reactivity of natural products and their analogs possessing this moiety.  In the midst of recently approved acrylamide-contg. drugs, it is clear that a good understanding of the hetero-Michael addn. reaction and the relative reactivities of biol. thiols with Michael acceptors under physiol. conditions is needed for the design and use of these compds. as biol. tools and potential therapeutics.  This Perspective provides information that will contribute to this understanding, such as kinetics of thiol addn. reactions, bioactivities, as well as steric and electronic factors that influence the electrophilicity and reversibility of Michael acceptors.  This Perspective is focused on α,β-unsatd. carbonyls given their preponderance in bioactive natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn4jDqxoos17Vg90H21EOLACvtfcHk0ljHuaa9lo6cZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2rtbnM&md5=36d3be5bf688c4e4a8cf4bcf42073009</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00788%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DP.%2BA.%26aulast%3DWiden%26aufirst%3DJ.%2BC.%26aulast%3DHarki%26aufirst%3DD.%2BA.%26aulast%3DBrummond%26aufirst%3DK.%2BM.%26atitle%3DCovalent%2520modifiers%253A%2520A%2520chemical%2520perspective%2520on%2520the%2520reactivity%2520of%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520carbonyls%2520with%2520thiols%2520via%2520hetero-michael%2520addition%2520reactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D839%26epage%3D885%26doi%3D10.1021%2Facs.jmedchem.6b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span>; <span class="NLM_string-name">Claremon, D. A.</span>; <span class="NLM_string-name">Connolly, T. M.</span>; <span class="NLM_string-name">Dean, D. C.</span>; <span class="NLM_string-name">Karczewski, J.</span>; <span class="NLM_string-name">Koblan, K. S.</span>; <span class="NLM_string-name">Kostura, M. J.</span>; <span class="NLM_string-name">Liverton, N. J.</span>; <span class="NLM_string-name">Melillo, D. G.</span></span> <span> </span><span class="NLM_article-title">Radioligand and Binding Assay</span>. PCT Int. Appl. <span class="NLM_patent">WO 2002005860 A1</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+W.+Butcher&author=D.+A.+Claremon&author=T.+M.+Connolly&author=D.+C.+Dean&author=J.+Karczewski&author=K.+S.+Koblan&author=M.+J.+Kostura&author=N.+J.+Liverton&author=D.+G.+Melillo&title=Radioligand+and+Binding+Assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26atitle%3DRadioligand%2520and%2520Binding%2520Assay%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">The free drug concentrations in the brain or the drug concentrations in the CSF were not measured for these compounds. In the absence of these measured concentrations, free drug levels were aproximated using the measured plasma free fraction.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Notch recognition by human γ-secretase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>565</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0813-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1038%2Fs41586-018-0813-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=30598546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlslKgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=565&publication_year=2019&pages=192-197&author=G.+Yangauthor=R.+Zhouauthor=Q.+Zhouauthor=X.+Guoauthor=C.+Yanauthor=M.+Keauthor=J.+Leiauthor=Y.+Shi&title=Structural+basis+of+Notch+recognition+by+human+%CE%B3-secretase&doi=10.1038%2Fs41586-018-0813-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of Notch recognition by human γ-secretase</span></div><div class="casAuthors">Yang, Guanghui; Zhou, Rui; Zhou, Qiang; Guo, Xuefei; Yan, Chuangye; Ke, Meng; Lei, Jianlin; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">565</span>
        (<span class="NLM_cas:issue">7738</span>),
    <span class="NLM_cas:pages">192-197</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Aberrant cleavage of Notch by γ-secretase leads to several types of cancer, but how γ-secretase recognizes its substrate remains unknown.  Here we report the cryo-electron microscopy structure of human γ-secretase in complex with a Notch fragment at a resoln. of 2.7 Å.  The transmembrane helix of Notch is surrounded by three transmembrane domains of presenilin 1 (PS1), and the carboxyl-terminal β-strand of the Notch fragment forms a β-sheet with two substrate-induced β-strands of PS1 on the intracellular side.  Formation of the hybrid β-sheet is essential for substrate cleavage, which occurs at the carboxyl-terminal end of the Notch transmembrane helix.  PS1 undergoes pronounced conformational rearrangement upon substrate binding.  These features reveal the structural basis of Notch recognition and have implications for the recruitment of the amyloid precursor protein by γ-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCV04n34QyLVg90H21EOLACvtfcHk0lij-_nRaIDngw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlslKgtLo%253D&md5=135fbb5aedbd1a0e28a8837b604d5861</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0813-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0813-8%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DKe%26aufirst%3DM.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520Notch%2520recognition%2520by%2520human%2520%25CE%25B3-secretase%26jtitle%3DNature%26date%3D2019%26volume%3D565%26spage%3D192%26epage%3D197%26doi%3D10.1038%2Fs41586-018-0813-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Recognition of the amyloid precursor protein by human γ-secretase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">aaw0930</span>, <span class="refDoi"> DOI: 10.1126/science.aaw0930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1126%2Fscience.aaw0930" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2019&pages=aaw0930&author=R.+Zhouauthor=G.+Yangauthor=X.+Guoauthor=Q.+Zhouauthor=J.+Leiauthor=Y.+Shi&title=Recognition+of+the+amyloid+precursor+protein+by+human+%CE%B3-secretase&doi=10.1126%2Fscience.aaw0930"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaw0930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaw0930%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DRecognition%2520of%2520the%2520amyloid%2520precursor%2520protein%2520by%2520human%2520%25CE%25B3-secretase%26jtitle%3DScience%26date%3D2019%26volume%3D363%26spage%3Daaw0930%26doi%3D10.1126%2Fscience.aaw0930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imahori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyauchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahata, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of both enantiomers of hydroxypipecolic acid derivatives equivalent to 5-azapyranuronic acids and evaluation of their inhibitory activities against glycosidases</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">8273</span>– <span class="NLM_lpage">8286</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmc.2008.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=18703340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVykur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8273-8286&author=Y.+Yoshimuraauthor=C.+Oharaauthor=T.+Imahoriauthor=Y.+Saitoauthor=A.+Katoauthor=S.+Miyauchiauthor=I.+Adachiauthor=H.+Takahata&title=Synthesis+of+both+enantiomers+of+hydroxypipecolic+acid+derivatives+equivalent+to+5-azapyranuronic+acids+and+evaluation+of+their+inhibitory+activities+against+glycosidases&doi=10.1016%2Fj.bmc.2008.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of both enantiomers of hydroxypipecolic acid derivatives equivalent to 5-azapyranuronic acids and evaluation of their inhibitory activities against glycosidases</span></div><div class="casAuthors">Yoshimura, Yuichi; Ohara, Chiaki; Imahori, Tatsushi; Saito, Yukako; Kato, Atsushi; Miyauchi, Saori; Adachi, Isao; Takahata, Hiroki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8273-8286</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We have synthesized 3-hydroxy- and 3,4,5-trihydroxypipecolic acid derivs. corresponding to 5-aza derivs. of uronic acids and evaluated their inhibitory activities against various glycosidases including β-glucuronidase.  Compds. 4 and 5 were chosen as common intermediates for the synthesis of 3,4,5-trihydroxypipecolic acids and 3-hydroxypipecolic acids as well as for 3-hydroxybaikiain, a unique natural product isolated from a toxic mushroom.  Cross aldol reaction of N-Boc-allylglycine deriv. with acrolein followed by the ring-closing metathesis gave 4 and 5 as a mixt. of diastereomers which could be sepd. by silica gel column chromatog.  By employing lipase-catalyzed kinetic resoln., the synthesis of both - and -isomers of 3,4,5-trihydroxy- and 3-hydroxypipecolic acids was achieved.  None of the compds. tested showed inhibitory activity against α- and β-glucosidases.  On the other hand, -23 and -29 were found to have potent inhibitory activity against β-glucuronidase.  In addn., it is interesting that some uronic-type azasugar derivs. showed moderate inhibitory activities against β-N-acetylglucosaminidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUUyMAMfM63rVg90H21EOLACvtfcHk0lij-_nRaIDngw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVykur7O&md5=10a639a391f92ea9e0d4a793345dc47c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DY.%26aulast%3DOhara%26aufirst%3DC.%26aulast%3DImahori%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DMiyauchi%26aufirst%3DS.%26aulast%3DAdachi%26aufirst%3DI.%26aulast%3DTakahata%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520both%2520enantiomers%2520of%2520hydroxypipecolic%2520acid%2520derivatives%2520equivalent%2520to%25205-azapyranuronic%2520acids%2520and%2520evaluation%2520of%2520their%2520inhibitory%2520activities%2520against%2520glycosidases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8273%26epage%3D8286%26doi%3D10.1016%2Fj.bmc.2008.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b','cit2c','cit2d'],'ref3':['cit3a','cit3b','cit3c','cit3d','cit3e'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e','cit5f','cit5g'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f','cit6g'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e','cit7f','cit7g','cit7h','cit7i','cit7j','cit7k'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14'],'ref15':['cit15'],'ref16':[],'ref17':['cit17a','cit17b'],'ref18':['cit18']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ángel Santiago, Dulce C. Guzmán-Ocampo, Rodrigo Aguayo-Ortiz, <span class="NLM_string-name hlFld-ContribAuthor">Laura Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (15)
                                     , 2765-2775. <a href="https://doi.org/10.1021/acschemneuro.1c00313" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00313%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCharacterizing%252Bthe%252BChemical%252BSpace%252Bof%252B%2525CE%2525B3-Secretase%252BInhibitors%252Band%252BModulators%26aulast%3DSantiago%26aufirst%3D%25C3%2581ngel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21052021%26date%3D09072021%26date%3D22072021%26volume%3D12%26issue%3D15%26spage%3D2765%26epage%3D2775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the first non-NSAID GSMs <b>1</b>, <b>2</b> and the discovery of oxadiazoline <b>3</b>, oxadiazine <b>4</b>, <b>5</b>, and <b>6</b>, and in parenthesis Aβ<sub>42</sub> IC<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Rationale for designing disubstituted oxadiazines. (a) Structure of <b>4</b> and <b>7</b> and conceptualization of 3,4-disubstituted oxadiazine <b>8</b>. Compounds <b>9</b> and <b>10</b> are the diastereomeric pairs differing in orientation of the substitution at their 3 position; (b) overlay of <b>9ea</b> (yellow) and <b>7</b> (magenta) with unsubstituted phenyl at its 2 position; (c) conformational analysis by density functional theory (DFT) at the B3LYP/6-31+G(d,p) level of theory. <b>9ea</b> (R<sup>1</sup> = equatorial Ph, R<sup>2</sup> = axial Me), <b>9ae</b> (R<sup>1</sup> = axial Ph, R<sup>2</sup> = equatorial Me), <b>10ee</b> (R<sup>1</sup> = equatorial Ph, R<sup>2</sup> = equatorial Me), and <b>10aa</b> (R<sup>1</sup> = axial Ph, R<sup>2</sup> = axial Me).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Previous strategies to mask the exocyclic double bond.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Conformational analysis and building hypothesis for the synthesis of <b>20</b> and <b>21</b>. The calculated energy difference between <b>19t</b> and <b>19c</b> is ∼2.3 kcal/mmol (energy calculations were done at the B3LYP/6-31+g(d,p) level of theory).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Analysis on the importance of the lone pairs of the amide carbonyl of <b>2</b> for potency and building hypothesis for the synthesis <b>26</b> and <b>27</b> via deconstruction of <b>24</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Dose-dependent reduction of Aβ<sub>42</sub> by compound <b>11</b> in male CD rats. The value of CSF Aβ<sub>42</sub> is the geometric mean of 29 (for 3 and 10 mg/kg dosing group) and 10 animals (30 mg/kg dosing group), respectively, and the value of <i>C</i><sub>P</sub> and <i>C</i><sub>B</sub> is the geometric mean of 10 (3 mg/kg dosing group), 15 (10 mg/kg dosing group), and 5 (30 mg/kg dosing group) animals. (b) Measured total concentration of <b>11</b> in plasma (<i>C</i><sub>P</sub>) and brain (<i>C</i><sub>B</sub>) of rats at doses ranging from 3 to 30 mg/kg. All animal procedures were performed according to the protocol reviewed and approved by the institutional Animal Care and Use Committee of Merck & Co., Inc., Kenilworth, NJ, USA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Initial Approach to 3,4-Disubstituted Oxadiazines <b>11</b> and <b>13–15</b> Based on the Mitsunobu Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EDCI, HOBT, DIEA, DMF; (b) NaOMe (25 wt % in MeOH), THF, 25%; (c) (COCl)<sub>2</sub>, DMSO, DCM, −78 °C, 100%; (d) 3,5-difluorophenyl magnesium bromide, THF, 48%; (e) <i>N</i>-hydroxyphthalimide, <i>n</i>-Bu<sub>3</sub>P, ADDP, 2MeTHF, 18%; (f) NH<sub>2</sub>NH<sub>2</sub>, EtOH; and (g) H<sub>3</sub>PO<sub>4</sub>, <i>n</i>-BuOH, 100 °C, 29% yield for <b>11</b>, and 8% yield for <b>12</b>.</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Stereoselective Approach to 3,4-Disubstituted Oxadiazines Based on the Observation of Retention of the Configuration Mitsunobu Reaction in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (COCl)<sub>2</sub>, DMSO, DCM, −78 °C; (b) 3,5-difluorophenyl magnesium bromide, THF, 100%; (c) Pd/C, H<sub>2</sub>, MeOH, 84%; (d) EDCI, HOBT, DIEA, DMF; (e) NaOMe (25 wt % in MeOH), THF, 81%; (f) <i>N</i>-hydroxyphthalimide, <i>n</i>-Bu<sub>3</sub>P, DIAD, THF, 76%; and (g) NH<sub>2</sub>NH<sub>2</sub>, EtOH; (h) H<sub>3</sub>PO<sub>4</sub>, <i>n</i>-BuOH, 100 °C, 51%.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogue 15 Based on the Observation of Retention of the Configuration Mitsunobu Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (COCl)<sub>2</sub>, DMSO, DCM, −78 °C; (b) 3,5-difluorophenyl magnesium bromide, THF, 94%; (c) Pd/C, H<sub>2</sub>, MeOH, 100%; (d) EDCI, HOBT, DIEA, DMF; (e) NaOMe, MeOH, 66%; (f) <i>N</i>-hydroxyphthalimide, PPh<sub>3</sub>, DIAD, THF, 0 °C; (g) NH<sub>2</sub>NH<sub>2</sub>, EtOH, 48%; (h) H<sub>3</sub>PO<sub>4</sub>, <i>n</i>-BuOH, 100 °C, 86%; and (i) BCl<sub>3</sub>, DCM, 0 °C, 23%.</p></p></figure><figure data-id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Key Intermediate <b>47</b> for the Synthesis of Azepine Analogues <b>20</b> and <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>n</i>-BuLi, Et<sub>2</sub>O, THF, −30 °C, (Boc)<sub>2</sub>O, 34%; (b) Me<sub>6</sub>Sn<sub>2</sub>, Pd(Ph<sub>3</sub>)<sub>4</sub>, 80 °C, THF, 77%; (c) CuCl, DMF, H<sub>2</sub>O, rt, 72%; (d) CuCl, Pd(dppf)Cl<sub>2</sub>, DMF, 100 °C; and (e) TFA, DCM, rt, 68%.</p></p></figure><figure data-id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Failed Attempt to Transform the Hydroxyl Functionality to Hydroxylamine for the Synthesis of <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (1) <i>N</i>-hydroxyphthalimide, <i>n</i>Bu<sub>3</sub>P, DIAD, THF; (2) <i>N</i>-hydroxyphthalimide, <i>n</i>Bu<sub>3</sub>P, ADDP, THF.</p></p></figure><figure data-id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>20</b> via Development of a New Synthetic Strategy<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) allyl bromide, K<sub>2</sub>CO<sub>3</sub>, <i>n</i>-butyronitrile, 120 °C, 50%; (b) <i>N</i>-hydroxyphthalimide, <i>n</i>-Bu<sub>3</sub>P, DIAD, THF, 0 °C; (c) NH<sub>2</sub>NH<sub>2</sub>, DCM, EtOH; (d) (Boc)<sub>2</sub>O, rt, 65%; (e) 1,3-dimethylbarbituric acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, DCM, rt, 84%; (f) EDCI, HOBt, DIEA, DMF, 0 °C, 85%; (g) KHMDS, THF/DMF, −50 °C, 56%; (h) TFA, DCM, rt; (i) H<sub>3</sub>PO<sub>4</sub>, 105 °C; and (j) Chiralpak AD column, 22% for <b>20</b>, 17% for <b>59</b>.</p></p></figure><figure data-id="sch7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Unanticipated Transformation of <b>61</b> to <b>62</b> Leading to Stereocontrolled Synthesis of 20<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) allyl bromide, K<sub>2</sub>CO<sub>3</sub>, MeCN, 80 °C, 38%; (b) <i>N</i>-hydroxyphthalimide, <i>n</i>-Bu<sub>3</sub>P, DIAD, THF, 0 °C; (c) NH<sub>2</sub>–NH<sub>2</sub>, EtOH, DCM, 0 °C; and (d) (BOC)<sub>2</sub>O, 37%.</p></p></figure><figure data-id="sch8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Stereocontrolled Synthesis of <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-hydroxyphthalimide, Ph<sub>3</sub>P, DIAD, THF, −30 °C, 98%; (b) NH<sub>2</sub>NH<sub>2</sub>, DCM, EtOH, 88%; (c) DCM, (Boc)<sub>2</sub>O, rt, 80%; (d) Pd/C, H<sub>2</sub>, EtOH, rt, 100%; (e) EDCI, HOBt, DIEA, DMF, 0 °C, 65%; (f) KHMDS, DMF, −30 °C, 64%; and (g) POCl<sub>3</sub>, 80 °C, 20%.</p></p></figure><figure data-id="sch9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/medium/jm0c00446_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Racemic Synthesis of 27<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00446/20200806/images/large/jm0c00446_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00446&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 3,5-difluorophenol, DEAD, PPh<sub>3</sub>, THF, 0 °C; (b) LiAlH<sub>4</sub>,, THF, 42%; (c) 4 N HCl in dioxane, rt; (d) EDCI, HOBt, DIEA, DMF, 50%; (e) Pd/C, H<sub>2</sub>, MeOH, 57%; (f) MeSO<sub>2</sub>Cl, Et<sub>3</sub>N, <i>N</i>-hydroxyl phthalimide, DCM, 43%; (g) NH<sub>2</sub>NH<sub>2</sub>, EtOH, DCM, 63%; and (h) POCl<sub>3</sub>, 90 °C, 22%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 18 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alzheimer’s
Association</span>. <span> </span><span class="NLM_article-title">Alzheimer’s
Disease Facts and Figures</span>, <span class="NLM_year">2017</span>. <a href="http://www.alz.org/documentscustom/2017-facts-and-figures.pdf" class="extLink">http://www.alz.org/documentscustom/2017-facts-and-figures.pdf</a> (accessed July, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Alzheimer%E2%80%99s%0AAssociation&title=Alzheimer%E2%80%99s%0ADisease+Facts+and+Figures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAlzheimer%25E2%2580%2599s%250ADisease%2520Facts%2520and%2520Figures%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alzheimer’s Disease International</span>. <span> </span><span class="NLM_article-title">World Alzheimer Report</span>, <span class="NLM_year">2016</span>. <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf</a> (accessed July 7, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Alzheimer%E2%80%99s+Disease+International&title=World+Alzheimer+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DWorld%2520Alzheimer%2520Report%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alzheimer’s
Association</span>. <span> </span><span class="NLM_article-title">FDA-approved drugs</span>, <span class="NLM_year">2017</span>. <a href="http://www.alz.org/research/science/alzheimersdiseasetreatments.asp" class="extLink">http://www.alz.org/research/science/alzheimersdiseasetreatments.asp</a> (accessed July, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Alzheimer%E2%80%99s%0AAssociation&title=FDA-approved+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DFDA-approved%2520drugs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federoff, H. J.</span></span> <span> </span><span class="NLM_article-title">Current treatment for Alzheimer’s disease and future prospects</span>. <i>Alzheimer Dis. Assoc. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">S105</span>– <span class="NLM_lpage">S113</span>, <span class="refDoi"> DOI: 10.1097/00002093-200307004-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1097%2F00002093-200307004-00005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=14512816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns1Chtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=S105-S113&author=P.+N.+Tariotauthor=H.+J.+Federoff&title=Current+treatment+for+Alzheimer%E2%80%99s+disease+and+future+prospects&doi=10.1097%2F00002093-200307004-00005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Current Treatment for Alzheimer Disease and Future Prospects</span></div><div class="casAuthors">Tariot, Pierre N.; Federoff, Howard J.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">S105-S113</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  A cascade of pathophysiol. events is triggered in Alzheimer disease (AD) that ultimately involves common cellular signaling pathways and leads to cellular and network dysfunction, failure of neurotransmission, cell death, and a common clin. outcome.  The process is asynchronous, meaning that viable neurons remain as targets for therapy even in the diseased state, and each stage of the cascade affords the possibility for therapeutic intervention.  Cholinesterase inhibitors are the only available treatment in the United States for patients with mild to moderate AD, helping maintain cognitive and functional abilities in most patients and conferring beneficial behavioral effects in some.  Memantine is an NMDA receptor antagonist that has recently been approved in Europe for treatment of moderately severe to severe AD and is under investigation in the United States.  Its mechanism of action may include enhanced neurotransmission in several systems as well as antiexcitotoxic effects.  There are data regarding the effectiveness of the combination of memantine with cholinesterase inhibitors that will be useful for the practicing clinician.  Other agents have shown some benefit in clin. trials, including the antioxidants vitamin E, selegiline, and Ginkgo biloba exts., although the wt. of evidence regarding their effects is not sufficient to define clin. practice.  Potential future therapies currently are in development that target multiple aspects of the illness cascade, including aberrant inflammation, neuro-trophic function, and processing of β amyloid and tau proteins.  These newer approaches hold promise for disease modification but are as yet unproven.  Whether or not disease-modifying or preventive therapies become a reality, clinicians will be faced with AD patients who require treatment at all stages of illness for the indefinite future.  Cholinergic and emerging noncholinergic medications will likely prevail as the stds. of treatment for years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOmJz_fGk1ubVg90H21EOLACvtfcHk0li3wf1rUwfG0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns1Chtr4%253D&md5=cf722487ce40361e860b2f890dd8753f</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1097%2F00002093-200307004-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002093-200307004-00005%26sid%3Dliteratum%253Aachs%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26atitle%3DCurrent%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520future%2520prospects%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2003%26volume%3D17%26spage%3DS105%26epage%3DS113%26doi%3D10.1097%2F00002093-200307004-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nordberg, A.</span></span> <span> </span><span class="NLM_article-title">Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease</span>. <i>Alzheimer Dis. Assoc. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">S12</span>– <span class="NLM_lpage">S18</span>, <span class="refDoi"> DOI: 10.1097/01.wad.0000213804.59187.2d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1097%2F01.wad.0000213804.59187.2d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=16772751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFeju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=S12-S18&author=A.+Nordberg&title=Mechanisms+behind+the+neuroprotective+actions+of+cholinesterase+inhibitors+in+Alzheimer+disease&doi=10.1097%2F01.wad.0000213804.59187.2d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer's disease</span></div><div class="casAuthors">Nordberg, Agneta</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2, Suppl. 1</span>),
    <span class="NLM_cas:pages">S12-S18</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the enzyme acetylcholinesterase (AChE) are presently used as long-term symptomatic treatments for patients with Alzheimer's disease (AD), as they enhance central levels of synaptic acetylcholine.  The accumulation of evidence implicating AChE in the pathogenesis of AD raises the question of whether, in addn. to their palliative actions, inhibitors of this enzyme are able to act as disease-modifying agents.  In addn. to their catalytic effects, there is a suggestion that AChE inhibitors may influence expression of AChE isoforms and increase expression of nicotinic receptors, both of which correlate with cognitive improvements in AD patients.  The neuroprotective effect of nicotine, presumably mediated via nicotinic receptors, against β-amyloid (Aβ) toxicity and its effect on amyloid precursor protein (APP) and Aβ prodn. has previously been established.  It has also been shown that AChE inhibitors influence APP processing and attenuate Aβ-induced toxicity via mechanisms including interruption of the prodn. of Aβ, alteration of the levels of Aβ 1-50 and 1-52, and formation of the sol. form of APP.  Some of these effects seem to occur independently of nicotinic receptors, however.  If such exptl. in vitro observations can be extrapolated into clin. neuroprotective properties, AChE inhibitors could pos. modulate the disease course of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_vn_esJ9_SLVg90H21EOLACvtfcHk0li03o-8_cKQIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFeju7k%253D&md5=367c676ee4a4c2f1e6eb1985f5f7a556</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1097%2F01.wad.0000213804.59187.2d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.wad.0000213804.59187.2d%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26atitle%3DMechanisms%2520behind%2520the%2520neuroprotective%2520actions%2520of%2520cholinesterase%2520inhibitors%2520in%2520Alzheimer%2520disease%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2006%26volume%3D20%26spage%3DS12%26epage%3DS18%26doi%3D10.1097%2F01.wad.0000213804.59187.2d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, R.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date</span>. <i>Alzheimer Dis. Assoc. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1097/01.wad.0000201847.29836.a5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1097%2F01.wad.0000201847.29836.a5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=16493232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslemu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=23-29&author=R.+Bullock&title=Efficacy+and+safety+of+memantine+in+moderate-to-severe+Alzheimer+disease%3A+the+evidence+to+date&doi=10.1097%2F01.wad.0000201847.29836.a5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of memantine in moderate-to-severe Alzheimer's disease: the evidence to date</span></div><div class="casAuthors">Bullock, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Memantine, a moderate-affinity, uncompetitive N-methyl-D-aspartate receptor antagonist, is currently the only agent approved for moderately severe to severe Alzheimer disease (AD) in Europe and for moderate-to-severe Alzheimer disease in the United States.  In clin. trials, memantine has consistently demonstrated a reduced rate of deterioration on global, cognitive, functional, and behavioral measures, across a range of outcome measures compared with usual care.  Notably, improvements vs. placebo were seen in individual activities of daily living and behavior, particularly agitation.  Efficacy was demonstrated in patients with newly diagnosed Alzheimer disease, patients previously or currently receiving acetylcholinesterase inhibitors, and both institutionalized and community-dwelling Alzheimer disease patients.  Memantine has a tolerability profile similar to placebo.  This review presents the results of key clin. trials, and includes clin. relevant analyses, such as nos.-needed-to-treat and effect sizes.  Increased dependency and institutionalization are significant cost drivers in Alzheimer disease.  Memantine is able to reduce dependency, caregiver time required, and mean monthly caregiver and societal costs.  Recent studies of the relationship between Alzheimer disease progression, caregiver burden, and health-care costs emphasize the need for treatments such as memantine that can slow the rate of decline in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoek-h3moVHKrVg90H21EOLACvtfcHk0li03o-8_cKQIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslemu7Y%253D&md5=4c1ef99e957070d2f300d2e6b5c48de8</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1097%2F01.wad.0000201847.29836.a5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.wad.0000201847.29836.a5%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520memantine%2520in%2520moderate-to-severe%2520Alzheimer%2520disease%253A%2520the%2520evidence%2520to%2520date%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2006%26volume%3D20%26spage%3D23%26epage%3D29%26doi%3D10.1097%2F01.wad.0000201847.29836.a5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the “amyloid cascade hypothesis”</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">1040</span>– <span class="NLM_lpage">1044</span>, <span class="refDoi"> DOI: 10.1111/febs.14004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1111%2Ffebs.14004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=28054745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltl2ltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2017&pages=1040-1044&author=J.+Hardy&title=The+discovery+of+Alzheimer-causing+mutations+in+the+APP+gene+and+the+formulation+of+the+%E2%80%9Camyloid+cascade+hypothesis%E2%80%9D&doi=10.1111%2Ffebs.14004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the "amyloid cascade hypothesis"</span></div><div class="casAuthors">Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1040-1044</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The cloning of APP and genetic anal. of families with Alzheimer's disease were both reported in 1987 and much present work on the disease is based upon the foundations laid at that time.  Progress was not smooth, however, and many errors were made.  In this memoir, I lay out both the progress and the errors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI5L3CEo5OErVg90H21EOLACvtfcHk0li03o-8_cKQIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltl2ltrs%253D&md5=90f7fbd5565cd181d62ce22b81f4b68a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14004%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DThe%2520discovery%2520of%2520Alzheimer-causing%2520mutations%2520in%2520the%2520APP%2520gene%2520and%2520the%2520formulation%2520of%2520the%2520%25E2%2580%259Camyloid%2520cascade%2520hypothesis%25E2%2580%259D%26jtitle%3DFEBS%2520J.%26date%3D2017%26volume%3D284%26spage%3D1040%26epage%3D1044%26doi%3D10.1111%2Ffebs.14004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease at 25 years</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.15252/emmm.201606210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.15252%2Femmm.201606210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=27025652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=595-608&author=D.+J.+Selkoeauthor=J.+Hardy&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease+at+25+years&doi=10.15252%2Femmm.201606210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease at 25 years</span></div><div class="casAuthors">Selkoe, Dennis J.; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">595-608</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Despite continuing debate about the amyloid β-protein or Aβ hypothesis, new lines of evidence from labs. and clinics worldwide support the concept that an imbalance between prodn. and clearance of Aβ42 and related Aβ peptides is a very early, often initiating factor in Alzheimer's disease AD.  Confirmation that presenilin is the catalytic site of γ-secretase has provided a linchpin: all dominant mutations causing early-onset AD occur either in the substrate amyloid precursor protein, APP or the protease presenilin of the reaction that generates Aβ.  Duplication of the wild-type APP gene in Down's syndrome leads to Aβ deposits in the teens, followed by microgliosis, astrocytosis, and neurofibrillary tangles typical of AD.  Apolipoprotein E4, which predisposes to AD in > 40% of cases, has been found to impair Aβ clearance from the brain.  Sol. oligomers of Aβ42 isolated from AD patients' brains can decrease synapse no., inhibit long-term potentiation, and enhance long-term synaptic depression in rodent hippocampus, and injecting them into healthy rats impairs memory.  The human oligomers also induce hyperphosphorylation of tau at AD-relevant epitopes and cause neuritic dystrophy in cultured neurons.  Crossing human APP with human tau transgenic mice enhances tau-pos. neurotoxicity.  In humans, new studies show that low cerebrospinal fluid CSF Aβ42 and amyloid-PET positivity precede other AD manifestations by many years.  Most importantly, recent trials of three different Aβ antibodies solanezumab, crenezumab, and aducanumab have suggested a slowing of cognitive decline in post hoc analyses of mild AD subjects.  Although many factors contribute to AD pathogenesis, Aβ dyshomeostasis has emerged as the most extensively validated and compelling therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGo1qmyvVtbVg90H21EOLACvtfcHk0lhipaaqm2bGzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVOhtL8%253D&md5=b7a2003ba5d341f5eef5c7e9454235ce</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.15252%2Femmm.201606210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201606210%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520at%252025%2520years%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D595%26epage%3D608%26doi%3D10.15252%2Femmm.201606210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+Hardyauthor=G.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lhipaaqm2bGzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DHiggins%26aufirst%3DG.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problem on the road to therapeutics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problem+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3dR"><div class="casContent"><span class="casTitleNuber">3d</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lhipaaqm2bGzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problem%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Aβ oligomers: a decade of discovery</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1172</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.04426.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1111%2Fj.1471-4159.2006.04426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=17286590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1172-1184&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=A%CE%B2+oligomers%3A+a+decade+of+discovery&doi=10.1111%2Fj.1471-4159.2006.04426.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3eR"><div class="casContent"><span class="casTitleNuber">3e</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers - a decade of discovery</span></div><div class="casAuthors">Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1172-1184</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Converging lines of evidence suggest that progressive accumulation of the amyloid β-protein (Aβ) plays a central role in the genesis of Alzheimer's disease, but it was long assumed that Aβ had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects.  Over the past decade, data have emerged from the use of synthetic Aβ peptides, cell culture models, β-amyloid precursor protein transgenic mice and human brain to suggest that pre-fibrillar, diffusible assemblies of Aβ are also deleterious.  Although the precise mol. identity of these sol. toxins remains unsettled, accumulating evidence suggests that sol. forms of Aβ are indeed the proximate effectors of synapse loss and neuronal injury.  Here the authors review recent progress in understanding the role of sol. oligomers in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrWrluV1aL7Vg90H21EOLACvtfcHk0lg7tsSijF7sqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D&md5=263855754364d2ab520e6fd705b9f5f7</span></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04426.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DA%25CE%25B2%2520oligomers%253A%2520a%2520decade%2520of%2520discovery%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D1172%26epage%3D1184%26doi%3D10.1111%2Fj.1471-4159.2006.04426.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span> <span> </span><span class="NLM_article-title">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1002/ana.24188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1002%2Fana.24188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=24853080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=185-205&author=E.+Karranauthor=J.+Hardy&title=A+critique+of+the+drug+discovery+and+phase+3+clinical+programs+targeting+the+amyloid+hypothesis+for+Alzheimer+disease&doi=10.1002%2Fana.24188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span></div><div class="casAuthors">Karran, Eric; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-205</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Review of a critique of the drug discovery and phase 3 clin. programs targeting the amyloid hypothesis for Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjQE-UU2jSXbVg90H21EOLACvtfcHk0lg7tsSijF7sqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K&md5=64287890331df95f3e2594ef711cdc27</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1002%2Fana.24188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24188%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DA%2520critique%2520of%2520the%2520drug%2520discovery%2520and%2520phase%25203%2520clinical%2520programs%2520targeting%2520the%2520amyloid%2520hypothesis%2520for%2520Alzheimer%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2014%26volume%3D76%26spage%3D185%26epage%3D205%26doi%3D10.1002%2Fana.24188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tse, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrup, K.</span></span> <span> </span><span class="NLM_article-title">Re-imagining Alzheimer’s disease - the diminishing importance of amyloid and a glimpse of what lies ahead</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">432</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1111/jnc.14079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1111%2Fjnc.14079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=28547865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVanu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2017&pages=432-444&author=K.-H.+Tseauthor=K.+Herrup&title=Re-imagining+Alzheimer%E2%80%99s+disease+-+the+diminishing+importance+of+amyloid+and+a+glimpse+of+what+lies+ahead&doi=10.1111%2Fjnc.14079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Re-imagining Alzheimer's disease - the diminishing importance of amyloid and a glimpse of what lies ahead</span></div><div class="casAuthors">Tse, Kai-Hei; Herrup, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">432-444</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Many have criticized the amyloid cascade hypothesis of Alzheimer's disease for its inconsistencies and failures to either accurately predict disease symptoms or guide the development of productive therapies.  In addn. to criticisms, however, we believe that the field would benefit from having alternative narratives and disease models that can either replace or function alongside of an amyloid-centric view of Alzheimer's.  This review is an attempt to meet that need.  We offer three exptl. verified amyloid-independent mechanisms, each of which plausibly contributes substantially to the etiol. of Alzheimer's disease: loss of DNA integrity, faulty cell cycle regulation, regression of myelination.  We outline the ways in which the failure of each can contribute to AD initiation and progression, and review how, acting alone or in combination with each other, they are sufficient for explaining the full range of AD pathologies.  Yet, these three alternatives represent only a few of the many non-amyloid mechanisms that can explain AD pathogenesis.  Therefore instead of proposing a single 'alternative hypothesis' to the amyloid cascade theory, sporadic AD is pictured as the result of independent yet intersecting age-related pathologies that afflict the ageing human brain. .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfYujk-b2vULVg90H21EOLACvtfcHk0lg7tsSijF7sqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVanu7jL&md5=957b5135a8eba9702e442ea80d431c09</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1111%2Fjnc.14079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.14079%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DK.-H.%26aulast%3DHerrup%26aufirst%3DK.%26atitle%3DRe-imagining%2520Alzheimer%25E2%2580%2599s%2520disease%2520-%2520the%2520diminishing%2520importance%2520of%2520amyloid%2520and%2520a%2520glimpse%2520of%2520what%2520lies%2520ahead%26jtitle%3DJ.%2520Neurochem.%26date%3D2017%26volume%3D143%26spage%3D432%26epage%3D444%26doi%3D10.1111%2Fjnc.14079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Das, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span> <span> </span><span class="NLM_article-title">A close look at BACE1 inhibitors for Alzheimer’s Disease treatment</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1007/s40263-019-00613-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1007%2Fs40263-019-00613-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=30830576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotFSgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=251-263&author=B.+Dasauthor=R.+Yan&title=A+close+look+at+BACE1+inhibitors+for+Alzheimer%E2%80%99s+Disease+treatment&doi=10.1007%2Fs40263-019-00613-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment</span></div><div class="casAuthors">Das, Brati; Yan, Riqiang</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-263</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), the most common cause of age-dependent dementia, is one of the most significant healthcare problems worldwide.  Aggravating this situation, drugs that are currently US Food and Drug Administration (FDA)-approved for AD treatment do not prevent or delay disease progression.  Therefore, developing effective therapies for AD patients is of crit. urgency.  Human genetic and clin. studies over the past three decades have indicated that abnormal generation or accumulation of amyloid-β (Aβ) peptides is a likely culprit in AD pathogenesis.  Aβ is generated from amyloid precursor protein (APP) via proteolytic cleavage by β-site APP cleaving enzyme 1 (BACE1) (memapsin 2, β-secretase, Asp 2 protease) and γ-secretase.  Mice deficient in BACE1 show abrogated prodn. of Aβ.  Therefore, pharmacol. inhibition of BACE1 is being intensively pursued as a therapeutic approach to treat AD patients.  Recent setbacks in clin. trials with BACE1 inhibitors have highlighted the crit. importance of understanding how to properly inhibit BACE1 to treat AD patients.  This review summarizes the recent studies on the role of BACE1 in synaptic functions as well as our views on BACE1 inhibition as an effective AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogSOzaAUyLKLVg90H21EOLACvtfcHk0lg2W090Kizs8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotFSgsrs%253D&md5=fb021e993301bde0aeb2be8c5cba6e8c</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1007%2Fs40263-019-00613-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-019-00613-7%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DB.%26aulast%3DYan%26aufirst%3DR.%26atitle%3DA%2520close%2520look%2520at%2520BACE1%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%2520treatment%26jtitle%3DCNS%2520Drugs%26date%3D2019%26volume%3D33%26spage%3D251%26epage%3D263%26doi%3D10.1007%2Fs40263-019-00613-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pettus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbeau, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartberger, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegmund, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of AM-6494: A potent and orally efficacious β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor with in vivo selectivity over BACE2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2263</span>– <span class="NLM_lpage">2281</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01034</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01034" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A280%3ADC%252BB3MnlsFemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2263-2281&author=L.+H.+Pettusauthor=M.+P.+Bourbeauauthor=J.+Bradleyauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=D.+Hickmanauthor=M.+Johnsonauthor=Q.+Liuauthor=J.+R.+Manningauthor=A.+Nanezauthor=A.+C.+Siegmundauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=J.+R.+Allenauthor=S.+Wood&title=Discovery+of+AM-6494%3A+A+potent+and+orally+efficacious+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitor+with+in+vivo+selectivity+over+BACE2&doi=10.1021%2Facs.jmedchem.9b01034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2</span></div><div class="casAuthors">Pettus Liping H; Bourbeau Matthew P; Bradley Jodi; Bartberger Michael D; Chen Kui; Hickman Dean; Johnson Michael; Liu Qingyian; Manning James R; Nanez Adrian; Siegmund Aaron C; Wen Paul H; Whittington Douglas A; Allen Jennifer R; Wood Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2263-2281</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is an aspartyl protease that plays a key role in the production of amyloid β (Aβ) in the brain and has been extensively pursued as a target for the treatment of Alzheimer's disease (AD).  BACE2, an aspartyl protease that is structurally related to BACE1, has been recently reported to be involved in melanosome maturation and pigmentation.  Herein, we describe the development of a series of cyclopropylthiazines as potent and orally efficacious BACE1 inhibitors.  Lead optimization led to the identification of 20, a molecule with biochemical IC50 BACE2/BACE1 ratio of 47.  Administration of 20 resulted in no skin/fur color change in a 13-day mouse hypopigmentation study and demonstrated robust and sustained reduction of CSF and brain Aβ40 levels in rat and monkey pharmacodynamic models.  On the basis of a compelling data package, 20 (AM-6494) was advanced to preclinical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmgrDHvGragzjk2McQZ6XmfW6udTcc2ea9LzuCwcQqMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnlsFemug%253D%253D&md5=abc7ed1f6b97a705d9b43ea992712a97</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01034%26sid%3Dliteratum%253Aachs%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DBourbeau%26aufirst%3DM.%2BP.%26aulast%3DBradley%26aufirst%3DJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DManning%26aufirst%3DJ.%2BR.%26aulast%3DNanez%26aufirst%3DA.%26aulast%3DSiegmund%26aufirst%3DA.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520AM-6494%253A%2520A%2520potent%2520and%2520orally%2520efficacious%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitor%2520with%2520in%2520vivo%2520selectivity%2520over%2520BACE2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2263%26epage%3D2281%26doi%3D10.1021%2Facs.jmedchem.9b01034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kido, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukushima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teisman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urmaliya, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Bergh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Discovery of an extremely potent thiazine-based β-secretase inhibitor with reduced cardiovascular and liver toxicity at a low projected human dose</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9337</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01140</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01140" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVentrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9331-9337&author=G.+Tadanoauthor=K.+Komanoauthor=S.+Yoshidaauthor=S.+Suzukiauthor=K.+Nakaharaauthor=K.+Fuchinoauthor=K.+Fujimotoauthor=E.+Matsuokaauthor=T.+Yamamotoauthor=N.+Asadaauthor=H.+Itoauthor=G.+Sakaguchiauthor=N.+Kanegawaauthor=Y.+Kidoauthor=S.+Andoauthor=T.+Fukushimaauthor=A.+Teismanauthor=V.+Urmaliyaauthor=D.+Dhuyvetterauthor=H.+Borghysauthor=A.+Van+Den+Berghauthor=N.+Austinauthor=H.+J.+M.+Gijsenauthor=Y.+Yamanoauthor=Y.+Isoauthor=K.-I.+Kusakabe&title=Discovery+of+an+extremely+potent+thiazine-based+%CE%B2-secretase+inhibitor+with+reduced+cardiovascular+and+liver+toxicity+at+a+low+projected+human+dose&doi=10.1021%2Facs.jmedchem.9b01140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose</span></div><div class="casAuthors">Tadano, Genta; Komano, Kazuo; Yoshida, Shuhei; Suzuki, Shinji; Nakahara, Kenji; Fuchino, Kouki; Fujimoto, Kazuki; Matsuoka, Eriko; Yamamoto, Takahiko; Asada, Naoya; Ito, Hisanori; Sakaguchi, Gaku; Kanegawa, Naoki; Kido, Yasuto; Ando, Shigeru; Fukushima, Tamio; Teisman, Ard; Urmaliya, Vijay; Dhuyvetter, Deborah; Borghys, Herman; Van Den Bergh, An; Austin, Nigel; Gijsen, Harrie J. M.; Yamano, Yoshinori; Iso, Yasuyoshi; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9331-9337</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Genetic evidence points to deposition of amyloid-β (Aβ) as a causal factor for Alzheimer's disease.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  Starting with an oxazine lead 1, we describe the discovery of a thiazine-based BACE1 inhibitor 5 with robust Aβ redn. in vivo at low concns., leading to a low projected human dose of 14 mg/day where 5 achieved sustained Aβ redn. of 80% at trough level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCgZp0A9J8rbVg90H21EOLACvtfcHk0li_lWqa8FcoOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVentrnO&md5=8f6c618bad3fc4bcf7bfb97b48972fa3</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01140%26sid%3Dliteratum%253Aachs%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DKomano%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DG.%26aulast%3DKanegawa%26aufirst%3DN.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DAndo%26aufirst%3DS.%26aulast%3DFukushima%26aufirst%3DT.%26aulast%3DTeisman%26aufirst%3DA.%26aulast%3DUrmaliya%26aufirst%3DV.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BDen%2BBergh%26aufirst%3DA.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DYamano%26aufirst%3DY.%26aulast%3DIso%26aufirst%3DY.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DDiscovery%2520of%2520an%2520extremely%2520potent%2520thiazine-based%2520%25CE%25B2-secretase%2520inhibitor%2520with%2520reduced%2520cardiovascular%2520and%2520liver%2520toxicity%2520at%2520a%2520low%2520projected%2520human%2520dose%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9331%26epage%3D9337%26doi%3D10.1021%2Facs.jmedchem.9b01140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakahara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanegawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusakabe, K.-I.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of selective β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: Targeting the flap to gain selectivity over BACE2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5080</span>– <span class="NLM_lpage">5095</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00309</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00309" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotl2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5080-5095&author=K.+Fujimotoauthor=E.+Matsuokaauthor=N.+Asadaauthor=G.+Tadanoauthor=T.+Yamamotoauthor=K.+Nakaharaauthor=K.+Fuchinoauthor=H.+Itoauthor=N.+Kanegawaauthor=D.+Moecharsauthor=H.+J.+M.+Gijsenauthor=K.-I.+Kusakabe&title=Structure-based+design+of+selective+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+Targeting+the+flap+to+gain+selectivity+over+BACE2&doi=10.1021%2Facs.jmedchem.9b00309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2</span></div><div class="casAuthors">Fujimoto, Kazuki; Matsuoka, Eriko; Asada, Naoya; Tadano, Genta; Yamamoto, Takahiko; Nakahara, Kenji; Fuchino, Kouki; Ito, Hisanori; Kanegawa, Naoki; Moechars, Diederik; Gijsen, Harrie J. M.; Kusakabe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5080-5095</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer's disease.  BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin pigments.  This role of BACE2 implies that nonselective and chronic inhibition of BACE1 may cause side effects derived from BACE2.  Herein, we describe the discovery of potent and selective BACE1 inhibitors using structure-based drug design.  We targeted the flap region, where the shape and flexibility differ between these enzymes.  Anal. of the cocrystal structures of an initial lead 8 prompted us to incorporate spirocycles followed by its fine-tuning, culminating in highly selective compds. 21 and 22.  The structures of 22 bound to BACE1 and BACE2 revealed that a relatively high energetic penalty in the flap of the 22-bound BACE2 structure may cause a loss in BACE2 potency, thereby leading to its high selectivity.  These findings and insights should contribute to responding to the challenges in exploring selective BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGdAN0ejWNyrVg90H21EOLACvtfcHk0lhKFO0m-V0Y8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotl2nt7w%253D&md5=9ceba959612bdac96dfdda689ad6f0e8</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00309%26sid%3Dliteratum%253Aachs%26aulast%3DFujimoto%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DE.%26aulast%3DAsada%26aufirst%3DN.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNakahara%26aufirst%3DK.%26aulast%3DFuchino%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DKanegawa%26aufirst%3DN.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DStructure-based%2520design%2520of%2520selective%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520Targeting%2520the%2520flap%2520to%2520gain%2520selectivity%2520over%2520BACE2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5080%26epage%3D5095%26doi%3D10.1021%2Facs.jmedchem.9b00309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzelak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michener, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of an iminoheterocyclic β-site amyloid precursor protein cleaving enzyme (BACE) inhibitor that lowers central Aβ in nonhuman primates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3231</span>– <span class="NLM_lpage">3248</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01995</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01995" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFaqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3231-3248&author=M.+Mandalauthor=Y.+Wuauthor=J.+Misiaszekauthor=G.+Liauthor=A.+Buevichauthor=J.+P.+Caldwellauthor=X.+Liuauthor=R.+D.+Mazzolaauthor=P.+Orthauthor=C.+Stricklandauthor=J.+Voigtauthor=H.+Wangauthor=Z.+Zhuauthor=X.+Chenauthor=M.+Grzelakauthor=L.+A.+Hydeauthor=R.+Kuvelkarauthor=P.+T.+Leachauthor=G.+Terracinaauthor=L.+Zhangauthor=Q.+Zhangauthor=M.+S.+Michenerauthor=B.+Smithauthor=K.+Coxauthor=D.+Grotzauthor=L.+Favreauauthor=K.+Mitraauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=M.+E.+Kennedyauthor=E.+M.+Parkerauthor=J.+N.+Cummingauthor=A.+W.+Stamford&title=Structure-based+design+of+an+iminoheterocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE%29+inhibitor+that+lowers+central+A%CE%B2+in+nonhuman+primates&doi=10.1021%2Facs.jmedchem.5b01995"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates</span></div><div class="casAuthors">Mandal, Mihirbaran; Wu, Yusheng; Misiaszek, Jeffrey; Li, Guoqing; Buevich, Alexei; Caldwell, John P.; Liu, Xiaoxiang; Mazzola, Robert D.; Orth, Peter; Strickland, Corey; Voigt, Johannes; Wang, Hongwu; Zhu, Zhaoning; Chen, Xia; Grzelak, Michael; Hyde, Lynn A.; Kuvelkar, Reshma; Leach, Prescott T.; Terracina, Giuseppe; Zhang, Lili; Zhang, Qi; Michener, Maria S.; Smith, Brad; Cox, Kathleen; Grotz, Diane; Favreau, Leonard; Mitra, Kaushik; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Kennedy, Matthew E.; Parker, Eric M.; Cumming, Jared N.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3231-3248</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe successful efforts to optimize the in vivo profile and address off-target liabilities of a series of BACE1 inhibitors represented by 6 that embodies the recently validated fused pyrrolidine iminopyrimidinone scaffold.  Employing structure-based design, truncation of the cyanophenyl group of I that binds in the S3 pocket of BACE1 followed by modification of the thienyl group in S1 was pursued.  Optimization of the pyrimidine substituent that binds in the S2'-S2'' pocket of BACE1 remediated time-dependent CYP3A4 inhibition of earlier analogs in this series and imparted high BACE1 affinity.  These efforts resulted in the discovery of difluorophenyl analog II (MBi-4), which robustly lowered CSF and cortex Aβ40 in both rats and cynomolgus monkeys following a single oral dose.  II represents a unique mol. shape among BACE inhibitors reported to potently lower central Aβ in nonrodent preclin. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoscm_jumartLVg90H21EOLACvtfcHk0ljBlBzo7v6TJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFaqur4%253D&md5=7715946acdd54d5b11d856a37e1ef0a2</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01995%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLeach%26aufirst%3DP.%2BT.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DMichener%26aufirst%3DM.%2BS.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DGrotz%26aufirst%3DD.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure-based%2520design%2520of%2520an%2520iminoheterocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE%2529%2520inhibitor%2520that%2520lowers%2520central%2520A%25CE%25B2%2520in%2520nonhuman%2520primates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3231%26epage%3D3248%26doi%3D10.1021%2Facs.jmedchem.5b01995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzelak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favreau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9331</span>– <span class="NLM_lpage">9345</span>, <span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5fR"><div class="casContent"><span class="casTitleNuber">5f</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0ljBlBzo7v6TJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)-A β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29-A+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5g</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0lhxDop6bHthcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529-A%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertsik, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-M.</span></span> <span> </span><span class="NLM_article-title">γ-Secretase inhibitors: from chemical probes to drug development</span>. <i>Dev. Ther. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1016/b978-0-12-802173-6.00004-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fb978-0-12-802173-6.00004-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisV2lsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=63-76&author=J.-Y.+Hurauthor=N.+Gertsikauthor=D.+S.+Johnsonauthor=Y.-M.+Li&title=%CE%B3-Secretase+inhibitors%3A+from+chemical+probes+to+drug+development&doi=10.1016%2Fb978-0-12-802173-6.00004-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase inhibitors: from chemical probes to drug development</span></div><div class="casAuthors">Hur, J.-Y.; Gertsik, N.; Johnson, D. S.; Li, Y.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Developing Therapeutics for Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-76</span>CODEN:
                <span class="NLM_cas:coden">69UPPR</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  This chapter discusses about the structure and activity of γ-secretase inhibitors for drug development in treatment of Alzheimer's disease in patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu0ZKZYvGcprVg90H21EOLACvtfcHk0lguT4Xof7DDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisV2lsbvK&md5=b62b7897b8d09a67f14b4c8490b62f79</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fb978-0-12-802173-6.00004-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fb978-0-12-802173-6.00004-6%26sid%3Dliteratum%253Aachs%26aulast%3DHur%26aufirst%3DJ.-Y.%26aulast%3DGertsik%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DY.-M.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%253A%2520from%2520chemical%2520probes%2520to%2520drug%2520development%26jtitle%3DDev.%2520Ther.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2016%26spage%3D63%26epage%3D76%26doi%3D10.1016%2Fb978-0-12-802173-6.00004-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guarino, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everlof, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haskell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lentz, K. A.</span></span> <span> </span><span class="NLM_article-title">An amide-based sulfenamide prodrug of gamma secretase inhibitor BMS-708163 delivers parent drug from an oral conventional solid dosage form in male beagle dog</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">126856</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.126856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmcl.2019.126856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=31870650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A280%3ADC%252BB3MbjsVartg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=126856&author=V.+R.+Guarinoauthor=R.+E.+Olsonauthor=J.+G.+Everlofauthor=N.+Wangauthor=I.+McDonaldauthor=R.+Haskellauthor=W.+Clarkeauthor=K.+A.+Lentz&title=An+amide-based+sulfenamide+prodrug+of+gamma+secretase+inhibitor+BMS-708163+delivers+parent+drug+from+an+oral+conventional+solid+dosage+form+in+male+beagle+dog&doi=10.1016%2Fj.bmcl.2019.126856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">An amide-based sulfenamide prodrug of gamma secretase inhibitor BMS-708163 delivers parent drug from an oral conventional solid dosage form in male beagle dog</span></div><div class="casAuthors">Guarino Victor R; Olson Richard E; Wang Nenghui; McDonald Ivar; Everlof J Gerry; Haskell Roy; Clarke Wendy; Lentz Kimberley A</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">126856</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The objective of this Letter is to report the first (to our knowledge) in vivo proof of concept for a sulfenamide prodrug to orally deliver a poorly soluble drug containing a weakly-acidic NH-acid from a conventional solid dosage formulation.  This proof of concept was established using BMS-708163 (1), a gamma secretase inhibitor containing a weakly acidic primary amide NH-acid as the chemical handle for attaching a series of thiol-based promoieties via a sulfenamide linkage.  Aqueous stabilities and solubilities are reported for a series of six sulfenamide prodrugs (2-7) of 1.  The sulfenamide prodrug containing the cysteine methyl ester promoiety (5) was chosen for a orally-dosed PK study in male beagle dog comparing a solubilized formulation of 1 against a solid dosage form of 5 in a cross-over fashion at an equivalent molar dose of 3 mg/kg.  Prodrug 5 delivered essentially a superimposable PK profile of 1 compared to the solubilized formulation of 1, without any detectable exposure of 5 in systemic circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_3rnxaibCxsjl5L8hwNX0fW6udTcc2eYKINSZPGTzLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MbjsVartg%253D%253D&md5=223425bc99cab3739d72695cf3604071</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.126856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.126856%26sid%3Dliteratum%253Aachs%26aulast%3DGuarino%26aufirst%3DV.%2BR.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DEverlof%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DMcDonald%26aufirst%3DI.%26aulast%3DHaskell%26aufirst%3DR.%26aulast%3DClarke%26aufirst%3DW.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26atitle%3DAn%2520amide-based%2520sulfenamide%2520prodrug%2520of%2520gamma%2520secretase%2520inhibitor%2520BMS-708163%2520delivers%2520parent%2520drug%2520from%2520an%2520oral%2520conventional%2520solid%2520dosage%2520form%2520in%2520male%2520beagle%2520dog%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D30%26spage%3D126856%26doi%3D10.1016%2Fj.bmcl.2019.126856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josien, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel, potent spirocyclic series of γ-secretase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8806</span>– <span class="NLM_lpage">8817</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00774</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00774" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWltrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8806-8817&author=Z.+Zhaoauthor=D.+A.+Pissarnitskiauthor=H.+B.+Josienauthor=W.-L.+Wuauthor=R.+Xuauthor=H.+Liauthor=J.+W.+Claderauthor=D.+A.+Burnettauthor=G.+Terracinaauthor=L.+Hydeauthor=J.+Leeauthor=L.+Songauthor=L.+Zhangauthor=E.+M.+Parker&title=Discovery+of+a+novel%2C+potent+spirocyclic+series+of+%CE%B3-secretase+inhibitors&doi=10.1021%2Facs.jmedchem.5b00774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors</span></div><div class="casAuthors">Zhao, Zhiqiang; Pissarnitski, Dmitri A.; Josien, Hubert B.; Wu, Wen-Lian; Xu, Ruo; Li, Hongmei; Clader, John W.; Burnett, Duane A.; Terracina, Giuseppe; Hyde, Lynn; Lee, Julie; Song, Lixin; Zhang, Lili; Parker, Eric M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8806-8817</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present paper, we described the design, synthesis, SAR, and biol. profile of a novel spirocyclic sulfone series of γ-secretase inhibitors (GSIs) related to MRK-560.  We utilized an addnl. spirocyclic ring system to stabilize the active chair conformation of the parent γ-secretase inhibitors.  The resulting series is devoid of the CYP2C9 inhibition liability of MRK-560.  A few representative analogs were assessed in a nontransgenic animal model of Alzheimer's disease (AD), demonstrating redn. of amyloid-β (Aβ) in the CNS after acute oral dosing.  A spirocyclic phosphonate was identified as the optimal ring system for both potency and pharmacokinetics.  Compared to GSIs studied in the clinic, representative spirocyclic phosphonate 18a(-) features improved selectivity for the inhibition of the PS-1 isoform of γ-secretase (33-fold vs PS-2), which may alleviate the adverse effect profile of the clin. GSIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7tRDNg55f57Vg90H21EOLACvtfcHk0lguT4Xof7DDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWltrjO&md5=18b4d8358b5768006308934f471a2c3b</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00774%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DJosien%26aufirst%3DH.%2BB.%26aulast%3DWu%26aufirst%3DW.-L.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DClader%26aufirst%3DJ.%2BW.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520novel%252C%2520potent%2520spirocyclic%2520series%2520of%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8806%26epage%3D8817%26doi%3D10.1021%2Facs.jmedchem.5b00774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubele, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dressen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garofalo, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hom, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konradi, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marugg, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neitzel, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semko, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dappen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagodzinski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keim, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latimer, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quincy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldbach, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ness, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zmolek, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigham, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kholodenko, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motter, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacayon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santiago, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willits, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bova, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemphill, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruslim, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yednock, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basi, G. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of-(R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-Cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): Metabolically stable γ-secretase inhibitors that selectively inhibit the production of amyloid-β over notch</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5261</span>– <span class="NLM_lpage">5274</span>, <span class="refDoi"> DOI: 10.1021/jm301741t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301741t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVejurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5261-5274&author=G.+Probstauthor=D.+L.+Aubeleauthor=S.+Bowersauthor=D.+Dressenauthor=A.+W.+Garofaloauthor=R.+K.+Homauthor=A.+W.+Konradiauthor=J.+L.+Maruggauthor=M.+N.+Mattsonauthor=M.+L.+Neitzelauthor=C.+M.+Semkoauthor=H.+L.+Shamauthor=J.+Smithauthor=M.+Sunauthor=A.+P.+Truongauthor=X.+M.+Yeauthor=Y.-Z.+Xuauthor=M.+S.+Dappenauthor=J.+J.+Jagodzinskiauthor=P.+S.+Keimauthor=B.+Petersonauthor=L.+H.+Latimerauthor=D.+Quincyauthor=J.+Wuauthor=E.+Goldbachauthor=D.+K.+Nessauthor=K.+P.+Quinnauthor=J.-M.+Sauerauthor=K.+Wongauthor=H.+Zhangauthor=W.+Zmolekauthor=E.+F.+Brighamauthor=D.+Kholodenkoauthor=K.+Huauthor=G.+T.+Kwongauthor=M.+Leeauthor=A.+Liaoauthor=R.+N.+Motterauthor=P.+Sacayonauthor=P.+Santiagoauthor=C.+Willitsauthor=F.+Bardauthor=M.+P.+Bovaauthor=S.+S.+Hemphillauthor=L.+Nguyenauthor=L.+Ruslimauthor=K.+Tanakaauthor=P.+Tanakaauthor=W.+Wallaceauthor=T.+A.+Yednockauthor=G.+S.+Basi&title=Discovery+of-%28R%29-4-cyclopropyl-7%2C8-difluoro-5-%284-%28trifluoromethyl%29phenylsulfonyl%29-4%2C5-dihydro-1H-pyrazolo%5B4%2C3-c%5Dquinoline+%28ELND006%29+and+%28R%29-4-Cyclopropyl-8-fluoro-5-%286-%28trifluoromethyl%29pyridin-3-ylsulfonyl%29-4%2C5-dihydro-2H-pyrazolo%5B4%2C3-c%5Dquinoline+%28ELND007%29%3A+Metabolically+stable+%CE%B3-secretase+inhibitors+that+selectively+inhibit+the+production+of+amyloid-%CE%B2+over+notch&doi=10.1021%2Fjm301741t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (R)-4-Cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-Cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007): Metabolically Stable γ-Secretase Inhibitors that Selectively Inhibit the Production of Amyloid-β over Notch</span></div><div class="casAuthors">Probst, Gary; Aubele, Danielle L.; Bowers, Simeon; Dressen, Darren; Garofalo, Albert W.; Hom, Roy K.; Konradi, Andrei W.; Marugg, Jennifer L.; Mattson, Matthew N.; Neitzel, Martin L.; Semko, Chris M.; Sham, Hing L.; Smith, Jenifer; Sun, Minghua; Truong, Anh P.; Ye, Xiaocong M.; Xu, Ying-zi; Dappen, Michael S.; Jagodzinski, Jacek J.; Keim, Pamela S.; Peterson, Brian; Latimer, Lee H.; Quincy, David; Wu, Jing; Goldbach, Erich; Ness, Daniel K.; Quinn, Kevin P.; Sauer, John-Michael; Wong, Karina; Zhang, Hongbin; Zmolek, Wes; Brigham, Elizabeth F.; Kholodenko, Dora; Hu, Kang; Kwong, Grace T.; Lee, Michael; Liao, Anna; Motter, Ruth N.; Sacayon, Patricia; Santiago, Pamela; Willits, Christopher; Bard, Frederique; Bova, Michael P.; Hemphill, Susanna S.; Nguyen, Lam; Ruslim, Lany; Tanaka, Kevin; Tanaka, Pearl; Wallace, William; Yednock, Ted A.; Basi, Guriqbal S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5261-5274</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the authors describe the authors' strategy to design metabolically stable γ-secretase inhibitors which are selective for inhibition of Aβ generation over Notch.  The authors highlight the authors' synthetic strategy to incorporate diversity and chirality.  Compds. ELND006 and ELND007 both entered human clin. trials.  The in vitro and in vivo characteristics for these two compds. are described.  A comparison of inhibition of Aβ generation in vivo between ELND006, ELND007, Semagacestat, Begacestat, and Avagacestat in mice is made. ELND006 lowered Aβ in the CSF of healthy human volunteers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphqWQAuadKJLVg90H21EOLACvtfcHk0lhOluEFD9vsfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVejurg%253D&md5=48ab2a533f077a313c9d934bffd3d713</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1021%2Fjm301741t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301741t%26sid%3Dliteratum%253Aachs%26aulast%3DProbst%26aufirst%3DG.%26aulast%3DAubele%26aufirst%3DD.%2BL.%26aulast%3DBowers%26aufirst%3DS.%26aulast%3DDressen%26aufirst%3DD.%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DHom%26aufirst%3DR.%2BK.%26aulast%3DKonradi%26aufirst%3DA.%2BW.%26aulast%3DMarugg%26aufirst%3DJ.%2BL.%26aulast%3DMattson%26aufirst%3DM.%2BN.%26aulast%3DNeitzel%26aufirst%3DM.%2BL.%26aulast%3DSemko%26aufirst%3DC.%2BM.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DA.%2BP.%26aulast%3DYe%26aufirst%3DX.%2BM.%26aulast%3DXu%26aufirst%3DY.-Z.%26aulast%3DDappen%26aufirst%3DM.%2BS.%26aulast%3DJagodzinski%26aufirst%3DJ.%2BJ.%26aulast%3DKeim%26aufirst%3DP.%2BS.%26aulast%3DPeterson%26aufirst%3DB.%26aulast%3DLatimer%26aufirst%3DL.%2BH.%26aulast%3DQuincy%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGoldbach%26aufirst%3DE.%26aulast%3DNess%26aufirst%3DD.%2BK.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DSauer%26aufirst%3DJ.-M.%26aulast%3DWong%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZmolek%26aufirst%3DW.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DKholodenko%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DKwong%26aufirst%3DG.%2BT.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DA.%26aulast%3DMotter%26aufirst%3DR.%2BN.%26aulast%3DSacayon%26aufirst%3DP.%26aulast%3DSantiago%26aufirst%3DP.%26aulast%3DWillits%26aufirst%3DC.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DBova%26aufirst%3DM.%2BP.%26aulast%3DHemphill%26aufirst%3DS.%2BS.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DP.%26aulast%3DWallace%26aufirst%3DW.%26aulast%3DYednock%26aufirst%3DT.%2BA.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26atitle%3DDiscovery%2520of-%2528R%2529-4-cyclopropyl-7%252C8-difluoro-5-%25284-%2528trifluoromethyl%2529phenylsulfonyl%2529-4%252C5-dihydro-1H-pyrazolo%255B4%252C3-c%255Dquinoline%2520%2528ELND006%2529%2520and%2520%2528R%2529-4-Cyclopropyl-8-fluoro-5-%25286-%2528trifluoromethyl%2529pyridin-3-ylsulfonyl%2529-4%252C5-dihydro-2H-pyrazolo%255B4%252C3-c%255Dquinoline%2520%2528ELND007%2529%253A%2520Metabolically%2520stable%2520%25CE%25B3-secretase%2520inhibitors%2520that%2520selectively%2520inhibit%2520the%2520production%2520of%2520amyloid-%25CE%25B2%2520over%2520notch%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5261%26epage%3D5274%26doi%3D10.1021%2Fjm301741t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorff, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiRico, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efremov, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustilnik, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sneed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capetta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallgren, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7772</span>– <span class="NLM_lpage">7783</span>, <span class="refDoi"> DOI: 10.1021/jm200893p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200893p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7772-7783&author=A.+F.+Stepanauthor=K.+Karkiauthor=W.+S.+McDonaldauthor=P.+H.+Dorffauthor=J.+K.+Dutraauthor=K.+J.+DiRicoauthor=A.+Wonauthor=C.+Subramanyamauthor=I.+V.+Efremovauthor=C.+J.+O%E2%80%99Donnellauthor=C.+E.+Nolanauthor=S.+L.+Beckerauthor=L.+R.+Pustilnikauthor=B.+Sneedauthor=H.+Sunauthor=Y.+Luauthor=A.+E.+Robshawauthor=D.+Riddellauthor=T.+J.+O%E2%80%99Sullivanauthor=E.+Sibleyauthor=S.+Capettaauthor=K.+Atchisonauthor=A.+J.+Hallgrenauthor=E.+Millerauthor=A.+Woodauthor=R.+S.+Obach&title=Metabolism-directed+design+of+oxetane-containing+arylsulfonamide+derivatives+as+%CE%B3-secretase+inhibitors&doi=10.1021%2Fjm200893p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase Inhibitors</span></div><div class="casAuthors">Stepan, Antonia F.; Karki, Kapil; McDonald, W. Scott; Dorff, Peter H.; Dutra, Jason K.; DiRico, Kenneth J.; Won, Annie; Subramanyam, Chakrapani; Efremov, Ivan V.; O'Donnell, Christopher J.; Nolan, Charles E.; Becker, Stacey L.; Pustilnik, Leslie R.; Sneed, Blossom; Sun, Hao; Lu, Yasong; Robshaw, Ashley E.; Riddell, David; O'Sullivan, Theresa J.; Sibley, Evelyn; Capetta, Steven; Atchison, Kevin; Hallgren, Andrew J.; Miller, Emily; Wood, Anthony; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7772-7783</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A metab.-based approach toward the optimization of a series of N-arylsulfonamide-based γ-secretase inhibitors is reported.  The lead cyclohexyl analog 6 suffered from extensive oxidn. on the cycloalkyl motif by cytochrome P 450 3A4, translating into poor human liver microsomal stability.  Knowledge of the metabolic pathways of 6 triggered a structure-activity relationship study aimed at lowering lipophilicity through the introduction of polarity.  This effort led to several tetrahydropyran and THF analogs, wherein the 3- and 4-substituted variants exhibited greater microsomal stability relative to their 2-substituted counterparts.  Further redn. in lipophilicity led to the potent γ-secretase inhibitor and 3-substituted oxetane 1 with a reduced propensity toward oxidative metab., relative to its 2-substituted isomer.  The slower rates of metab. with 3-substituted cyclic ethers most likely originate from redns. in lipophilicity and/or unfavorable CYP active site interactions with the heteroatom.  Preliminary animal pharmacol. studies with a representative oxetane indicate that the series is generally capable of lowering Aβ in vivo.  As such, the study also illustrates the improvement in drug likeness of mols. through the use of the oxetane motif.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1kWyZJuyD97Vg90H21EOLACvtfcHk0lg9Qb3VlxPPjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOgu7rK&md5=b3e9725954a155900563cc5d2f73263b</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1021%2Fjm200893p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200893p%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DW.%2BS.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DDiRico%26aufirst%3DK.%2BJ.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSneed%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DCapetta%26aufirst%3DS.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DHallgren%26aufirst%3DA.%2BJ.%26aulast%3DMiller%26aufirst%3DE.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DMetabolism-directed%2520design%2520of%2520oxetane-containing%2520arylsulfonamide%2520derivatives%2520as%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7772%26epage%3D7783%26doi%3D10.1021%2Fjm200893p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Keown, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaimi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, J. D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Best, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearman, M. S.</span></span> <span> </span><span class="NLM_article-title">Novel orally bioavailable gamma-secretase inhibitors with excellent in vivo activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3441</span>– <span class="NLM_lpage">3444</span>, <span class="refDoi"> DOI: 10.1021/jm900056p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900056p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Grsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3441-3444&author=L.+E.+Keownauthor=I.+Collinsauthor=L.+C.+Cooperauthor=T.+Harrisonauthor=A.+Madinauthor=J.+Mistryauthor=M.+Reillyauthor=M.+Shaimiauthor=C.+J.+Welchauthor=E.+E.+Clarkeauthor=H.+D.+Lewisauthor=J.+D.+J.+Wrigleyauthor=J.+D.+Bestauthor=F.+Murrayauthor=M.+S.+Shearman&title=Novel+orally+bioavailable+gamma-secretase+inhibitors+with+excellent+in+vivo+activity&doi=10.1021%2Fjm900056p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6fR"><div class="casContent"><span class="casTitleNuber">6f</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Orally Bioavailable γ-Secretase Inhibitors with Excellent in Vivo Activity</span></div><div class="casAuthors">Keown, Linda E.; Collins, Ian; Cooper, Laura C.; Harrison, Timothy; Madin, Andrew; Mistry, Jayesh; Reilly, Michael; Shaimi, Mohamed; Welch, Christopher J.; Clarke, Earl E.; Lewis, Huw D.; Wrigley, Jonathan D. J.; Best, Jonathan D.; Murray, Fraser; Shearman, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3441-3444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of potent γ-secretase inhibitors having substituted heterocycles attached to a benzobicyclo[4.2.1]nonane core is described.  This work led to the identification of [6S,9R,11R]-2',3',4',5,5',6,7,8,9,10-decahydro-2-(5-(4-fluorophenyl)-1-methylpyrazol-3-yl)-5'-(2,2,2-trifluoroethyl)spiro[6,9-methanobenzocyclooctene-11,3'-[1,2,5]thiadiazole] 1',1'-dioxide (16), which has excellent in vitro potency (0.06 nM) and which reduced amyloid-β in APP-YAC mice with an ED50 of 1 mg/kg (po).  16 Had a good pharmacokinetic profile in three preclin. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7OIXbqPklvbVg90H21EOLACvtfcHk0lgpMuU9GDhHfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Grsrs%253D&md5=027fe580c1d9cc066cd780db2edf15c5</span></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1021%2Fjm900056p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900056p%26sid%3Dliteratum%253Aachs%26aulast%3DKeown%26aufirst%3DL.%2BE.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DCooper%26aufirst%3DL.%2BC.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DMadin%26aufirst%3DA.%26aulast%3DMistry%26aufirst%3DJ.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DShaimi%26aufirst%3DM.%26aulast%3DWelch%26aufirst%3DC.%2BJ.%26aulast%3DClarke%26aufirst%3DE.%2BE.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%2BJ.%26aulast%3DBest%26aufirst%3DJ.%2BD.%26aulast%3DMurray%26aufirst%3DF.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DNovel%2520orally%2520bioavailable%2520gamma-secretase%2520inhibitors%2520with%2520excellent%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3441%26epage%3D3444%26doi%3D10.1021%2Fjm900056p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, J. D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of highly potent benzodiazepine gamma-secretase inhibitors: preparation of (2S,3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2275</span>– <span class="NLM_lpage">2278</span>, <span class="refDoi"> DOI: 10.1021/jm034058a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm034058a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1Gnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2275-2278&author=I.+Churcherauthor=S.+Williamsauthor=S.+Kerradauthor=T.+Harrisonauthor=J.+L.+Castroauthor=M.+S.+Shearmanauthor=H.+D.+Lewisauthor=E.+E.+Clarkeauthor=J.+D.+J.+Wrigleyauthor=D.+Beherauthor=Y.+S.+Tangauthor=W.+Liu&title=Design+and+synthesis+of+highly+potent+benzodiazepine+gamma-secretase+inhibitors%3A+preparation+of+%282S%2C3R%29-3-%283%2C4-difluorophenyl%29-2-%284-fluorophenyl%29-4-+hydroxy-N-%28%283S%29-1-methyl-2-oxo-5-+phenyl-2%2C3-dihydro-1H-benzo%5Be%5D%5B1%2C4%5D-diazepin-3-yl%29butyramide+by+use+of+an+asymmetric+Ireland-Claisen+rearrangement&doi=10.1021%2Fjm034058a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6gR"><div class="casContent"><span class="casTitleNuber">6g</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Highly Potent Benzodiazepine γ-Secretase Inhibitors: Preparation of (2S,3R)-3-(3,4- Difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]- diazepin-3-yl)butyramide by Use of an Asymmetric Ireland-Claisen Rearrangement</span></div><div class="casAuthors">Churcher, Ian; Williams, Susie; Kerrad, Sonia; Harrison, Timothy; Castro, Jose L.; Shearman, Mark S.; Lewis, Huw D.; Clarke, Earl E.; Wrigley, Jonathan D. J.; Beher, Dirk; Tang, Yui S.; Liu, Wensheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2275-2278</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel benzodiazepine-contg. γ-secretase inhibitors I (R1 = H, Me; R2 = Me, 4-FC6H4; R3 = HO, HOCH2, Me, MeO, BrCH2, etc.; R4 = F, Cl), incorporating a substituted hydrocinnamide C-3 side chain, have been designed for potential use in Alzheimer's disease.  A syn combination of α-alkyl or aryl and β-hydroxy or hydroxymethyl substituents was shown to give highly potent compds.  In particular, benzodiazepine I [R1 = H; R2 = 4-FC6H4; R3 = HOCH2; R4 = F; (II)] demonstrated excellent in vitro potency (IC50 = 0.06nM).  II could also be selectively methylated to give I (R1 = T3C; R2 = 4-FC6H4; R3 = HOCH2; R4 = F), which is of use in radioligand binding assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPzJ36X0rnZrVg90H21EOLACvtfcHk0lgpMuU9GDhHfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1Gnsbg%253D&md5=7ee4d459a9abb6f6a3308f9736b64191</span></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1021%2Fjm034058a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034058a%26sid%3Dliteratum%253Aachs%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DKerrad%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DCastro%26aufirst%3DJ.%2BL.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DClarke%26aufirst%3DE.%2BE.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%2BJ.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DY.%2BS.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520highly%2520potent%2520benzodiazepine%2520gamma-secretase%2520inhibitors%253A%2520preparation%2520of%2520%25282S%252C3R%2529-3-%25283%252C4-difluorophenyl%2529-2-%25284-fluorophenyl%2529-4-%2520hydroxy-N-%2528%25283S%2529-1-methyl-2-oxo-5-%2520phenyl-2%252C3-dihydro-1H-benzo%255Be%255D%255B1%252C4%255D-diazepin-3-yl%2529butyramide%2520by%2520use%2520of%2520an%2520asymmetric%2520Ireland-Claisen%2520rearrangement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2275%26epage%3D2278%26doi%3D10.1021%2Fjm034058a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bursavich, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgdon, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrdlicka, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapadnis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffit, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patzke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blain, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, D. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of a novel series of oxadiazine gamma secretase modulators for familial Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2383</span>– <span class="NLM_lpage">2400</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01620</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01620" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlyjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2383-2400&author=M.+G.+Bursavichauthor=B.+A.+Harrisonauthor=R.+Acharyaauthor=D.+E.+Costaauthor=E.+A.+Freemanauthor=H.+E.+Hodgdonauthor=L.+A.+Hrdlickaauthor=H.+Jinauthor=S.+Kapadnisauthor=J.+S.+Moffitauthor=D.+A.+Murphyauthor=S.+Nolanauthor=H.+Patzkeauthor=C.+Tangauthor=M.+Wenauthor=G.+Koenigauthor=J.-F.+Blainauthor=D.+A.+Burnett&title=Design%2C+synthesis%2C+and+evaluation+of+a+novel+series+of+oxadiazine+gamma+secretase+modulators+for+familial+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b01620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer's Disease</span></div><div class="casAuthors">Bursavich, Matthew G.; Harrison, Bryce A.; Acharya, Raksha; Costa, Donald E.; Freeman, Emily A.; Hodgdon, Hilliary E.; Hrdlicka, Lori A.; Jin, Hong; Kapadnis, Sudarshan; Moffit, Jeffrey S.; Murphy, Deirdre A.; Nolan, Scott; Patzke, Holger; Tang, Cuyue; Wen, Melody; Koenig, Gerhard; Blain, Jean-Francois; Burnett, Duane A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2383-2400</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the design, synthesis, and evaluation of a novel series of oxadiazine-based gamma secretase modulators obtained via isosteric amide replacement and crit. consideration of conformational restriction.  Oxadiazine lead 47 possesses good in vitro potency with excellent predicted CNS drug-like properties and desirable ADME/PK profile.  This lead compd. demonstrated robust Aβ42 redns. and subsequent Aβ37 increases in both rodent brain and CSF at 30 mg/kg dosed orally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr84T77SPqu9LVg90H21EOLACvtfcHk0lhEPEWgdSrdaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlyjtrw%253D&md5=a14e653792d665cd842cf279c11b2be6</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01620%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DHarrison%26aufirst%3DB.%2BA.%26aulast%3DAcharya%26aufirst%3DR.%26aulast%3DCosta%26aufirst%3DD.%2BE.%26aulast%3DFreeman%26aufirst%3DE.%2BA.%26aulast%3DHodgdon%26aufirst%3DH.%2BE.%26aulast%3DHrdlicka%26aufirst%3DL.%2BA.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DKapadnis%26aufirst%3DS.%26aulast%3DMoffit%26aufirst%3DJ.%2BS.%26aulast%3DMurphy%26aufirst%3DD.%2BA.%26aulast%3DNolan%26aufirst%3DS.%26aulast%3DPatzke%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DM.%26aulast%3DKoenig%26aufirst%3DG.%26aulast%3DBlain%26aufirst%3DJ.-F.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520oxadiazine%2520gamma%2520secretase%2520modulators%2520for%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2383%26epage%3D2400%26doi%3D10.1021%2Facs.jmedchem.6b01620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">am Ende, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fish, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetelino, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustilnik, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span> <span> </span><span class="NLM_article-title">Design of pyridopyrazine-1,6-dione γ-secretase modulators that align potency, MDR efflux ratio, and metabolic stability</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVaksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=596-601&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=J.+M.+Humphreyauthor=T.+W.+Butlerauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=P.+B.+Mullinsauthor=C.+J.+O%E2%80%99Donnellauthor=A.+F.+Stepanauthor=C.+M.+Stiffauthor=C.+Subramanyamauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=E.+Yangauthor=L.+Xieauthor=K.+R.+Balesauthor=L.+R.+Pustilnikauthor=S.+J.+Steynauthor=K.+M.+Woodauthor=P.+R.+Verhoest&title=Design+of+pyridopyrazine-1%2C6-dione+%CE%B3-secretase+modulators+that+align+potency%2C+MDR+efflux+ratio%2C+and+metabolic+stability&doi=10.1021%2Facsmedchemlett.5b00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Humphrey, John M.; Butler, Todd W.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Mullins, Patrick B.; O'Donnell, Christopher J.; Stepan, Antonia F.; Stiff, Cory M.; Subramanyam, Chakrapani; Tran, Tuan P.; Vetelino, Beth Cooper; Yang, Eddie; Xie, Longfei; Bales, Kelly R.; Pustilnik, Leslie R.; Steyn, Stefanus J.; Wood, Kathleen M.; Verhoest, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the design and synthesis of a series of pyridopyrazine-1,6-dione γ-secretase modulators (GSMs) for Alzheimer's disease (AD) that achieve good alignment of potency, metabolic stability, and low MDR efflux ratios, while also maintaining favorable physicochem. properties.  Specifically, incorporation of fluorine enabled design of metabolically less liable lipophilic alkyl substituents to increase potency without compromising the sp3-character.  The lead compd. I (PF-06442609) displayed a favorable rodent pharmacokinetic profile, and robust redns. of brain Aβ42 and Aβ40 were obsd. in a guinea pig time-course expt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhW3RYEYEcOrVg90H21EOLACvtfcHk0lhEPEWgdSrdaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVaksrg%253D&md5=ba402f2e67fd9500123cbc7b215d3361</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00070%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DButler%26aufirst%3DT.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDesign%2520of%2520pyridopyrazine-1%252C6-dione%2520%25CE%25B3-secretase%2520modulators%2520that%2520align%2520potency%252C%2520MDR%2520efflux%2520ratio%252C%2520and%2520metabolic%2520stability%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D596%26epage%3D601%26doi%3D10.1021%2Facsmedchemlett.5b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">am Ende, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fish, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navaratnam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustilnik, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetelino, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozdnyakov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-Secretase Modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1062</span>, <span class="refDoi"> DOI: 10.1021/jm401782h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401782h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1046-1062&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=B.+C.+Vetelinoauthor=K.+M.+Woodauthor=N.+Pozdnyakovauthor=P.+R.+Verhoestauthor=C.+J.+O%E2%80%99Donnell&title=Design%2C+synthesis%2C+and+pharmacological+evaluation+of+a+novel+series+of+pyridopyrazine-1%2C6-dione+%CE%B3-Secretase+Modulators&doi=10.1021%2Fjm401782h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Vetelino, Beth C.; Wood, Kathleen M.; Pozdnyakov, Nikolay; Verhoest, Patrick R.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1046-1062</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we describe the design and synthesis of a novel series of γ-secretase modulators (GSMs) that incorporates a pyridopiperazine-1,6-dione ring system.  To align improved potency with favorable ADME and in vitro safety, we applied prospective physicochem. property-driven design coupled with parallel medicinal chem. techniques to arrive at a novel series contg. a conformationally restricted core.  Lead compd. I exhibited good in vitro potency and ADME, which translated into a favorable in vivo pharmacokinetic profile.  Furthermore, robust redn. of brain Aβ42 was obsd. in guinea pig at 30 mg/kg dosed orally.  Through chem. biol. efforts involving the design and synthesis of a clickable photoreactive probe, we demonstrated specific labeling of the presenilin N-terminal fragment (PS1-NTF) within the γ-secretase complex, thus gaining insight into the binding site of this series of GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZjw9nXaFFiLVg90H21EOLACvtfcHk0lj9TuWsoNNfiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVGkug%253D%253D&md5=a3d743eea05981a29143a0ec6b43549f</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1021%2Fjm401782h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401782h%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DPozdnyakov%26aufirst%3DN.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520evaluation%2520of%2520a%2520novel%2520series%2520of%2520pyridopyrazine-1%252C6-dione%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1046%26epage%3D1062%26doi%3D10.1021%2Fjm401782h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhondi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicarel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josien, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span> <span> </span><span class="NLM_article-title">The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer’s disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmcl.2012.11.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=23253441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVOrurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=466-471&author=H.+Liauthor=J.+Qinauthor=P.+Dhondiauthor=W.+Zhouauthor=M.+Vicarelauthor=T.+Baraauthor=D.+Coleauthor=H.+Josienauthor=D.+Pissarnitskiauthor=Z.+Zhuauthor=A.+Palaniauthor=R.+Aslanianauthor=J.+Claderauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=M.+Cohen-Williamsauthor=L.+Hydeauthor=L.+Songauthor=L.+Zhangauthor=I.+Chuauthor=X.+Huang&title=The+discovery+of+fused+oxadiazepines+as+gamma+secretase+modulators+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2012.11.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's disease</span></div><div class="casAuthors">Li, Hongmei; Qin, Jun; Dhondi, Pawan; Zhou, Wei; Vicarel, Monica; Bara, Thomas; Cole, David; Josien, Hubert; Pissarnitski, Dmitri; Zhu, Zhaoning; Palani, Anandan; Aslanian, Robert; Clader, John; Czarniecki, Michael; Greenlee, William; Cohen-Williams, Mary; Hyde, Lynn; Song, Lixin; Zhang, Lili; Chu, Inhou; Huang, Xianhai</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">466-471</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an attempt to further improve overall profiles of the oxadiazine series of GSMs, in particular the hERG activity, conformational modifications of the core structure resulted in the identification of fused oxadiazepines such as 7i (I) which had an improved hERG inhibition profile and was a highly efficacious GSM in vitro and in vivo in rats.  These SAR explorations offer opportunities to identify potential drugs to treat Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJUUyjEiaFDbVg90H21EOLACvtfcHk0lj9TuWsoNNfiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVOrurrI&md5=d2c0ec5773714fe62e9056a98823343e</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.055%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DThe%2520discovery%2520of%2520fused%2520oxadiazepines%2520as%2520gamma%2520secretase%2520modulators%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D466%26epage%3D471%26doi%3D10.1016%2Fj.bmcl.2012.11.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthelot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minne, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieters, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masungi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9089</span>– <span class="NLM_lpage">9106</span>, <span class="refDoi"> DOI: 10.1021/jm201710f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201710f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9089-9106&author=F.+Bischoffauthor=D.+Berthelotauthor=M.+De+Cleynauthor=G.+Macdonaldauthor=G.+Minneauthor=D.+Oehlrichauthor=S.+Pietersauthor=M.+Surkynauthor=A.+A.+Trabancoauthor=G.+Tresadernauthor=S.+Van+Brandtauthor=I.+Velterauthor=M.+Zajaauthor=H.+Borghysauthor=C.+Masungiauthor=M.+Merckenauthor=H.+J.+M.+Gijsen&title=Design+and+synthesis+of+a+novel+series+of+bicyclic+heterocycles+as+potent+%CE%B3-secretase+modulators&doi=10.1021%2Fjm201710f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators</span></div><div class="casAuthors">Bischoff, Francois; Berthelot, Didier; De Cleyn, Michel; MacDonald, Gregor; Minne, Garrett; Oehlrich, Daniel; Pieters, Serge; Surkyn, Michel; Trabanco, Andres A.; Tresadern, Gary; Van Brandt, Sven; Velter, Ingrid; Zaja, Mirko; Borghys, Herman; Masungi, Chantal; Mercken, Marc; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9089-9106</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and the synthesis of several chem. subclasses of imidazole contg. γ-secretase modulators (GSMs) is described.  Conformational restriction of an aminopyridone into bicyclic pyridone isosteres has led to compds. with high in vitro and in vivo potency.  This has resulted in the identification of benzimidazole I as a GSM with low nanomolar potency in vitro.  In mouse, rat, and dog, this compd. displayed the typical γ-secretase modulatory profile by lowering Aβ42 and Aβ40 levels combined with an esp. pronounced increase in Aβ38 and Aβ37 levels while leaving the total levels of amyloid peptides unchanged.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtfwoI1AvXwLVg90H21EOLACvtfcHk0lgyrU05AMn5eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGrurw%253D&md5=8edaf14f066220910e0d510a563ce02f</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1021%2Fjm201710f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201710f%26sid%3Dliteratum%253Aachs%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DBerthelot%26aufirst%3DD.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMinne%26aufirst%3DG.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DVelter%26aufirst%3DI.%26aulast%3DZaja%26aufirst%3DM.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DMasungi%26aufirst%3DC.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520novel%2520series%2520of%2520bicyclic%2520heterocycles%2520as%2520potent%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9089%26epage%3D9106%26doi%3D10.1021%2Fjm201710f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbs, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creaser, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loureiro, R. M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ives, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronk, B. S.</span></span> <span> </span><span class="NLM_article-title">Optimization of a Natural Product-Based Class of γ-Secretase Modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9270</span>– <span class="NLM_lpage">9282</span>, <span class="refDoi"> DOI: 10.1021/jm300976b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300976b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9270-9282&author=J.+L.+Hubbsauthor=N.+O.+Fullerauthor=W.+F.+Austinauthor=R.+Shenauthor=S.+P.+Creaserauthor=T.+D.+McKeeauthor=R.+M.+B.+Loureiroauthor=B.+Tateauthor=W.+Xiaauthor=J.+Ivesauthor=B.+S.+Bronk&title=Optimization+of+a+Natural+Product-Based+Class+of+%CE%B3-Secretase+Modulators&doi=10.1021%2Fjm300976b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a Natural Product-Based Class of γ-Secretase Modulators</span></div><div class="casAuthors">Hubbs, Jed L.; Fuller, Nathan O.; Austin, Wesley F.; Shen, Ruichao; Creaser, Steffen P.; McKee, Timothy D.; Loureiro, Robyn M. B.; Tate, Barbara; Xia, Weiming; Ives, Jeffrey; Bronk, Brian S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9270-9282</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of triterpene-based γ-secretase modulators is optimized.  An acetate present at the C24 position of the natural product was replaced with either carbamates or ethers to provide compds. with better metabolic stability.  With one of those pharmacophores in place at C24, morpholines or carbamates were installed at the C3 position to refine the physicochem. properties of the analogs.  This strategy gave compds. with low clearance and good distribution into the central nervous system (CNS) of CD-1 mice.  Two of these compds., I and II, were tested for a pharmacodynamic effect and exhibited statistically significant lowering of brain Aβ42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHBWy3p0wjU7Vg90H21EOLACvtfcHk0lgyrU05AMn5eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLfO&md5=3a826577aa836f3235a4b61468fa0c0e</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1021%2Fjm300976b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300976b%26sid%3Dliteratum%253Aachs%26aulast%3DHubbs%26aufirst%3DJ.%2BL.%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DAustin%26aufirst%3DW.%2BF.%26aulast%3DShen%26aufirst%3DR.%26aulast%3DCreaser%26aufirst%3DS.%2BP.%26aulast%3DMcKee%26aufirst%3DT.%2BD.%26aulast%3DLoureiro%26aufirst%3DR.%2BM.%2BB.%26aulast%3DTate%26aufirst%3DB.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DIves%26aufirst%3DJ.%26aulast%3DBronk%26aufirst%3DB.%2BS.%26atitle%3DOptimization%2520of%2520a%2520Natural%2520Product-Based%2520Class%2520of%2520%25CE%25B3-Secretase%2520Modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9270%26epage%3D9282%26doi%3D10.1021%2Fjm300976b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">am Ende, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fish, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navaratnam, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiff, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetelino, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustilnik, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2906</span>– <span class="NLM_lpage">2911</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmcl.2012.02.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=22429469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2906-2911&author=M.+Petterssonauthor=D.+S.+Johnsonauthor=C.+Subramanyamauthor=K.+R.+Balesauthor=C.+W.+am+Endeauthor=B.+A.+Fishauthor=M.+E.+Greenauthor=G.+W.+Kauffmanauthor=R.+Liraauthor=P.+B.+Mullinsauthor=T.+Navaratnamauthor=S.+M.+Sakyaauthor=C.+M.+Stiffauthor=T.+P.+Tranauthor=B.+C.+Vetelinoauthor=L.+Xieauthor=L.+Zhangauthor=L.+R.+Pustilnikauthor=K.+M.+Woodauthor=C.+J.+O%E2%80%99Donnell&title=Design+and+synthesis+of+dihydrobenzofuran+amides+as+orally+bioavailable%2C+centrally+active+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2012.02.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7gR"><div class="casContent"><span class="casTitleNuber">7g</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators</span></div><div class="casAuthors">Pettersson, Martin; Johnson, Douglas S.; Subramanyam, Chakrapani; Bales, Kelly R.; am Ende, Christopher W.; Fish, Benjamin A.; Green, Michael E.; Kauffman, Gregory W.; Lira, Ricardo; Mullins, Patrick B.; Navaratnam, Thayalan; Sakya, Subas M.; Stiff, Cory M.; Tran, Tuan P.; Vetelino, Beth C.; Xie, Longfei; Zhang, Liming; Pustilnik, Leslie R.; Wood, Kathleen M.; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2906-2911</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and optimization of a novel series of dihydrobenzofuran amides as γ-secretase modulators (GSMs) is reported.  Strategies for aligning in vitro potency with drug-like physicochem. properties and good microsomal stability while avoiding P-gp mediated efflux are discussed.  Lead compds. such as I and II have moderate to good in vitro potency and excellent selectivity against Notch.  Good oral bioavailability was achieved as well as robust brain Aβ42 lowering activity at 100 mg/kg po dose.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIcSb2qlgrNLVg90H21EOLACvtfcHk0ljk2u25fnYLvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSit7o%253D&md5=63746bd0db38a20bb33b5e990e66610c</span></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.059%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBales%26aufirst%3DK.%2BR.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DFish%26aufirst%3DB.%2BA.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMullins%26aufirst%3DP.%2BB.%26aulast%3DNavaratnam%26aufirst%3DT.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DStiff%26aufirst%3DC.%2BM.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DVetelino%26aufirst%3DB.%2BC.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dihydrobenzofuran%2520amides%2520as%2520orally%2520bioavailable%252C%2520centrally%2520active%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2906%26epage%3D2911%26doi%3D10.1016%2Fj.bmcl.2012.02.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asberom, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josien, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacCoss, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicarel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span> <span> </span><span class="NLM_article-title">Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.1021/jm201407j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201407j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=489-502&author=Z.-Y.+Sunauthor=T.+Asberomauthor=T.+Baraauthor=C.+Bennettauthor=D.+Burnettauthor=I.+Chuauthor=J.+Claderauthor=M.+Cohen-Williamsauthor=D.+Coleauthor=M.+Czarnieckiauthor=J.+Durkinauthor=G.+Galloauthor=W.+Greenleeauthor=H.+Josienauthor=X.+Huangauthor=L.+Hydeauthor=N.+Jonesauthor=I.+Kazakevichauthor=H.+Liauthor=X.+Liuauthor=J.+Leeauthor=M.+MacCossauthor=M.+B.+Mandalauthor=T.+McCrackenauthor=A.+Nomeirauthor=R.+Mazzolaauthor=A.+Palaniauthor=E.+M.+Parkerauthor=D.+A.+Pissarnitskiauthor=J.+Qinauthor=L.+Songauthor=G.+Terracinaauthor=M.+Vicarelauthor=J.+Voigtauthor=R.+Xuauthor=L.+Zhangauthor=Q.+Zhangauthor=Z.+Zhaoauthor=X.+Zhuauthor=Z.+Zhu&title=Cyclic+hydroxyamidines+as+amide+isosteres%3A+discovery+of+oxadiazolines+and+oxadiazines+as+potent+and+highly+efficacious+%CE%B3-secretase+modulators+in+vivo&doi=10.1021%2Fjm201407j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7hR"><div class="casContent"><span class="casTitleNuber">7h</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo</span></div><div class="casAuthors">Sun, Zhong-Yue; Asberom, Theodros; Bara, Thomas; Bennett, Chad; Burnett, Duane; Chu, Inhou; Clader, John; Cohen-Williams, Mary; Cole, David; Czarniecki, Michael; Durkin, James; Gallo, Gioconda; Greenlee, William; Josien, Hubert; Huang, Xianhai; Hyde, Lynn; Jones, Nicholas; Kazakevich, Irina; Li, Hongmei; Liu, Xiaoxiang; Lee, Julie; MacCoss, Malcolm; Mandal, Mihir B.; McCracken, Troy; Nomeir, Amin; Mazzola, Robert; Palani, Anandan; Parker, Eric M.; Pissarnitski, Dmitri A.; Qin, Jun; Song, Lixin; Terracina, Giuseppe; Vicarel, Monica; Voigt, Johannes; Xu, Ruo; Zhang, Lili; Zhang, Qi; Zhao, Zhiqiang; Zhu, Xiaohong; Zhu, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">489-502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality.  Compds. with these structural motifs were found to be metabolically stable and to possess highly desirable pharmacokinetic profiles.  These designs were applied in the identification of γ-secretase modulators leading to highly efficacious agents for redn. of central nervous system Aβ42 in various animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowGuNLMGYzw7Vg90H21EOLACvtfcHk0lgsvL-O-oINrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2jtbbL&md5=5f64483cba26060a60de990fa423014e</span></div><a href="/servlet/linkout?suffix=cit7h&amp;dbid=16384&amp;doi=10.1021%2Fjm201407j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201407j%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.-Y.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMandal%26aufirst%3DM.%2BB.%26aulast%3DMcCracken%26aufirst%3DT.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DPissarnitski%26aufirst%3DD.%2BA.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DCyclic%2520hydroxyamidines%2520as%2520amide%2520isosteres%253A%2520discovery%2520of%2520oxadiazolines%2520and%2520oxadiazines%2520as%2520potent%2520and%2520highly%2520efficacious%2520%25CE%25B3-secretase%2520modulators%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D489%26epage%3D502%26doi%3D10.1021%2Fjm201407j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicarel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCraken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR studies of fused oxadiazines as γ-secretase modulators for treatment of alzheimer’s disease</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">931</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1021/ml300209g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300209g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=931-935&author=X.+Huangauthor=W.+Zhouauthor=X.+Liuauthor=H.+Liauthor=G.+Sunauthor=M.+Mandalauthor=M.+Vicarelauthor=X.+Zhuauthor=C.+Bennettauthor=T.+McCrakenauthor=D.+Pissarnitskiauthor=Z.+Zhaoauthor=D.+Coleauthor=G.+Galloauthor=Z.+Zhuauthor=A.+Palaniauthor=R.+Aslanianauthor=J.+Claderauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=D.+Burnettauthor=M.+Cohen-Williamsauthor=L.+Hydeauthor=L.+Songauthor=L.+Zhangauthor=I.+Chuauthor=A.+Buevich&title=Synthesis+and+SAR+studies+of+fused+oxadiazines+as+%CE%B3-secretase+modulators+for+treatment+of+alzheimer%E2%80%99s+disease&doi=10.1021%2Fml300209g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7iR"><div class="casContent"><span class="casTitleNuber">7i</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Huang, Xianhai; Zhou, Wei; Liu, Xiaoxiang; Li, Hongmei; Sun, George; Mandal, Mihirbaran; Vicarel, Monica; Zhu, Xiaohong; Bennett, Chad; McCraken, Troy; Pissarnitski, Dmitri; Zhao, Zhiqiang; Cole, David; Gallo, Gioconda; Zhu, Zhaoning; Palani, Anandan; Aslanian, Robert; Clader, John; Czarniecki, Michael; Greenlee, William; Burnett, Duane; Cohen-Williams, Mary; Hyde, Lynn; Song, Lixin; Zhang, Lili; Chu, Inhou; Buevich, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">931-935</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fused oxadiazines such as imidazolylbenzylidene pyridooxadiazines I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) and imidazolylbenzylidene oxazinooxadiazines I (R = F; R1 = H, F; R2 = Me; X = O) were prepd. as selective and orally bioavailable γ-secretase modulators (GSMs) derived by analogy from pyridooxadiazoline GSMs.  The effect of structural modifications on pyridooxadiazoline GSMs differed significantly from the effects of modifications to pyridooxadiazine GSMs.  I (R = Cl, F; R1 = H, F; R2 = H; X = CH2) were found to be highly efficacious in vitro and in vivo in a no. of animal models with highly desirable phys. and pharmacol. properties.  Fused morpholine oxadiazines such as I (R = F; R1 = H, F; R2 = Me; X = O) showed improved in vitro activities and selectivities as GSMs.  The shift in specificity of APP cleavage rather than a redn. in overall γ-secretase activity and the lack of changes in substrate accumulation and Notch processing as obsd. in the animal studies of compd. I (R = R1 = F; R2 = H; X = CH2) confirm that imidazolylbenzylidene pyridooxadiazines are potent GSMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrLJKqS8YPSLVg90H21EOLACvtfcHk0lgsvL-O-oINrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12itr3L&md5=42883463705abaa95287df4ea07f8936</span></div><a href="/servlet/linkout?suffix=cit7i&amp;dbid=16384&amp;doi=10.1021%2Fml300209g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300209g%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DG.%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DVicarel%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DMcCraken%26aufirst%3DT.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DBuevich%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520fused%2520oxadiazines%2520as%2520%25CE%25B3-secretase%2520modulators%2520for%2520treatment%2520of%2520alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D931%26epage%3D935%26doi%3D10.1021%2Fml300209g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7j"><span><span class="NLM_label">(j) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talreja, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumaravel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humora, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackett, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollate, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunah, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snodgrass-Belt, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taveras, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of BIIB042, a potent, selective, and orally bioavailable γ-secretase modulator</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1021/ml200175q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200175q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVagsLzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=786-791&author=H.+Pengauthor=T.+Talrejaauthor=Z.+Xinauthor=J.+H.+Cuervoauthor=G.+Kumaravelauthor=M.+J.+Humoraauthor=L.+Xuauthor=E.+Rohdeauthor=L.+Ganauthor=M.-y.+Jungauthor=M.+N.+Shackettauthor=S.+Chollateauthor=A.+W.+Dunahauthor=P.+A.+Snodgrass-Beltauthor=H.+M.+Arnoldauthor=A.+G.+Taverasauthor=K.+J.+Rhodesauthor=R.+H.+Scannevin&title=Discovery+of+BIIB042%2C+a+potent%2C+selective%2C+and+orally+bioavailable+%CE%B3-secretase+modulator&doi=10.1021%2Fml200175q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7jR"><div class="casContent"><span class="casTitleNuber">7j</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BIIB042, a Potent, Selective, and Orally Bioavailable γ-Secretase Modulator</span></div><div class="casAuthors">Peng, Hairuo; Talreja, Tina; Xin, Zhili; Cuervo, J. Hernan; Kumaravel, Gnanasambandam; Humora, Michael J.; Xu, Lin; Rohde, Ellen; Gan, Lawrence; Jung, Mi-young; Shackett, Melanie N.; Chollate, Sowmya; Dunah, Anthone W.; Snodgrass-Belt, Pamela A.; Arnold, H. Moore; Taveras, Arthur G.; Rhodes, Kenneth J.; Scannevin, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">786-791</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have investigated a novel series of acid-derived γ-secretase modulators as a potential treatment of Alzheimer's disease.  Optimization based on cellular potency and brain pharmacodynamics after oral dosing led to the discovery of 10a (BIIB042).  Compd. 10a is a potent γ-secretase modulator, which lowered Aβ42, increased Aβ38, but had little to no effect on Aβ40 levels both in vitro and in vivo.  In addn., compd. 10a did not affect Notch signaling in our in vitro assessment.  Compd. 10a demonstrated excellent pharmacokinetic parameters in multiple species.  Oral administration of 10a significantly reduced brain Aβ42 levels in CF-1 mice and Fischer rats, as well as plasma Aβ42 levels in cynomolgus monkeys.  Compd. 10a was selected as a candidate for preclin. safety evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFxWt4VF-jWrVg90H21EOLACvtfcHk0li30VdelXmZjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVagsLzL&md5=10ca58300441819def9dc7a9b9b42386</span></div><a href="/servlet/linkout?suffix=cit7j&amp;dbid=16384&amp;doi=10.1021%2Fml200175q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200175q%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DTalreja%26aufirst%3DT.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DCuervo%26aufirst%3DJ.%2BH.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DHumora%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DRohde%26aufirst%3DE.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DJung%26aufirst%3DM.-y.%26aulast%3DShackett%26aufirst%3DM.%2BN.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DDunah%26aufirst%3DA.%2BW.%26aulast%3DSnodgrass-Belt%26aufirst%3DP.%2BA.%26aulast%3DArnold%26aufirst%3DH.%2BM.%26aulast%3DTaveras%26aufirst%3DA.%2BG.%26aulast%3DRhodes%26aufirst%3DK.%2BJ.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26atitle%3DDiscovery%2520of%2520BIIB042%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520%25CE%25B3-secretase%2520modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D786%26epage%3D791%26doi%3D10.1021%2Fml200175q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7k"><span><span class="NLM_label">(k) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCracken, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buevich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnett, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josein, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKittrick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terracina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span> <span> </span><span class="NLM_article-title">Iminoheterocycles as γ-secretase modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5380</span>– <span class="NLM_lpage">5384</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.07.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7k&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmcl.2010.07.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7k&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=20724152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5380-5384&author=J.+P.+Caldwellauthor=C.+E.+Bennettauthor=T.+M.+McCrackenauthor=R.+D.+Mazzolaauthor=T.+Baraauthor=A.+Buevichauthor=D.+A.+Burnettauthor=I.+Chuauthor=M.+Cohen-Williamsauthor=H.+Joseinauthor=L.+Hydeauthor=J.+Leeauthor=B.+McKittrickauthor=L.+Songauthor=G.+Terracinaauthor=J.+Voigtauthor=L.+Zhangauthor=Z.+Zhuauthor=Z.+Zhu&title=Iminoheterocycles+as+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2010.07.121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7kR"><div class="casContent"><span class="casTitleNuber">7k</span><div class="casTitle"><span class="NLM_cas:atitle">Iminoheterocycles as γ-secretase modulators</span></div><div class="casAuthors">Caldwell, John P.; Bennett, Chad E.; McCracken, Troy M.; Mazzola, Robert D.; Bara, Thomas; Buevich, Alexei; Burnett, Duane A.; Chu, Inhou; Cohen-Williams, Mary; Josein, Hubert; Hyde, Lynn; Lee, Julie; McKittrick, Brian; Song, Lixin; Terracina, Giuseppe; Voigt, Johannes; Zhang, Lili; Zhu, Zhaoning</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5380-5384</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis of a novel series of iminoheterocycles, e.g., I and their structure-activity relationship (SAR) as modulators of γ-secretase activity will be detailed.  Encouraging SAR generated from a monocyclic core led to a structurally unique bicyclic core.  Selected compds. exhibit good potency as γ-secretase modulators, excellent rat pharmacokinetics, and lowering of Aβ42 levels in various in vivo models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJTxu6-DIEj7Vg90H21EOLACvtfcHk0li30VdelXmZjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jt7%252FK&md5=4bf01dde9eac151d16e0ebd1fa681685</span></div><a href="/servlet/linkout?suffix=cit7k&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.07.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.07.121%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DBennett%26aufirst%3DC.%2BE.%26aulast%3DMcCracken%26aufirst%3DT.%2BM.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DJosein%26aufirst%3DH.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMcKittrick%26aufirst%3DB.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DIminoheterocycles%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5380%26epage%3D5384%26doi%3D10.1016%2Fj.bmcl.2010.07.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S.</span>; <span class="NLM_string-name">Comer, D. D.</span>; <span class="NLM_string-name">Mao, L.</span>; <span class="NLM_string-name">Balow, G. P.</span>; <span class="NLM_string-name">Pleynet, D.</span></span> <span> </span><span class="NLM_article-title">Aryl compounds and uses thereof in modulating amyloid β</span>. PCT Int. Appl. <span class="NLM_patent">WO 2004110350 A2</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Cheng&author=D.+D.+Comer&author=L.+Mao&author=G.+P.+Balow&author=D.+Pleynet&title=Aryl+compounds+and+uses+thereof+in+modulating+amyloid+%CE%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.%26atitle%3DAryl%2520compounds%2520and%2520uses%2520thereof%2520in%2520modulating%2520amyloid%2520%25CE%25B2%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kounnas, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danks, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyree, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Come, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleynet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digregorio, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velicelebi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauderman, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobley, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisodia, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanzi, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S. L.</span></span> <span> </span><span class="NLM_article-title">Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer’s disease</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">780</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2010.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.neuron.2010.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=20826309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=769-780&author=M.+Z.+Kounnasauthor=A.+M.+Danksauthor=S.+Chengauthor=C.+Tyreeauthor=E.+Ackermanauthor=X.+Zhangauthor=K.+Ahnauthor=P.+Nguyenauthor=D.+Comeauthor=L.+Comerauthor=C.+Yuauthor=D.+Pleynetauthor=P.+J.+Digregorioauthor=G.+Velicelebiauthor=K.+A.+Staudermanauthor=W.+T.+Comerauthor=W.+C.+Mobleyauthor=Y.-M.+Liauthor=S.+S.+Sisodiaauthor=R.+E.+Tanziauthor=S.+L.+Wagner&title=Modulation+of+gamma-secretase+reduces+beta-amyloid+deposition+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuron.2010.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Kounnas, Maria Z.; Danks, Anne M.; Cheng, Soan; Tyree, Curtis; Ackerman, Elizabeth; Zhang, Xulun; Ahn, Kwangwook; Nguyen, Phuong; Comer, Dan; Mao, Long; Yu, Chengzhi; Pleynet, David; Digregorio, Paul J.; Velicelebi, Gonul; Stauderman, Kenneth A.; Comer, William T.; Mobley, William C.; Li, Yue-Ming; Sisodia, Sangram S.; Tanzi, Rudolph E.; Wagner, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">769-780</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized pathol. by the abundance of senile plaques and neurofibrillary tangles in the brain.  We synthesized over 1200 novel γ-secretase modulator (GSM) compds. that reduced Aβ42 levels without inhibiting ε-site cleavage of APP and Notch, the generation of the APP and Notch intracellular domains, resp.  These compds. also reduced Aβ40 levels while concomitantly elevating levels of Aβ38 and Aβ37.  Immobilization of a potent GSM onto an agarose matrix quant. recovered Pen-2 and to a lesser degree PS-1 NTFs from cellular exts.  Moreover, oral administration (once daily) of another potent GSM to Tg 2576 transgenic AD mice displayed dose-responsive lowering of plasma and brain Aβ42; chronic daily administration led to significant redns. in both diffuse and neuritic plaques.  These effects were obsd. in the absence of Notch-related changes (e.g., intestinal proliferation of goblet cells), which are commonly assocd. with repeated exposure to functional γ-secretase inhibitors (GSIs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWuvRc6SXyvbVg90H21EOLACvtfcHk0lhjVwiUh6IQcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamtb%252FI&md5=0963d1dd659c7a9b0e7e876244eeab97</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DKounnas%26aufirst%3DM.%2BZ.%26aulast%3DDanks%26aufirst%3DA.%2BM.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DTyree%26aufirst%3DC.%26aulast%3DAckerman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DCome%26aufirst%3DD.%26aulast%3DComer%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPleynet%26aufirst%3DD.%26aulast%3DDigregorio%26aufirst%3DP.%2BJ.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DStauderman%26aufirst%3DK.%2BA.%26aulast%3DComer%26aufirst%3DW.%2BT.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DY.-M.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DModulation%2520of%2520gamma-secretase%2520reduces%2520beta-amyloid%2520deposition%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D769%26epage%3D780%26doi%3D10.1016%2Fj.neuron.2010.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span>; <span class="NLM_string-name">Kawano, K.</span>; <span class="NLM_string-name">Doi, E.</span>; <span class="NLM_string-name">Kitazawa, N.</span>; <span class="NLM_string-name">Shin, K.</span>; <span class="NLM_string-name">Miyagawa, T.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Ito, K.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Sasaki, T.</span>; <span class="NLM_string-name">Hagiwara, H.</span></span> <span> </span><span class="NLM_article-title">Cinnamide compound</span>. U.S. Patent <span class="NLM_patent">200,60,004,013 A1</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=K.+Shin&author=T.+Miyagawa&author=T.+Kaneko&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=H.+Hagiwara&title=Cinnamide+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DCinnamide%2520compound%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuck, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rege, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logovinsky, V.</span></span> <span> </span><span class="NLM_article-title">P3-415: E2012, a novel gamma-secretase modulator, decreases plasma amyloid-beta (Aβ) levels in humans</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">S574</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2010.05.1958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.jalz.2010.05.1958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=S574&author=C.+Nagyauthor=E.+Schuckauthor=A.+Ishibashiauthor=Y.+Nakataniauthor=B.+Regeauthor=V.+Logovinsky&title=P3-415%3A+E2012%2C+a+novel+gamma-secretase+modulator%2C+decreases+plasma+amyloid-beta+%28A%CE%B2%29+levels+in+humans&doi=10.1016%2Fj.jalz.2010.05.1958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.05.1958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.05.1958%26sid%3Dliteratum%253Aachs%26aulast%3DNagy%26aufirst%3DC.%26aulast%3DSchuck%26aufirst%3DE.%26aulast%3DIshibashi%26aufirst%3DA.%26aulast%3DNakatani%26aufirst%3DY.%26aulast%3DRege%26aufirst%3DB.%26aulast%3DLogovinsky%26aufirst%3DV.%26atitle%3DP3-415%253A%2520E2012%252C%2520a%2520novel%2520gamma-secretase%2520modulator%252C%2520decreases%2520plasma%2520amyloid-beta%2520%2528A%25CE%25B2%2529%2520levels%2520in%2520humans%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2010%26volume%3D6%26spage%3DS574%26doi%3D10.1016%2Fj.jalz.2010.05.1958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span>; <span class="NLM_string-name">Kitazawa, N.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Sato, N.</span>; <span class="NLM_string-name">Kawano, K.</span>; <span class="NLM_string-name">Ito, K.</span>; <span class="NLM_string-name">Doi, E.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Sasaki, T.</span>; <span class="NLM_string-name">Doko, T.</span>; <span class="NLM_string-name">Miyagawa, T.</span>; <span class="NLM_string-name">Hagiwara, H.</span></span> <span> </span><span class="NLM_article-title">Preparation of Phenylvinylheterocyclic Compounds as Amyloid β Production Lowering Agents for Treatment of Amyloid β-Induced Diseases</span>. PCT Int. Appl. <span class="NLM_patent">WO 2007102580 A1</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Kimura&author=N.+Kitazawa&author=T.+Kaneko&author=N.+Sato&author=K.+Kawano&author=K.+Ito&author=E.+Doi&author=M.+Takaishi&author=T.+Sasaki&author=T.+Doko&author=T.+Miyagawa&author=H.+Hagiwara&title=Preparation+of+Phenylvinylheterocyclic+Compounds+as+Amyloid+%CE%B2+Production+Lowering+Agents+for+Treatment+of+Amyloid+%CE%B2-Induced+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Phenylvinylheterocyclic%2520Compounds%2520as%2520Amyloid%2520%25CE%25B2%2520Production%2520Lowering%2520Agents%2520for%2520Treatment%2520of%2520Amyloid%2520%25CE%25B2-Induced%2520Diseases%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhondi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissarnitski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">664</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmcl.2010.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=21195610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=664-669&author=J.+Qinauthor=P.+Dhondiauthor=X.+Huangauthor=M.+Mandalauthor=Z.+Zhaoauthor=D.+Pissarnitskiauthor=W.+Zhouauthor=R.+Aslanianauthor=Z.+Zhuauthor=W.+Greenleeauthor=J.+Claderauthor=L.+Zhangauthor=M.+Cohen-Williamsauthor=N.+Jonesauthor=L.+Hydeauthor=A.+Palani&title=Discovery+of+fused+5%2C6-bicyclic+heterocycles+as+%CE%B3-secretase+modulators&doi=10.1016%2Fj.bmcl.2010.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators</span></div><div class="casAuthors">Qin, Jun; Dhondi, Pawan; Huang, Xianhai; Mandal, Mihirbaran; Zhao, Zhiqiang; Pissarnitski, Dmitri; Zhou, Wei; Aslanian, Robert; Zhu, Zhaoning; Greenlee, William; Clader, John; Zhang, Lili; Cohen-Williams, Mary; Jones, Nicholas; Hyde, Lynn; Palani, Anandan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">664-669</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery of four series of fused 5,6-bicyclic heterocycles, e.g., I [R = 4-FC6H4CHMe, 4-(MeO)C6H4CH2, n-pentyl, etc.], as γ-secretase modulators was reported.  The synthesis and SAR of these series were discussed.  These compds. represented a new class of γ-secretase modulators that demonstrated moderate to good in vitro potency in inhibiting Aβ42 prodn.  Specifically, compd. II demonstrated good in vitro and moderate in vivo efficacy as a γ-secretase modulator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnTq6NEaz9XbVg90H21EOLACvtfcHk0lhEaU0mxY8YoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqsw%253D%253D&md5=a85b7d068d89d39d18ce06d6ad748806</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520fused%25205%252C6-bicyclic%2520heterocycles%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D664%26epage%3D669%26doi%3D10.1016%2Fj.bmcl.2010.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhondi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent pyrazolopyridine series of γ-secretase modulators</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1021/ml2000438</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml2000438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=471-476&author=J.+Qinauthor=W.+Zhouauthor=X.+Huangauthor=P.+Dhondiauthor=A.+Palaniauthor=R.+Aslanianauthor=Z.+Zhuauthor=W.+Greenleeauthor=M.+Cohen-Williamsauthor=N.+Jonesauthor=L.+Hydeauthor=L.+Zhang&title=Discovery+of+a+potent+pyrazolopyridine+series+of+%CE%B3-secretase+modulators&doi=10.1021%2Fml2000438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent pyrazolopyridine series of γ-secretase modulators</span></div><div class="casAuthors">Qin, Jun; Zhou, Wei; Huang, Xianhai; Dhondi, Pawan; Palani, Anandan; Aslanian, Robert; Zhu, Zhaoning; Greenlee, William; Cohen-Williams, Mary; Jones, Nicholas; Hyde, Lynn; Zhang, Lili</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">471-476</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationship of a novel series of pyrazolopyridines are reported.  These compds. represent a new class of γ-secretase modulators that demonstrate good in vitro potency in inhibiting Aβ42 prodn.  Examples with statistically significant in vivo efficacy in reducing the prodn. of rat cerebrospinal fluid Aβ42 were also identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2w7CtUkvQh7Vg90H21EOLACvtfcHk0lhEaU0mxY8YoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOlsr0%253D&md5=6c36b585797281fe037510750b111d57</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fml2000438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2000438%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DDhondi%26aufirst%3DP.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DN.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520pyrazolopyridine%2520series%2520of%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D471%26epage%3D476%26doi%3D10.1021%2Fml2000438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aslanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen-Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, A.</span></span> <span> </span><span class="NLM_article-title">The discovery of pyridone and pyridazone heterocycles as γ-secretase modulators</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">187</span>, <span class="refDoi"> DOI: 10.1021/ml1000799</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000799" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlyjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=184-187&author=X.+Huangauthor=R.+Aslanianauthor=W.+Zhouauthor=X.+Zhuauthor=J.+Qinauthor=W.+Greenleeauthor=Z.+Zhuauthor=L.+Zhangauthor=L.+Hydeauthor=I.+Chuauthor=M.+Cohen-Williamsauthor=A.+Palani&title=The+discovery+of+pyridone+and+pyridazone+heterocycles+as+%CE%B3-secretase+modulators&doi=10.1021%2Fml1000799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase Modulators</span></div><div class="casAuthors">Huang, Xianhai; Aslanian, Robert; Zhou, Wei; Zhu, Xiaohong; Qin, Jun; Greenlee, William; Zhu, Zhaoning; Zhang, Lili; Hyde, Lynn; Chu, Inhou; Cohen-Williams, Mary; Palani, Anandan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">184-187</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel pyridazone and pyridone compds., e.g., I, as γ-secretase modulators were discovered.  Starting from the initial lead, structure-activity relationship studies were carried out in which an internal hydrogen bond was introduced to conformationally fix the side chain, and compds. with improved in vitro Aβ42 inhibition activity and good Aβtotal/Aβ42 selectivity were quickly discovered.  Compd. I displayed very good in vitro activity and excellent selectivity with good in vivo efficacy in both CRND8 mouse and nontransgenic rat models.  This compd. displayed a good overall profile in terms of rat pharmacokinetics and ancillary profile.  No abnormal behavior and side effects were obsd. in all of the studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqki-gEswVL97Vg90H21EOLACvtfcHk0liAJAJwIrDWew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlyjtbo%253D&md5=2e738a3fdbcddce0c87e7e25130e9f86</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1021%2Fml1000799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000799%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DAslanian%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DChu%26aufirst%3DI.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DPalani%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520pyridone%2520and%2520pyridazone%2520heterocycles%2520as%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D184%26epage%3D187%26doi%3D10.1021%2Fml1000799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, T.</span>; <span class="NLM_string-name">Kawano, K.</span>; <span class="NLM_string-name">Doi, E.</span>; <span class="NLM_string-name">Kitazawa, N.</span>; <span class="NLM_string-name">Shin, K.</span>; <span class="NLM_string-name">Miyagawa, T.</span>; <span class="NLM_string-name">Kaneko, T.</span>; <span class="NLM_string-name">Ito, K.</span>; <span class="NLM_string-name">Takaishi, M.</span>; <span class="NLM_string-name">Sasaki, T.</span>; <span class="NLM_string-name">Hagiwara, H.</span></span> <span> </span><span class="NLM_article-title">Preparation of Cinnamide, 3-Benzylidenepiperidin-2-one, Phenylpropynamide Compounds as Amyloid β Production Inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2005115990 A1</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=K.+Shin&author=T.+Miyagawa&author=T.+Kaneko&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=H.+Hagiwara&title=Preparation+of+Cinnamide%2C+3-Benzylidenepiperidin-2-one%2C+Phenylpropynamide+Compounds+as+Amyloid+%CE%B2+Production+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Cinnamide%252C%25203-Benzylidenepiperidin-2-one%252C%2520Phenylpropynamide%2520Compounds%2520as%2520Amyloid%2520%25CE%25B2%2520Production%2520Inhibitors%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span> <span> </span><span class="NLM_article-title">Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2499</span>– <span class="NLM_lpage">2510</span>, <span class="refDoi"> DOI: 10.1021/jm030563w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030563w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2499-2510&author=E.+Perolaauthor=P.+S.+Charifson&title=Conformational+analysis+of+drug-like+molecules+bound+to+proteins%3A+an+extensive+study+of+ligand+reorganization+upon+binding&doi=10.1021%2Fjm030563w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Analysis of Drug-Like Molecules Bound to Proteins: An Extensive Study of Ligand Reorganization upon Binding</span></div><div class="casAuthors">Perola, Emanuele; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2499-2510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes a large-scale study on the nature and the energetics of the conformational changes drug-like mols. experience upon binding.  Ligand strain energies and conformational reorganization were analyzed with different computational methods on 150 crystal structures of pharmaceutically relevant protein-ligand complexes.  The common knowledge that ligands rarely bind in their lowest calcd. energy conformation was confirmed.  Addnl., the authors found that over 60% of the ligands do not bind in a local min. conformation.  While approx. 60% of the ligands were calcd. to bind with strain energies lower than 5 kcal/mol, strain energies over 9 kcal/mol were calcd. in at least 10% of the cases regardless of the method used.  A clear correlation was found between acceptable strain energy and ligand flexibility, while there was no correlation between strain energy and binding affinity, thus indicating that expensive conformational rearrangements can be tolerated in some cases without overly penalizing the tightness of binding.  On the basis of the trends obsd., thresholds for the acceptable strain energies of bioactive conformations were defined with consideration of the impact of ligand flexibility.  An anal. of the degree of folding of the bound ligands confirmed the general tendency of small mols. to bind in an extended conformation.  The results suggest that the unfolding of hydrophobic ligands during binding, which exposes hydrophobic surfaces to contact with protein residues, could be one of the factors accounting for high reorganization energies.  Finally, different methods for conformational anal. were evaluated, and guidelines were defined to maximize the prevalence of bioactive conformations in computationally generated ensembles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMrN0dFKglcbVg90H21EOLACvtfcHk0liAJAJwIrDWew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVans78%253D&md5=8f54a8285ef1ffc5e1a19f748f4674bf</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1021%2Fjm030563w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030563w%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DConformational%2520analysis%2520of%2520drug-like%2520molecules%2520bound%2520to%2520proteins%253A%2520an%2520extensive%2520study%2520of%2520ligand%2520reorganization%2520upon%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2499%26epage%3D2510%26doi%3D10.1021%2Fjm030563w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span> <span> </span><span class="NLM_article-title">Toward accurate relative energy predictions of the bioactive conformation of drugs</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">601</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1002/jcc.21087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1002%2Fjcc.21087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=18711721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Knsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=601-610&author=K.+T.+Butlerauthor=F.+J.+Luqueauthor=X.+Barril&title=Toward+accurate+relative+energy+predictions+of+the+bioactive+conformation+of+drugs&doi=10.1002%2Fjcc.21087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Toward accurate relative energy predictions of the bioactive conformation of drugs</span></div><div class="casAuthors">Butler, Keith T.; Luque, F. Javier; Barril, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-610</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Quantifying the relative energy of a ligand in its target-bound state (i.e. the bioactive conformation) is essential to understand the process of mol. recognition, to optimize the potency of bioactive mols. and to increase the accuracy of structure-based drug design methods.  This is, nevertheless, seriously hampered by 2 inter-related issues, namely the difficulty in carrying out an exhaustive sampling of the conformational space and the shortcomings of the energy functions, usually based on parametric methods of limited accuracy.  Matters are further complicated by the exptl. uncertainty on the at. coordinates, which precludes a univocal definition of the bioactive conformation.  In this article the authors investigate the relative energy of bioactive conformations introducing 2 major improvements over previous studies: the use sophisticated QM-based methods to take into account both the internal energy of the ligand and the solvation effect, and the application of phys. meaningful constraints to refine the bioactive conformation.  On a set of 99 drug-like mols., the authors find that, contrary to previous observations, 2 thirds of bioactive conformations lie within 0.5 kcal mol-1 of a local min., with penalties above 2.0 kcal mol-1 being generally attributable to structural detn. inaccuracies.  The methodol. herein described opens the door to obtain quant. ests. of the energy of bioactive conformations and can be used both as an aid in refining crystallog. structures and as a tool in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoukwCddY9zl7Vg90H21EOLACvtfcHk0limlg6mXcr-zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Knsrw%253D&md5=31ddffa90fb7f61e96b3b97ddeaac367</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21087%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DBarril%26aufirst%3DX.%26atitle%3DToward%2520accurate%2520relative%2520energy%2520predictions%2520of%2520the%2520bioactive%2520conformation%2520of%2520drugs%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D601%26epage%3D610%26doi%3D10.1002%2Fjcc.21087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Boström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norrby, P.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liljefors, T.</span></span> <span> </span><span class="NLM_article-title">Conformational energy penalties of protein-bound ligands</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">383</span>, <span class="refDoi"> DOI: 10.1023/a:1008007507641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1023%2Fa%3A1008007507641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=9777496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADyaK1cXms1elsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=383&author=J.+Bostr%C3%B6mauthor=P.-O.+Norrbyauthor=T.+Liljefors&title=Conformational+energy+penalties+of+protein-bound+ligands&doi=10.1023%2Fa%3A1008007507641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational energy penalties of protein-bound ligands</span></div><div class="casAuthors">Bostrom, Jonas; Norrby, Per-Ola; Liljefors, Tommy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">383-396</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">The conformational energies required for ligands to adopt their bioactive conformations were calcd. for 33 ligand-protein complexes including 28 different ligands.  In order to monitor the force field dependence of the results, two force fields, MM3* and AMBER*, were employed for the calcns.  Conformational analyses were performed in vacuo and in aq. soln. by using the generalized Born/solvent accessible surface (GB/SA) solvation model.  The protein-bound conformations were relaxed by using flat-bottomed Cartesian constraints.  For about 70% of the ligand-protein complexes studied, the conformational energies of the bioactive conformations were calcd. to be ≤3 kcal/mol.  It is demonstrated that the aq. conformational ensemble for the unbound ligand must be used as a ref. state in this type of calcns.  The calcns. for the ligand-protein complexes with conformational energy penalties of the ligand calcd. to be larger than 3 kcal/mol suffer from uncertainties in the interpretation of the exptl. data or limitations of the computational methods.  For example, in the case of long-chain flexible ligands (e.g. fatty acids), it is demonstrated that several conformations may be found which are very similar to the conformation detd. by x-ray crystallog. and which display significantly lower conformational energy penalties for binding than obtained by using the exptl. conformation.  For strongly polar mols., e.g. amino acids, the results indicate that further developments of the force fields and of the dielec. continuum solvation model are required for reliable calcns. on the conformational properties of this type of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOYXSRdHvDEbVg90H21EOLACvtfcHk0limlg6mXcr-zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXms1elsr4%253D&md5=d3108c97e8b080d5567b65653f9eff0d</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1023%2Fa%3A1008007507641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252Fa%253A1008007507641%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DNorrby%26aufirst%3DP.-O.%26aulast%3DLiljefors%26aufirst%3DT.%26atitle%3DConformational%2520energy%2520penalties%2520of%2520protein-bound%2520ligands%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D1998%26volume%3D12%26spage%3D383%26doi%3D10.1023%2Fa%3A1008007507641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span> The rate of Michael
addition of GSH (kGSH (M<sup>–1</sup> s<sup>–1</sup>)) to cyclized β, β-disubstituted enone (cf. 3-methyl
cyclopentenone) is 11 time slower relative to α, β-disubstituted
acyclic enone (cf. (<i>E</i>)-3-methylpent-3-en-2-one).<span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harki, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummond, K. M.</span></span> <span> </span><span class="NLM_article-title">Covalent modifiers: A chemical perspective on the reactivity of α,β-unsaturated carbonyls with thiols via hetero-michael addition reactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2rtbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=839-885&author=P.+A.+Jacksonauthor=J.+C.+Widenauthor=D.+A.+Harkiauthor=K.+M.+Brummond&title=Covalent+modifiers%3A+A+chemical+perspective+on+the+reactivity+of+%CE%B1%2C%CE%B2-unsaturated+carbonyls+with+thiols+via+hetero-michael+addition+reactions&doi=10.1021%2Facs.jmedchem.6b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions</span></div><div class="casAuthors">Jackson, Paul A.; Widen, John C.; Harki, Daniel A.; Brummond, Kay M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">839-885</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Although Michael acceptors display a potent and broad spectrum of bioactivity, they have largely been ignored in drug discovery because of their presumed indiscriminate reactivity.  As such, a dearth of information exists relevant to the thiol reactivity of natural products and their analogs possessing this moiety.  In the midst of recently approved acrylamide-contg. drugs, it is clear that a good understanding of the hetero-Michael addn. reaction and the relative reactivities of biol. thiols with Michael acceptors under physiol. conditions is needed for the design and use of these compds. as biol. tools and potential therapeutics.  This Perspective provides information that will contribute to this understanding, such as kinetics of thiol addn. reactions, bioactivities, as well as steric and electronic factors that influence the electrophilicity and reversibility of Michael acceptors.  This Perspective is focused on α,β-unsatd. carbonyls given their preponderance in bioactive natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn4jDqxoos17Vg90H21EOLACvtfcHk0lg6-ZWrnJ_ciQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2rtbnM&md5=36d3be5bf688c4e4a8cf4bcf42073009</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00788%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DP.%2BA.%26aulast%3DWiden%26aufirst%3DJ.%2BC.%26aulast%3DHarki%26aufirst%3DD.%2BA.%26aulast%3DBrummond%26aufirst%3DK.%2BM.%26atitle%3DCovalent%2520modifiers%253A%2520A%2520chemical%2520perspective%2520on%2520the%2520reactivity%2520of%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520carbonyls%2520with%2520thiols%2520via%2520hetero-michael%2520addition%2520reactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D839%26epage%3D885%26doi%3D10.1021%2Facs.jmedchem.6b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span>; <span class="NLM_string-name">Claremon, D. A.</span>; <span class="NLM_string-name">Connolly, T. M.</span>; <span class="NLM_string-name">Dean, D. C.</span>; <span class="NLM_string-name">Karczewski, J.</span>; <span class="NLM_string-name">Koblan, K. S.</span>; <span class="NLM_string-name">Kostura, M. J.</span>; <span class="NLM_string-name">Liverton, N. J.</span>; <span class="NLM_string-name">Melillo, D. G.</span></span> <span> </span><span class="NLM_article-title">Radioligand and Binding Assay</span>. PCT Int. Appl. <span class="NLM_patent">WO 2002005860 A1</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+W.+Butcher&author=D.+A.+Claremon&author=T.+M.+Connolly&author=D.+C.+Dean&author=J.+Karczewski&author=K.+S.+Koblan&author=M.+J.+Kostura&author=N.+J.+Liverton&author=D.+G.+Melillo&title=Radioligand+and+Binding+Assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26atitle%3DRadioligand%2520and%2520Binding%2520Assay%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">The free drug concentrations in the brain or the drug concentrations in the CSF were not measured for these compounds. In the absence of these measured concentrations, free drug levels were aproximated using the measured plasma free fraction.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Notch recognition by human γ-secretase</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>565</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0813-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1038%2Fs41586-018-0813-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=30598546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlslKgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=565&publication_year=2019&pages=192-197&author=G.+Yangauthor=R.+Zhouauthor=Q.+Zhouauthor=X.+Guoauthor=C.+Yanauthor=M.+Keauthor=J.+Leiauthor=Y.+Shi&title=Structural+basis+of+Notch+recognition+by+human+%CE%B3-secretase&doi=10.1038%2Fs41586-018-0813-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of Notch recognition by human γ-secretase</span></div><div class="casAuthors">Yang, Guanghui; Zhou, Rui; Zhou, Qiang; Guo, Xuefei; Yan, Chuangye; Ke, Meng; Lei, Jianlin; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">565</span>
        (<span class="NLM_cas:issue">7738</span>),
    <span class="NLM_cas:pages">192-197</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Aberrant cleavage of Notch by γ-secretase leads to several types of cancer, but how γ-secretase recognizes its substrate remains unknown.  Here we report the cryo-electron microscopy structure of human γ-secretase in complex with a Notch fragment at a resoln. of 2.7 Å.  The transmembrane helix of Notch is surrounded by three transmembrane domains of presenilin 1 (PS1), and the carboxyl-terminal β-strand of the Notch fragment forms a β-sheet with two substrate-induced β-strands of PS1 on the intracellular side.  Formation of the hybrid β-sheet is essential for substrate cleavage, which occurs at the carboxyl-terminal end of the Notch transmembrane helix.  PS1 undergoes pronounced conformational rearrangement upon substrate binding.  These features reveal the structural basis of Notch recognition and have implications for the recruitment of the amyloid precursor protein by γ-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfCV04n34QyLVg90H21EOLACvtfcHk0lg6-ZWrnJ_ciQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlslKgtLo%253D&md5=135fbb5aedbd1a0e28a8837b604d5861</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0813-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0813-8%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DKe%26aufirst%3DM.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520Notch%2520recognition%2520by%2520human%2520%25CE%25B3-secretase%26jtitle%3DNature%26date%3D2019%26volume%3D565%26spage%3D192%26epage%3D197%26doi%3D10.1038%2Fs41586-018-0813-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Recognition of the amyloid precursor protein by human γ-secretase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">aaw0930</span>, <span class="refDoi"> DOI: 10.1126/science.aaw0930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1126%2Fscience.aaw0930" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2019&pages=aaw0930&author=R.+Zhouauthor=G.+Yangauthor=X.+Guoauthor=Q.+Zhouauthor=J.+Leiauthor=Y.+Shi&title=Recognition+of+the+amyloid+precursor+protein+by+human+%CE%B3-secretase&doi=10.1126%2Fscience.aaw0930"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaw0930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaw0930%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DLei%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DRecognition%2520of%2520the%2520amyloid%2520precursor%2520protein%2520by%2520human%2520%25CE%25B3-secretase%26jtitle%3DScience%26date%3D2019%26volume%3D363%26spage%3Daaw0930%26doi%3D10.1126%2Fscience.aaw0930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imahori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyauchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahata, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of both enantiomers of hydroxypipecolic acid derivatives equivalent to 5-azapyranuronic acids and evaluation of their inhibitory activities against glycosidases</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">8273</span>– <span class="NLM_lpage">8286</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=10.1016%2Fj.bmc.2008.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=18703340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVykur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=8273-8286&author=Y.+Yoshimuraauthor=C.+Oharaauthor=T.+Imahoriauthor=Y.+Saitoauthor=A.+Katoauthor=S.+Miyauchiauthor=I.+Adachiauthor=H.+Takahata&title=Synthesis+of+both+enantiomers+of+hydroxypipecolic+acid+derivatives+equivalent+to+5-azapyranuronic+acids+and+evaluation+of+their+inhibitory+activities+against+glycosidases&doi=10.1016%2Fj.bmc.2008.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of both enantiomers of hydroxypipecolic acid derivatives equivalent to 5-azapyranuronic acids and evaluation of their inhibitory activities against glycosidases</span></div><div class="casAuthors">Yoshimura, Yuichi; Ohara, Chiaki; Imahori, Tatsushi; Saito, Yukako; Kato, Atsushi; Miyauchi, Saori; Adachi, Isao; Takahata, Hiroki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8273-8286</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We have synthesized 3-hydroxy- and 3,4,5-trihydroxypipecolic acid derivs. corresponding to 5-aza derivs. of uronic acids and evaluated their inhibitory activities against various glycosidases including β-glucuronidase.  Compds. 4 and 5 were chosen as common intermediates for the synthesis of 3,4,5-trihydroxypipecolic acids and 3-hydroxypipecolic acids as well as for 3-hydroxybaikiain, a unique natural product isolated from a toxic mushroom.  Cross aldol reaction of N-Boc-allylglycine deriv. with acrolein followed by the ring-closing metathesis gave 4 and 5 as a mixt. of diastereomers which could be sepd. by silica gel column chromatog.  By employing lipase-catalyzed kinetic resoln., the synthesis of both - and -isomers of 3,4,5-trihydroxy- and 3-hydroxypipecolic acids was achieved.  None of the compds. tested showed inhibitory activity against α- and β-glucosidases.  On the other hand, -23 and -29 were found to have potent inhibitory activity against β-glucuronidase.  In addn., it is interesting that some uronic-type azasugar derivs. showed moderate inhibitory activities against β-N-acetylglucosaminidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUUyMAMfM63rVg90H21EOLACvtfcHk0liKf3Z00NlJew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVykur7O&md5=10a639a391f92ea9e0d4a793345dc47c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimura%26aufirst%3DY.%26aulast%3DOhara%26aufirst%3DC.%26aulast%3DImahori%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DMiyauchi%26aufirst%3DS.%26aulast%3DAdachi%26aufirst%3DI.%26aulast%3DTakahata%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520both%2520enantiomers%2520of%2520hydroxypipecolic%2520acid%2520derivatives%2520equivalent%2520to%25205-azapyranuronic%2520acids%2520and%2520evaluation%2520of%2520their%2520inhibitory%2520activities%2520against%2520glycosidases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D8273%26epage%3D8286%26doi%3D10.1016%2Fj.bmc.2008.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i39"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00446">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_46234"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00446?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00446</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Protocol for cell-based γ-secretase assay; overlay of <b>4</b>, <b>7</b>, <b>10aa</b>, and <b>10ee</b>; synthesis of compound <b>15</b>; chiral synthesis of compound <b>20</b>; and HPLC traces for compounds <b>11</b>–<b>15</b>, <b>20</b>, <b>21</b>, and <b>27</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00446/suppl_file/jm0c00446_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00446/suppl_file/jm0c00446_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00446/suppl_file/jm0c00446_si_001.pdf">jm0c00446_si_001.pdf (1.14 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00446/suppl_file/jm0c00446_si_002.csv">jm0c00446_si_002.csv (0.78 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00446&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-15%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00446" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00446" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799178d68ca3d2a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
